{"data_date":"2026-11-08","library_size":29380,"matched_against":"each record's title and abstract (summary field), case-insensitive","n":647,"page":"https://alzhub.org/answers/donepezil-and-memantine","query":"title or abstract mentions \"donepezil\"/\"Aricept\", \"memantine\"/\"Namenda\", \"rivastigmine\"/\"Exelon\", \"galantamine\" or \"(acetyl)cholinesterase inhibitor\"","studies":[{"alzhub_score":61,"alzhub_url":"https://alzhub.org/study/cholinesterase-inhibitors-and-memantine-are-associated-with-a-reduced-38812028","doi":"10.1186/s13195-024-01481-0","journal":"Alzheimer's Research & Therapy","n_participants":25358,"pmid":"38812028","source_url":"https://pubmed.ncbi.nlm.nih.gov/38812028/","study_design":"cohort","title":"Cholinesterase inhibitors and memantine are associated with a reduced mortality in nursing home residents with dementia: a longitudinal observational study","title_match":true,"year":2024},{"alzhub_score":64,"alzhub_url":"https://alzhub.org/study/long-term-effects-of-cholinesterase-inhibitors-and-memantine-on-39177108","doi":"10.1002/alz.14118","journal":"Alzheimer's & Dementia","n_participants":1095,"pmid":"39177108","source_url":"https://pubmed.ncbi.nlm.nih.gov/39177108/","study_design":"cohort","title":"Long-term effects of cholinesterase inhibitors and memantine on cognitive decline, cardiovascular events, and mortality in dementia with Lewy bodies: An up to 10-year follow-up study","title_match":true,"year":2024},{"alzhub_score":49,"alzhub_url":"https://alzhub.org/study/cost-effectiveness-of-traditional-and-novel-neurotherapeutic-agents-41837605","doi":"10.1177/13872877261430376","journal":"Journal of Alzheimer's Disease","n_participants":null,"pmid":"41837605","source_url":"https://pubmed.ncbi.nlm.nih.gov/41837605/","study_design":"systematic-review","title":"Cost-effectiveness of traditional and novel neurotherapeutic agents for Alzheimer's disease: A systematic review","title_match":false,"year":2026},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/modulation-of-human-neural-stem-cell-differentiation-in-alzheimer-17640880","doi":"10.1073/pnas.0705346104","journal":"Proceedings of the National Academy of Sciences of the United States of America","n_participants":null,"pmid":"17640880","source_url":"https://pubmed.ncbi.nlm.nih.gov/17640880/","study_design":null,"title":"Modulation of human neural stem cell differentiation in Alzheimer (APP23) transgenic mice by phenserine","title_match":false,"year":2007},{"alzhub_score":39,"alzhub_url":"https://alzhub.org/study/hippocampal-degeneration-and-behavioral-impairment-during-alzheimer-33420680","doi":"10.1007/s12031-020-01747-w","journal":"Journal of molecular neuroscience : MN","n_participants":null,"pmid":"33420680","source_url":"https://pubmed.ncbi.nlm.nih.gov/33420680/","study_design":null,"title":"Hippocampal Degeneration and Behavioral Impairment During Alzheimer-Like Pathogenesis Involves Glutamate Excitotoxicity","title_match":false,"year":2021},{"alzhub_score":32,"alzhub_url":"https://alzhub.org/study/clinical-utility-of-amyloid-imaging-in-a-complex-case-of-corticobasal-26225355","doi":"10.4172/2329-6895.1000194","journal":"Journal of neurological disorders","n_participants":null,"pmid":"26225355","source_url":"https://pubmed.ncbi.nlm.nih.gov/26225355/","study_design":null,"title":"Clinical Utility of Amyloid Imaging in a Complex Case of Corticobasal Syndrome Presenting with Psychiatric Symptoms","title_match":false,"year":2014},{"alzhub_score":51,"alzhub_url":"https://alzhub.org/study/apolipoprotein-e4-allele-as-a-predictor-of-cholinergic-deficits-and-8618881","doi":"10.1073/pnas.92.26.12260","journal":"Proceedings of the National Academy of Sciences of the United States of America","n_participants":40,"pmid":"8618881","source_url":"https://pubmed.ncbi.nlm.nih.gov/8618881/","study_design":null,"title":"Apolipoprotein E4 allele as a predictor of cholinergic deficits and treatment outcome in Alzheimer disease","title_match":false,"year":1995},{"alzhub_score":58,"alzhub_url":"https://alzhub.org/study/does-donepezil-treatment-slow-the-progression-of-hippocampal-atrophy-15800138","doi":"10.1176/appi.ajp.162.4.676","journal":"The American journal of psychiatry","n_participants":54,"pmid":"15800138","source_url":"https://pubmed.ncbi.nlm.nih.gov/15800138/","study_design":"cohort study","title":"Does donepezil treatment slow the progression of hippocampal atrophy in patients with Alzheimer's disease?","title_match":true,"year":2005},{"alzhub_score":69,"alzhub_url":"https://alzhub.org/study/clinical-predictors-of-progression-to-alzheimer-disease-in-amnestic-17287448","doi":"10.1212/01.wnl.0000258542.58725.4c","journal":"Neurology","n_participants":539,"pmid":"17287448","source_url":"https://pubmed.ncbi.nlm.nih.gov/17287448/","study_design":null,"title":"Clinical predictors of progression to Alzheimer disease in amnestic mild cognitive impairment","title_match":false,"year":2007},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/csf-biomarkers-predict-a-more-malignant-outcome-in-alzheimer-disease-20458070","doi":"10.1212/wnl.0b013e3181dd4dd8","journal":"Neurology","n_participants":151,"pmid":"20458070","source_url":"https://pubmed.ncbi.nlm.nih.gov/20458070/","study_design":null,"title":"CSF biomarkers predict a more malignant outcome in Alzheimer disease","title_match":false,"year":2010},{"alzhub_score":73,"alzhub_url":"https://alzhub.org/study/volumetric-mri-vs-clinical-predictors-of-alzheimer-disease-in-mild-18195264","doi":"10.1212/01.wnl.0000287091.57376.65","journal":"Neurology","n_participants":129,"pmid":"18195264","source_url":"https://pubmed.ncbi.nlm.nih.gov/18195264/","study_design":null,"title":"Volumetric MRI vs clinical predictors of Alzheimer disease in mild cognitive impairment","title_match":false,"year":2008},{"alzhub_score":61,"alzhub_url":"https://alzhub.org/study/effect-of-a-cyp2d6-polymorphism-on-the-efficacy-of-donepezil-in-19738170","doi":"10.1212/wnl.0b013e3181b6bbe3","journal":"Neurology","n_participants":115,"pmid":"19738170","source_url":"https://pubmed.ncbi.nlm.nih.gov/19738170/","study_design":"cohort study","title":"Effect of a CYP2D6 polymorphism on the efficacy of donepezil in patients with Alzheimer disease","title_match":true,"year":2009},{"alzhub_score":81,"alzhub_url":"https://alzhub.org/study/memantine-treatment-in-patients-with-moderate-to-severe-alzheimer-14734594","doi":"10.1001/jama.291.3.317","journal":"JAMA","n_participants":203,"pmid":"14734594","source_url":"https://pubmed.ncbi.nlm.nih.gov/14734594/","study_design":null,"title":"Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial","title_match":true,"year":2004},{"alzhub_score":61,"alzhub_url":"https://alzhub.org/study/effects-of-rofecoxib-or-naproxen-vs-placebo-on-alzheimer-disease-12783912","doi":"10.1001/jama.289.21.2819","journal":"JAMA","n_participants":474,"pmid":"12783912","source_url":"https://pubmed.ncbi.nlm.nih.gov/12783912/","study_design":null,"title":"Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: a randomized controlled trial","title_match":false,"year":2003},{"alzhub_score":72,"alzhub_url":"https://alzhub.org/study/donepezil-improves-cognition-and-global-function-in-alzheimer-disease-9588436","doi":"10.1001/archinte.158.9.1021","journal":"Archives of internal medicine","n_participants":468,"pmid":"9588436","source_url":"https://pubmed.ncbi.nlm.nih.gov/9588436/","study_design":"clinical trial","title":"Donepezil improves cognition and global function in Alzheimer disease: a 15-week, double-blind, placebo-controlled study. Donepezil Study Group","title_match":true,"year":1998},{"alzhub_score":80,"alzhub_url":"https://alzhub.org/study/effect-of-tarenflurbil-on-cognitive-decline-and-activities-of-daily-20009055","doi":"10.1001/jama.2009.1866","journal":"JAMA","n_participants":1684,"pmid":"20009055","source_url":"https://pubmed.ncbi.nlm.nih.gov/20009055/","study_design":"clinical trial","title":"Effect of tarenflurbil on cognitive decline and activities of daily living in patients with mild Alzheimer disease: a randomized controlled trial","title_match":false,"year":2009},{"alzhub_score":79,"alzhub_url":"https://alzhub.org/study/effect-of-vitamin-e-and-memantine-on-functional-decline-in-alzheimer-24381967","doi":"10.1001/jama.2013.282834","journal":"JAMA","n_participants":152,"pmid":"24381967","source_url":"https://pubmed.ncbi.nlm.nih.gov/24381967/","study_design":null,"title":"Effect of vitamin E and memantine on functional decline in Alzheimer disease: the TEAM-AD VA cooperative randomized trial","title_match":true,"year":2014},{"alzhub_score":58,"alzhub_url":"https://alzhub.org/study/screening-for-dementia-in-primary-care-a-summary-of-the-evidence-for-12779304","doi":"10.7326/0003-4819-138-11-200306030-00015","journal":"Annals of internal medicine","n_participants":null,"pmid":"12779304","source_url":"https://pubmed.ncbi.nlm.nih.gov/12779304/","study_design":null,"title":"Screening for dementia in primary care: a summary of the evidence for the U.S. Preventive Services Task Force","title_match":false,"year":2003},{"alzhub_score":76,"alzhub_url":"https://alzhub.org/study/randomized-controlled-trial-of-atorvastatin-in-mild-to-moderate-20200346","doi":"10.1212/wnl.0b013e3181d6476a","journal":"Neurology","n_participants":640,"pmid":"20200346","source_url":"https://pubmed.ncbi.nlm.nih.gov/20200346/","study_design":"randomized controlled trial","title":"Randomized controlled trial of atorvastatin in mild to moderate Alzheimer disease: LEADe","title_match":false,"year":2010},{"alzhub_score":74,"alzhub_url":"https://alzhub.org/study/efficacy-of-donepezil-in-mild-cognitive-impairment-a-randomized-15326237","doi":"10.1212/01.wnl.0000134664.80320.92","journal":"Neurology","n_participants":133,"pmid":"15326237","source_url":"https://pubmed.ncbi.nlm.nih.gov/15326237/","study_design":null,"title":"Efficacy of donepezil in mild cognitive impairment: a randomized placebo-controlled trial","title_match":true,"year":2004},{"alzhub_score":73,"alzhub_url":"https://alzhub.org/study/memantine-treatment-in-mild-to-moderate-alzheimer-disease-a-24-week-16861375","doi":"10.1097/01.jgp.0000224350.82719.83","journal":"The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry","n_participants":201,"pmid":"16861375","source_url":"https://pubmed.ncbi.nlm.nih.gov/16861375/","study_design":null,"title":"Memantine treatment in mild to moderate Alzheimer disease: a 24-week randomized, controlled trial","title_match":true,"year":2006},{"alzhub_score":74,"alzhub_url":"https://alzhub.org/study/tramiprosate-in-mild-to-moderate-alzheimer-s-disease-a-randomized-22291741","doi":"10.5114/aoms.2011.20612","journal":"Archives of medical science : AMS","n_participants":1052,"pmid":"22291741","source_url":"https://pubmed.ncbi.nlm.nih.gov/22291741/","study_design":"randomized controlled trial","title":"Tramiprosate in mild-to-moderate Alzheimer's disease - a randomized, double-blind, placebo-controlled, multi-centre study (the Alphase Study)","title_match":false,"year":2011},{"alzhub_score":62,"alzhub_url":"https://alzhub.org/study/cholinesterase-inhibitors-in-mild-cognitive-impairment-a-systematic-18044984","doi":"10.1371/journal.pmed.0040338","journal":"PLoS medicine","n_participants":null,"pmid":"18044984","source_url":"https://pubmed.ncbi.nlm.nih.gov/18044984/","study_design":null,"title":"Cholinesterase inhibitors in mild cognitive impairment: a systematic review of randomised trials","title_match":true,"year":2007},{"alzhub_score":68,"alzhub_url":"https://alzhub.org/study/donepezil-treatment-of-patients-with-mci-a-48-week-randomized-placebo-19176895","doi":"10.1212/01.wnl.0000344650.95823.03","journal":"Neurology","n_participants":null,"pmid":"19176895","source_url":"https://pubmed.ncbi.nlm.nih.gov/19176895/","study_design":null,"title":"Donepezil treatment of patients with MCI: a 48-week randomized, placebo-controlled trial","title_match":true,"year":2009},{"alzhub_score":70,"alzhub_url":"https://alzhub.org/study/a-randomized-pilot-clinical-trial-of-the-safety-of-pioglitazone-in-20837824","doi":"10.1001/archneurol.2010.229","journal":"Archives of neurology","n_participants":29,"pmid":"20837824","source_url":"https://pubmed.ncbi.nlm.nih.gov/20837824/","study_design":"randomized controlled trial","title":"A randomized pilot clinical trial of the safety of pioglitazone in treatment of patients with Alzheimer disease","title_match":false,"year":2011},{"alzhub_score":67,"alzhub_url":"https://alzhub.org/study/lack-of-evidence-for-the-efficacy-of-memantine-in-mild-alzheimer-21482915","doi":"10.1001/archneurol.2011.69","journal":"Archives of neurology","n_participants":431,"pmid":"21482915","source_url":"https://pubmed.ncbi.nlm.nih.gov/21482915/","study_design":"meta-analysis","title":"Lack of evidence for the efficacy of memantine in mild Alzheimer disease","title_match":true,"year":2011},{"alzhub_score":66,"alzhub_url":"https://alzhub.org/study/memantine-treatment-in-patients-with-mild-to-moderate-alzheimer-s-18288936","doi":"10.2174/156720508783884576","journal":"Current Alzheimer research","n_participants":433,"pmid":"18288936","source_url":"https://pubmed.ncbi.nlm.nih.gov/18288936/","study_design":null,"title":"Memantine treatment in patients with mild to moderate Alzheimer's disease already receiving a cholinesterase inhibitor: a randomized, double-blind, placebo-controlled trial","title_match":true,"year":2008},{"alzhub_score":72,"alzhub_url":"https://alzhub.org/study/donepezil-preserves-cognition-and-global-function-in-patients-with-17664405","doi":"10.1212/01.wnl.0000266627.96040.5a","journal":"Neurology","n_participants":176,"pmid":"17664405","source_url":"https://pubmed.ncbi.nlm.nih.gov/17664405/","study_design":null,"title":"Donepezil preserves cognition and global function in patients with severe Alzheimer disease","title_match":true,"year":2007},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/efficacy-of-donepezil-in-early-stage-alzheimer-disease-a-randomized-15596605","doi":"10.1001/archneur.61.12.1852","journal":"Archives of neurology","n_participants":96,"pmid":"15596605","source_url":"https://pubmed.ncbi.nlm.nih.gov/15596605/","study_design":null,"title":"Efficacy of donepezil in early-stage Alzheimer disease: a randomized placebo-controlled trial","title_match":true,"year":2004},{"alzhub_score":62,"alzhub_url":"https://alzhub.org/study/dementia-prevention-and-treatment-a-narrative-review-38436963","doi":"10.1001/jamainternmed.2023.8522","journal":"JAMA internal medicine","n_participants":null,"pmid":"38436963","source_url":"https://pubmed.ncbi.nlm.nih.gov/38436963/","study_design":null,"title":"Dementia Prevention and Treatment: A Narrative Review","title_match":false,"year":2024},{"alzhub_score":69,"alzhub_url":"https://alzhub.org/study/a-phase-ii-trial-of-huperzine-a-in-mild-to-moderate-alzheimer-disease-21502597","doi":"10.1212/wnl.0b013e318216eb7b","journal":"Neurology","n_participants":70,"pmid":"21502597","source_url":"https://pubmed.ncbi.nlm.nih.gov/21502597/","study_design":null,"title":"A phase II trial of huperzine A in mild to moderate Alzheimer disease","title_match":false,"year":2011},{"alzhub_score":62,"alzhub_url":"https://alzhub.org/study/ginkgo-biloba-and-donepezil-a-comparison-in-the-treatment-of-16930364","doi":"10.1111/j.1468-1331.2006.01409.x","journal":"European journal of neurology","n_participants":null,"pmid":"16930364","source_url":"https://pubmed.ncbi.nlm.nih.gov/16930364/","study_design":null,"title":"Ginkgo biloba and donepezil: a comparison in the treatment of Alzheimer's dementia in a randomized placebo-controlled double-blind study","title_match":true,"year":2006},{"alzhub_score":67,"alzhub_url":"https://alzhub.org/study/a-24-week-randomized-controlled-trial-of-memantine-in-patients-with-17545739","doi":"10.1097/wad.0b013e318065c495","journal":"Alzheimer disease and associated disorders","n_participants":350,"pmid":"17545739","source_url":"https://pubmed.ncbi.nlm.nih.gov/17545739/","study_design":null,"title":"A 24-week randomized, controlled trial of memantine in patients with moderate-to-severe Alzheimer disease","title_match":true,"year":2007},{"alzhub_score":78,"alzhub_url":"https://alzhub.org/study/effect-of-idalopirdine-as-adjunct-to-cholinesterase-inhibitors-on-29318278","doi":"10.1001/jama.2017.20373","journal":"JAMA","n_participants":933,"pmid":"29318278","source_url":"https://pubmed.ncbi.nlm.nih.gov/29318278/","study_design":null,"title":"Effect of Idalopirdine as Adjunct to Cholinesterase Inhibitors on Change in Cognition in Patients With Alzheimer Disease: Three Randomized Clinical Trials","title_match":true,"year":2018},{"alzhub_score":71,"alzhub_url":"https://alzhub.org/study/using-a-distribution-based-approach-and-systematic-review-methods-to-33637039","doi":"10.1186/s12874-021-01228-7","journal":"BMC medical research methodology","n_participants":12449,"pmid":"33637039","source_url":"https://pubmed.ncbi.nlm.nih.gov/33637039/","study_design":"systematic review","title":"Using a distribution-based approach and systematic review methods to derive minimum clinically important differences","title_match":false,"year":2021},{"alzhub_score":53,"alzhub_url":"https://alzhub.org/study/metaanalysis-of-randomized-trials-of-the-efficacy-and-safety-of-15249273","doi":"10.1176/appi.ajgp.12.4.358","journal":"The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry","n_participants":null,"pmid":"15249273","source_url":"https://pubmed.ncbi.nlm.nih.gov/15249273/","study_design":null,"title":"Metaanalysis of randomized trials of the efficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of Alzheimer disease","title_match":true,"year":2004},{"alzhub_score":65,"alzhub_url":"https://alzhub.org/study/a-24-week-open-label-extension-study-of-memantine-in-moderate-to-16401736","doi":"10.1001/archneur.63.1.49","journal":"Archives of neurology","n_participants":175,"pmid":"16401736","source_url":"https://pubmed.ncbi.nlm.nih.gov/16401736/","study_design":"open-label trial","title":"A 24-week open-label extension study of memantine in moderate to severe Alzheimer disease","title_match":true,"year":2006},{"alzhub_score":56,"alzhub_url":"https://alzhub.org/study/randomized-placebo-controlled-clinical-trial-of-donepezil-in-vascular-20395618","doi":"10.1161/strokeaha.109.570077","journal":"Stroke","n_participants":974,"pmid":"20395618","source_url":"https://pubmed.ncbi.nlm.nih.gov/20395618/","study_design":null,"title":"Randomized, placebo-controlled, clinical trial of donepezil in vascular dementia: differential effects by hippocampal size","title_match":true,"year":2010},{"alzhub_score":66,"alzhub_url":"https://alzhub.org/study/the-cognitive-benefits-of-galantamine-are-sustained-for-at-least-36-14967774","doi":"10.1001/archneur.61.2.252","journal":"Archives of neurology","n_participants":119,"pmid":"14967774","source_url":"https://pubmed.ncbi.nlm.nih.gov/14967774/","study_design":"open-label trial","title":"The cognitive benefits of galantamine are sustained for at least 36 months: a long-term extension trial","title_match":true,"year":2004},{"alzhub_score":60,"alzhub_url":"https://alzhub.org/study/circulating-cholesterol-levels-apolipoprotein-e-genotype-and-dementia-16866904","doi":"10.1111/j.1600-0404.2006.00690.x","journal":"Acta neurologica Scandinavica. Supplementum","n_participants":null,"pmid":"16866904","source_url":"https://pubmed.ncbi.nlm.nih.gov/16866904/","study_design":null,"title":"Circulating cholesterol levels, apolipoprotein E genotype and dementia severity influence the benefit of atorvastatin treatment in Alzheimer's disease: results of the Alzheimer's Disease Cholesterol-Lowering Treatment (ADCLT) trial","title_match":false,"year":2006},{"alzhub_score":58,"alzhub_url":"https://alzhub.org/study/sb-742457-and-donepezil-in-alzheimer-disease-a-randomized-placebo-20872778","doi":"10.1002/gps.2562","journal":"International journal of geriatric psychiatry","n_participants":61,"pmid":"20872778","source_url":"https://pubmed.ncbi.nlm.nih.gov/20872778/","study_design":null,"title":"SB-742457 and donepezil in Alzheimer disease: a randomized, placebo-controlled study","title_match":true,"year":2011},{"alzhub_score":65,"alzhub_url":"https://alzhub.org/study/donepezil-improves-obstructive-sleep-apnea-in-alzheimer-disease-a-18198262","doi":"10.1378/chest.07-1446","journal":"Chest","n_participants":null,"pmid":"18198262","source_url":"https://pubmed.ncbi.nlm.nih.gov/18198262/","study_design":null,"title":"Donepezil improves obstructive sleep apnea in Alzheimer disease: a double-blind, placebo-controlled study","title_match":true,"year":2008},{"alzhub_score":60,"alzhub_url":"https://alzhub.org/study/early-statin-use-and-the-progression-of-alzheimer-disease-a-total-26632742","doi":"10.1097/md.0000000000002143","journal":"Medicine","n_participants":null,"pmid":"26632742","source_url":"https://pubmed.ncbi.nlm.nih.gov/26632742/","study_design":"randomized controlled trial","title":"Early Statin Use and the Progression of Alzheimer Disease: A Total Population-Based Case-Control Study","title_match":false,"year":2015},{"alzhub_score":62,"alzhub_url":"https://alzhub.org/study/a-three-country-randomized-controlled-trial-of-a-psychosocial-18978250","doi":"10.1097/jgp.0b013e3181898095","journal":"The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry","n_participants":null,"pmid":"18978250","source_url":"https://pubmed.ncbi.nlm.nih.gov/18978250/","study_design":"randomized controlled trial","title":"A three-country randomized controlled trial of a psychosocial intervention for caregivers combined with pharmacological treatment for patients with Alzheimer disease: effects on caregiver depression","title_match":false,"year":2008},{"alzhub_score":65,"alzhub_url":"https://alzhub.org/study/challenging-the-cholinergic-system-in-mild-cognitive-impairment-a-15589109","doi":"10.1016/j.neuroimage.2004.08.006","journal":"NeuroImage","n_participants":28,"pmid":"15589109","source_url":"https://pubmed.ncbi.nlm.nih.gov/15589109/","study_design":"randomized controlled trial","title":"Challenging the cholinergic system in mild cognitive impairment: a pharmacological fMRI study","title_match":false,"year":2004},{"alzhub_score":62,"alzhub_url":"https://alzhub.org/study/response-of-patients-with-alzheimer-disease-to-rivastigmine-treatment-11255445","doi":"10.1001/archneur.58.3.417","journal":"Archives of neurology","n_participants":187,"pmid":"11255445","source_url":"https://pubmed.ncbi.nlm.nih.gov/11255445/","study_design":"open-label trial","title":"Response of patients with Alzheimer disease to rivastigmine treatment is predicted by the rate of disease progression","title_match":true,"year":2001},{"alzhub_score":63,"alzhub_url":"https://alzhub.org/study/efficacy-safety-and-tolerability-of-rivastigmine-capsules-in-patients-18674411","doi":"10.1185/03007990802328142","journal":"Current medical research and opinion","n_participants":710,"pmid":"18674411","source_url":"https://pubmed.ncbi.nlm.nih.gov/18674411/","study_design":null,"title":"Efficacy, safety and tolerability of rivastigmine capsules in patients with probable vascular dementia: the VantagE study","title_match":true,"year":2008},{"alzhub_score":66,"alzhub_url":"https://alzhub.org/study/economic-evaluation-of-donepezil-in-moderate-to-severe-alzheimer-15326236","doi":"10.1212/01.wnl.0000134663.79663.6e","journal":"Neurology","n_participants":144,"pmid":"15326236","source_url":"https://pubmed.ncbi.nlm.nih.gov/15326236/","study_design":null,"title":"Economic evaluation of donepezil in moderate to severe Alzheimer disease","title_match":true,"year":2004},{"alzhub_score":66,"alzhub_url":"https://alzhub.org/study/magnetic-resonance-imaging-predictors-of-cognition-in-mild-cognitive-17620494","doi":"10.1001/archneur.64.7.1023","journal":"Archives of neurology","n_participants":896,"pmid":"17620494","source_url":"https://pubmed.ncbi.nlm.nih.gov/17620494/","study_design":"cohort study","title":"Magnetic resonance imaging predictors of cognition in mild cognitive impairment","title_match":false,"year":2007},{"alzhub_score":66,"alzhub_url":"https://alzhub.org/study/caregiver-preference-for-rivastigmine-patches-versus-capsules-for-the-17646620","doi":"10.1212/01.wnl.0000281848.25142.11","journal":"Neurology","n_participants":1059,"pmid":"17646620","source_url":"https://pubmed.ncbi.nlm.nih.gov/17646620/","study_design":null,"title":"Caregiver preference for rivastigmine patches versus capsules for the treatment of Alzheimer disease","title_match":true,"year":2007},{"alzhub_score":59,"alzhub_url":"https://alzhub.org/study/atomoxetine-augmentation-of-cholinesterase-inhibitor-therapy-in-19700948","doi":"10.1097/jgp.0b013e3181aad585","journal":"The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry","n_participants":92,"pmid":"19700948","source_url":"https://pubmed.ncbi.nlm.nih.gov/19700948/","study_design":null,"title":"Atomoxetine augmentation of cholinesterase inhibitor therapy in patients with Alzheimer disease: 6-month, randomized, double-blind, placebo-controlled, parallel-trial study","title_match":true,"year":2009},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/memantine-in-the-treatment-of-senile-dementia-of-the-alzheimer-type-3517967","doi":"10.1016/0278-5846(86)90047-3","journal":"Progress in neuro-psychopharmacology & biological psychiatry","n_participants":null,"pmid":"3517967","source_url":"https://pubmed.ncbi.nlm.nih.gov/3517967/","study_design":null,"title":"Memantine in the treatment of senile dementia of the Alzheimer type","title_match":true,"year":1986},{"alzhub_score":67,"alzhub_url":"https://alzhub.org/study/the-efficacy-safety-and-tolerability-of-donepezil-for-the-treatment-19606472","doi":"10.1002/ajmg.a.32953","journal":"American journal of medical genetics. Part A","n_participants":123,"pmid":"19606472","source_url":"https://pubmed.ncbi.nlm.nih.gov/19606472/","study_design":"open-label trial","title":"The efficacy, safety, and tolerability of donepezil for the treatment of young adults with Down syndrome","title_match":true,"year":2009},{"alzhub_score":59,"alzhub_url":"https://alzhub.org/study/activities-of-daily-living-in-moderate-to-severe-alzheimer-disease-an-17132971","doi":"10.1097/01.wad.0000213859.35355.59","journal":"Alzheimer disease and associated disorders","n_participants":404,"pmid":"17132971","source_url":"https://pubmed.ncbi.nlm.nih.gov/17132971/","study_design":null,"title":"Activities of daily living in moderate-to-severe Alzheimer disease: an analysis of the treatment effects of memantine in patients receiving stable donepezil treatment","title_match":true,"year":2006},{"alzhub_score":59,"alzhub_url":"https://alzhub.org/study/the-effects-of-counseling-spouse-caregivers-of-people-with-alzheimer-19705519","doi":"10.1097/jgp.0b013e3181a65187","journal":"The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry","n_participants":null,"pmid":"19705519","source_url":"https://pubmed.ncbi.nlm.nih.gov/19705519/","study_design":"randomized controlled trial","title":"The effects of counseling spouse caregivers of people with Alzheimer disease taking donepezil and of country of residence on rates of admission to nursing homes and mortality","title_match":true,"year":2009},{"alzhub_score":59,"alzhub_url":"https://alzhub.org/study/memantine-versus-donepezil-in-mild-to-moderate-alzheimer-s-disease-a-19874395","doi":"10.1111/j.1468-1331.2009.02816.x","journal":"European journal of neurology","n_participants":32,"pmid":"19874395","source_url":"https://pubmed.ncbi.nlm.nih.gov/19874395/","study_design":"randomized controlled trial","title":"Memantine versus donepezil in mild to moderate Alzheimer's disease: a randomized trial with magnetic resonance spectroscopy","title_match":true,"year":2010},{"alzhub_score":68,"alzhub_url":"https://alzhub.org/study/a-multicenter-double-blind-study-of-controlled-release-physostigmine-8960716","doi":"10.1212/wnl.47.6.1389","journal":"Neurology","n_participants":366,"pmid":"8960716","source_url":"https://pubmed.ncbi.nlm.nih.gov/8960716/","study_design":null,"title":"A multicenter double-blind study of controlled-release physostigmine for the treatment of symptoms secondary to Alzheimer's disease. Physostigmine Study Group","title_match":false,"year":1996},{"alzhub_score":58,"alzhub_url":"https://alzhub.org/study/cognitive-response-to-memantine-in-moderate-to-severe-alzheimer-17132970","doi":"10.1097/01.wad.0000213860.35355.d4","journal":"Alzheimer disease and associated disorders","n_participants":null,"pmid":"17132970","source_url":"https://pubmed.ncbi.nlm.nih.gov/17132970/","study_design":"post-hoc analysis","title":"Cognitive response to memantine in moderate to severe Alzheimer disease patients already receiving donepezil: an exploratory reanalysis","title_match":true,"year":2006},{"alzhub_score":61,"alzhub_url":"https://alzhub.org/study/effect-of-galantamine-on-verbal-repetition-in-ad-a-secondary-analysis-17404193","doi":"10.1212/01.wnl.0000258661.61577.b7","journal":"Neurology","n_participants":57,"pmid":"17404193","source_url":"https://pubmed.ncbi.nlm.nih.gov/17404193/","study_design":null,"title":"Effect of galantamine on verbal repetition in AD: a secondary analysis of the VISTA trial","title_match":true,"year":2007},{"alzhub_score":59,"alzhub_url":"https://alzhub.org/study/a-responder-analysis-of-memantine-treatment-in-patients-with-16670247","doi":"10.1097/01.jgp.0000203151.17311.38","journal":"The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry","n_participants":404,"pmid":"16670247","source_url":"https://pubmed.ncbi.nlm.nih.gov/16670247/","study_design":null,"title":"A responder analysis of memantine treatment in patients with Alzheimer disease maintained on donepezil","title_match":true,"year":2006},{"alzhub_score":71,"alzhub_url":"https://alzhub.org/study/bupropion-for-the-treatment-of-apathy-in-alzheimer-disease-a-32463470","doi":"10.1001/jamanetworkopen.2020.6027","journal":"JAMA network open","n_participants":108,"pmid":"32463470","source_url":"https://pubmed.ncbi.nlm.nih.gov/32463470/","study_design":null,"title":"Bupropion for the Treatment of Apathy in Alzheimer Disease: A Randomized Clinical Trial","title_match":false,"year":2020},{"alzhub_score":57,"alzhub_url":"https://alzhub.org/study/donepezil-significantly-improves-abilities-in-daily-lives-of-female-21495523","doi":"10.2190/pm.41.1.g","journal":"International journal of psychiatry in medicine","n_participants":null,"pmid":"21495523","source_url":"https://pubmed.ncbi.nlm.nih.gov/21495523/","study_design":null,"title":"Donepezil significantly improves abilities in daily lives of female Down syndrome patients with severe cognitive impairment: a 24-week randomized, double-blind, placebo-controlled trial","title_match":true,"year":2011},{"alzhub_score":73,"alzhub_url":"https://alzhub.org/study/effect-of-cholinesterase-inhibitors-on-mortality-in-patients-with-36096687","doi":"10.1212/wnl.0000000000201161","journal":"Neurology","n_participants":79153,"pmid":"36096687","source_url":"https://pubmed.ncbi.nlm.nih.gov/36096687/","study_design":"systematic review","title":"Effect of Cholinesterase Inhibitors on Mortality in Patients With Dementia: A Systematic Review of Randomized and Nonrandomized Trials","title_match":true,"year":2022},{"alzhub_score":64,"alzhub_url":"https://alzhub.org/study/test-retest-reliability-of-memory-task-functional-magnetic-resonance-21555634","doi":"10.1001/archneurol.2011.94","journal":"Archives of neurology","n_participants":24,"pmid":"21555634","source_url":"https://pubmed.ncbi.nlm.nih.gov/21555634/","study_design":"randomized controlled trial","title":"Test-retest reliability of memory task functional magnetic resonance imaging in Alzheimer disease clinical trials","title_match":false,"year":2011},{"alzhub_score":59,"alzhub_url":"https://alzhub.org/study/memantine-treatment-of-cognitive-symptoms-in-mild-to-moderate-17334274","doi":"10.1097/wad.0b013e318032cf29","journal":"Alzheimer disease and associated disorders","n_participants":null,"pmid":"17334274","source_url":"https://pubmed.ncbi.nlm.nih.gov/17334274/","study_design":null,"title":"Memantine treatment of cognitive symptoms in mild to moderate Alzheimer disease: secondary analyses from a placebo-controlled randomized trial","title_match":true,"year":2007},{"alzhub_score":56,"alzhub_url":"https://alzhub.org/study/effects-of-memantine-on-clinical-ratings-fluorodeoxyglucose-positron-23948786","doi":"10.1097/jcp.0b013e31829a876a","journal":"Journal of clinical psychopharmacology","n_participants":null,"pmid":"23948786","source_url":"https://pubmed.ncbi.nlm.nih.gov/23948786/","study_design":null,"title":"Effects of memantine on clinical ratings, fluorodeoxyglucose positron emission tomography measurements, and cerebrospinal fluid assays in patients with moderate to severe Alzheimer dementia: a 24-week, randomized, clinical trial","title_match":true,"year":2013},{"alzhub_score":71,"alzhub_url":"https://alzhub.org/study/association-of-plasma-phosphorylated-tau-with-the-response-to-37657939","doi":"10.1212/wnl.0000000000207755","journal":"Neurology","n_participants":45,"pmid":"37657939","source_url":"https://pubmed.ncbi.nlm.nih.gov/37657939/","study_design":null,"title":"Association of Plasma Phosphorylated Tau With the Response to Neflamapimod Treatment in Patients With Dementia With Lewy Bodies","title_match":false,"year":2023},{"alzhub_score":56,"alzhub_url":"https://alzhub.org/study/effects-of-donepezil-on-verbal-memory-after-semantic-processing-in-18541979","doi":"10.1097/wnn.0b013e3181799df1","journal":"Cognitive and behavioral neurology : official journal of the Society for Behavioral and Cognitive Neurology","n_participants":null,"pmid":"18541979","source_url":"https://pubmed.ncbi.nlm.nih.gov/18541979/","study_design":null,"title":"Effects of donepezil on verbal memory after semantic processing in healthy older adults","title_match":true,"year":2008},{"alzhub_score":59,"alzhub_url":"https://alzhub.org/study/adaptive-dose-finding-phase-2-trial-evaluating-the-safety-and-25973909","doi":"10.1097/wad.0000000000000093","journal":"Alzheimer disease and associated disorders","n_participants":337,"pmid":"25973909","source_url":"https://pubmed.ncbi.nlm.nih.gov/25973909/","study_design":"longitudinal study","title":"Adaptive, dose-finding phase 2 trial evaluating the safety and efficacy of ABT-089 in mild to moderate Alzheimer disease","title_match":false,"year":2015},{"alzhub_score":60,"alzhub_url":"https://alzhub.org/study/a-double-blind-randomized-placebo-controlled-withdrawal-trial-25523285","doi":"10.1016/j.jamda.2014.11.002","journal":"Journal of the American Medical Directors Association","n_participants":199,"pmid":"25523285","source_url":"https://pubmed.ncbi.nlm.nih.gov/25523285/","study_design":null,"title":"A double-blind randomized placebo-controlled withdrawal trial comparing memantine and antipsychotics for the long-term treatment of function and neuropsychiatric symptoms in people with Alzheimer's disease (MAIN-AD)","title_match":true,"year":2015},{"alzhub_score":51,"alzhub_url":"https://alzhub.org/study/chinese-herbal-medicine-for-patients-with-mild-to-moderate-alzheimer-22805083","doi":"10.3736/jcim20120707","journal":"Zhong xi yi jie he xue bao = Journal of Chinese integrative medicine","n_participants":131,"pmid":"22805083","source_url":"https://pubmed.ncbi.nlm.nih.gov/22805083/","study_design":null,"title":"[Chinese herbal medicine for patients with mild to moderate Alzheimer disease based on syndrome differentiation: a randomized controlled trial]","title_match":false,"year":2012},{"alzhub_score":54,"alzhub_url":"https://alzhub.org/study/effects-of-chinese-medicine-for-tonifying-the-kidney-and-resolving-22500712","doi":"10.3736/jcim20120407","journal":"Zhong xi yi jie he xue bao = Journal of Chinese integrative medicine","n_participants":null,"pmid":"22500712","source_url":"https://pubmed.ncbi.nlm.nih.gov/22500712/","study_design":null,"title":"Effects of Chinese medicine for tonifying the kidney and resolving phlegm and blood stasis in treating patients with amnestic mild cognitive impairment: a randomized, double-blind and parallel-controlled trial","title_match":false,"year":2012},{"alzhub_score":42,"alzhub_url":"https://alzhub.org/study/characteristics-and-performance-of-a-modified-version-of-the-adcs-19812469","doi":"10.1097/wad.0b013e31819cb760","journal":"Alzheimer disease and associated disorders","n_participants":null,"pmid":"19812469","source_url":"https://pubmed.ncbi.nlm.nih.gov/19812469/","study_design":null,"title":"Characteristics and performance of a modified version of the ADCS-CGIC CIBIC+ for mild cognitive impairment clinical trials","title_match":false,"year":2009},{"alzhub_score":50,"alzhub_url":"https://alzhub.org/study/extended-release-physostigmine-in-alzheimer-disease-a-multicenter-10665618","doi":"10.1001/archpsyc.57.2.157","journal":"Archives of general psychiatry","n_participants":850,"pmid":"10665618","source_url":"https://pubmed.ncbi.nlm.nih.gov/10665618/","study_design":null,"title":"Extended-release physostigmine in Alzheimer disease: a multicenter, double-blind, 12-week study with dose enrichment. Physostigmine Study Group","title_match":false,"year":2000},{"alzhub_score":47,"alzhub_url":"https://alzhub.org/study/donepezil-treatment-and-alzheimer-disease-can-the-results-of-17974866","doi":"10.1097/jgp.0b013e3180986138","journal":"The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry","n_participants":91,"pmid":"17974866","source_url":"https://pubmed.ncbi.nlm.nih.gov/17974866/","study_design":null,"title":"Donepezil treatment and Alzheimer disease: can the results of randomized clinical trials be applied to Alzheimer disease patients in clinical practice?","title_match":true,"year":2007},{"alzhub_score":56,"alzhub_url":"https://alzhub.org/study/rates-of-cognitive-change-in-alzheimer-disease-observations-across-a-19561444","doi":"10.1097/wad.0b013e31819cd4be","journal":"Alzheimer disease and associated disorders","n_participants":3403,"pmid":"19561444","source_url":"https://pubmed.ncbi.nlm.nih.gov/19561444/","study_design":null,"title":"Rates of cognitive change in Alzheimer disease: observations across a decade of placebo-controlled clinical trials with donepezil","title_match":true,"year":2009},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/effects-of-the-association-of-sulbutiamine-with-an-17675917","doi":"10.1016/s0013-7006(07)91552-3","journal":"L'Encephale","n_participants":null,"pmid":"17675917","source_url":"https://pubmed.ncbi.nlm.nih.gov/17675917/","study_design":null,"title":"[Effects of the association of sulbutiamine with an acetylcholinesterase inhibitor in early stage and moderate Alzheimer disease]","title_match":true,"year":2007},{"alzhub_score":51,"alzhub_url":"https://alzhub.org/study/impact-of-donepezil-and-memantine-on-behavioral-and-psychological-34851866","doi":"10.1097/wnn.0000000000000285","journal":"Cognitive and behavioral neurology : official journal of the Society for Behavioral and Cognitive Neurology","n_participants":42,"pmid":"34851866","source_url":"https://pubmed.ncbi.nlm.nih.gov/34851866/","study_design":null,"title":"Impact of Donepezil and Memantine on Behavioral and Psychological Symptoms of Alzheimer Disease: Six-month Open-label Study","title_match":true,"year":2021},{"alzhub_score":80,"alzhub_url":"https://alzhub.org/study/memantine-for-dementia-30891742","doi":"10.1002/14651858.cd003154.pub6","journal":"The Cochrane database of systematic reviews","n_participants":10000,"pmid":"30891742","source_url":"https://pubmed.ncbi.nlm.nih.gov/30891742/","study_design":"post-hoc analysis","title":"Memantine for dementia","title_match":true,"year":2019},{"alzhub_score":56,"alzhub_url":"https://alzhub.org/study/effects-of-galantamine-and-galantamine-combined-with-nimodipine-on-24964105","doi":"10.1590/0004-282x20140055","journal":"Arquivos de neuro-psiquiatria","n_participants":null,"pmid":"24964105","source_url":"https://pubmed.ncbi.nlm.nih.gov/24964105/","study_design":null,"title":"Effects of galantamine and galantamine combined with nimodipine on cognitive speed and quality of life in mixed dementia: a 24-week, randomized, placebo-controlled exploratory trial (the REMIX study)","title_match":true,"year":2014},{"alzhub_score":57,"alzhub_url":"https://alzhub.org/study/lecanemab-questions-38484213","doi":"10.1212/wnl.0000000000209320","journal":"Neurology","n_participants":null,"pmid":"38484213","source_url":"https://pubmed.ncbi.nlm.nih.gov/38484213/","study_design":"randomized controlled trial","title":"Lecanemab Questions","title_match":false,"year":2024},{"alzhub_score":51,"alzhub_url":"https://alzhub.org/study/comprehensive-individualized-person-centered-management-of-community-28122366","doi":"10.1159/000455397","journal":"Dementia and geriatric cognitive disorders","n_participants":null,"pmid":"28122366","source_url":"https://pubmed.ncbi.nlm.nih.gov/28122366/","study_design":null,"title":"Comprehensive, Individualized, Person-Centered Management of Community-Residing Persons with Moderate-to-Severe Alzheimer Disease: A Randomized Controlled Trial","title_match":false,"year":2017},{"alzhub_score":53,"alzhub_url":"https://alzhub.org/study/rivastigmine-treatment-for-the-prevention-of-electroconvulsive-22751086","doi":"10.1097/wnf.0b013e31825e7945","journal":"Clinical neuropharmacology","n_participants":null,"pmid":"22751086","source_url":"https://pubmed.ncbi.nlm.nih.gov/22751086/","study_design":null,"title":"Rivastigmine treatment for the prevention of electroconvulsive therapy-induced memory deficits in patients with schizophrenia","title_match":true,"year":2012},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/the-role-of-copper-in-the-pathophysiology-of-alzheimer-s-disease-15905983","doi":"10.1007/s00115-004-1849-6","journal":"Der Nervenarzt","n_participants":null,"pmid":"15905983","source_url":"https://pubmed.ncbi.nlm.nih.gov/15905983/","study_design":"longitudinal study","title":"[The role of copper in the pathophysiology of Alzheimer's disease]","title_match":false,"year":2005},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/treatments-for-alzheimer-disease-16004170","doi":"10.1097/01.smj.0000166671.86815.c1","journal":"Southern medical journal","n_participants":null,"pmid":"16004170","source_url":"https://pubmed.ncbi.nlm.nih.gov/16004170/","study_design":"randomized controlled trial","title":"Treatments for Alzheimer disease","title_match":false,"year":2005},{"alzhub_score":53,"alzhub_url":"https://alzhub.org/study/effects-of-risperidone-and-galantamine-treatment-on-alzheimer-s-28269767","doi":"10.3233/jad-160758","journal":"Journal of Alzheimer's disease : JAD","n_participants":44,"pmid":"28269767","source_url":"https://pubmed.ncbi.nlm.nih.gov/28269767/","study_design":null,"title":"Effects of Risperidone and Galantamine Treatment on Alzheimer's Disease Biomarker Levels in Cerebrospinal Fluid","title_match":true,"year":2017},{"alzhub_score":53,"alzhub_url":"https://alzhub.org/study/effects-of-rivastigmine-transdermal-patch-and-capsule-on-aspects-of-20502014","doi":"10.1159/000296073","journal":"Dementia and geriatric cognitive disorders","n_participants":null,"pmid":"20502014","source_url":"https://pubmed.ncbi.nlm.nih.gov/20502014/","study_design":null,"title":"Effects of rivastigmine transdermal patch and capsule on aspects of clinical global impression of change in Alzheimer's disease: a retrospective analysis","title_match":true,"year":2010},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/potentially-inappropriate-prescribing-in-australian-nursing-home-30106321","doi":"10.1089/jpm.2018.0070","journal":"Journal of palliative medicine","n_participants":65,"pmid":"30106321","source_url":"https://pubmed.ncbi.nlm.nih.gov/30106321/","study_design":"randomized controlled trial","title":"Potentially Inappropriate Prescribing in Australian Nursing Home Residents with Advanced Dementia: A Substudy of the IDEAL Study","title_match":false,"year":2018},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/efficacy-of-rivastigmine-for-cognitive-symptoms-in-parkinson-disease-19590387","doi":"10.1097/nrl.0b013e3181a968df","journal":"The neurologist","n_participants":541,"pmid":"19590387","source_url":"https://pubmed.ncbi.nlm.nih.gov/19590387/","study_design":"randomized controlled trial","title":"Efficacy of rivastigmine for cognitive symptoms in Parkinson disease with dementia","title_match":true,"year":2009},{"alzhub_score":46,"alzhub_url":"https://alzhub.org/study/efficacy-and-safety-of-an-herbal-therapy-in-patients-with-amnestic-28596794","doi":"10.1155/2017/4251747","journal":"Evidence-based complementary and alternative medicine : eCAM","n_participants":216,"pmid":"28596794","source_url":"https://pubmed.ncbi.nlm.nih.gov/28596794/","study_design":null,"title":"Efficacy and Safety of an Herbal Therapy in Patients with Amnestic Mild Cognitive Impairment: A 24-Week Randomized Phase III Trial","title_match":false,"year":2017},{"alzhub_score":50,"alzhub_url":"https://alzhub.org/study/effects-of-a-neuropsychology-program-based-on-mindfulness-on-24880524","doi":"10.1016/j.regg.2014.03.002","journal":"Revista espanola de geriatria y gerontologia","n_participants":null,"pmid":"24880524","source_url":"https://pubmed.ncbi.nlm.nih.gov/24880524/","study_design":null,"title":"[Effects of a neuropsychology program based on mindfulness on Alzheimer's disease: randomized double-blind clinical study]","title_match":false,"year":2014},{"alzhub_score":61,"alzhub_url":"https://alzhub.org/study/comparative-study-of-choline-alfoscerate-as-a-combination-therapy-38875437","doi":"10.1097/md.0000000000038067","journal":"Medicine","n_participants":119,"pmid":"38875437","source_url":"https://pubmed.ncbi.nlm.nih.gov/38875437/","study_design":null,"title":"Comparative study of choline alfoscerate as a combination therapy with donepezil: A mixed double-blind randomized controlled and open-label observation trial","title_match":true,"year":2024},{"alzhub_score":58,"alzhub_url":"https://alzhub.org/study/a-randomized-double-blind-study-to-assess-the-skin-irritation-and-37695107","doi":"10.1097/wad.0000000000000578","journal":"Alzheimer disease and associated disorders","n_participants":198,"pmid":"37695107","source_url":"https://pubmed.ncbi.nlm.nih.gov/37695107/","study_design":"clinical trial","title":"A Randomized Double-blind Study to Assess the Skin Irritation and Sensitization Potential of a Once-weekly Donepezil Transdermal Delivery System in Healthy Volunteers","title_match":true,"year":2023},{"alzhub_score":50,"alzhub_url":"https://alzhub.org/study/practical-lessons-from-amyloid-immunotherapy-trials-in-alzheimer-22631442","doi":"10.2174/156720512804142958","journal":"Current Alzheimer research","n_participants":20,"pmid":"22631442","source_url":"https://pubmed.ncbi.nlm.nih.gov/22631442/","study_design":null,"title":"Practical lessons from amyloid immunotherapy trials in Alzheimer disease","title_match":false,"year":2012},{"alzhub_score":39,"alzhub_url":"https://alzhub.org/study/neurochemical-ameliorating-of-the-hippocampus-in-dyslipidemic-38318412","doi":"10.47176/mjiri.37.123","journal":"Medical journal of the Islamic Republic of Iran","n_participants":12,"pmid":"38318412","source_url":"https://pubmed.ncbi.nlm.nih.gov/38318412/","study_design":null,"title":"Neurochemical Ameliorating of the Hippocampus in Dyslipidemic Alzheimer Patients Following Silymarin; a Double-Blind Placebo-Controlled Randomized Clinical Trial","title_match":false,"year":2023},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/the-efficacy-and-safety-of-hachimijiogan-for-mild-alzheimer-disease-32957414","doi":"10.1097/md.0000000000022370","journal":"Medicine","n_participants":null,"pmid":"32957414","source_url":"https://pubmed.ncbi.nlm.nih.gov/32957414/","study_design":null,"title":"The efficacy and safety of hachimijiogan for mild Alzheimer disease in an exploratory, open standard treatment controlled, randomized allocation, multicenter trial: A study protocol","title_match":false,"year":2020},{"alzhub_score":47,"alzhub_url":"https://alzhub.org/study/clinical-efficacy-and-safety-of-akatinol-memantine-in-treatment-of-16780671","doi":null,"journal":"Zhonghua nei ke za zhi","n_participants":50,"pmid":"16780671","source_url":"https://pubmed.ncbi.nlm.nih.gov/16780671/","study_design":null,"title":"[Clinical efficacy and safety of akatinol memantine in treatment of mild to moderate Alzheimer disease: a donepezil-controlled, randomized trial]","title_match":true,"year":2006},{"alzhub_score":74,"alzhub_url":"https://alzhub.org/study/practice-guideline-update-summary-mild-cognitive-impairment-retired-29282327","doi":"10.1212/wnl.0000000000004826","journal":"Neurology","n_participants":null,"pmid":"29282327","source_url":"https://pubmed.ncbi.nlm.nih.gov/29282327/","study_design":null,"title":"Practice guideline update summary: Mild cognitive impairment [RETIRED]: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology","title_match":false,"year":2018},{"alzhub_score":77,"alzhub_url":"https://alzhub.org/study/interventions-for-preventing-delirium-in-hospitalised-non-icu-patients-26967259","doi":"10.1002/14651858.cd005563.pub3","journal":"The Cochrane database of systematic reviews","n_participants":39,"pmid":"26967259","source_url":"https://pubmed.ncbi.nlm.nih.gov/26967259/","study_design":null,"title":"Interventions for preventing delirium in hospitalised non-ICU patients","title_match":false,"year":2016},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/therapies-for-prevention-and-treatment-of-alzheimer-s-disease-27547756","doi":"10.1155/2016/2589276","journal":"BioMed research international","n_participants":null,"pmid":"27547756","source_url":"https://pubmed.ncbi.nlm.nih.gov/27547756/","study_design":null,"title":"Therapies for Prevention and Treatment of Alzheimer's Disease","title_match":false,"year":2016},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/pet-amyloid-beta-imaging-in-preclinical-alzheimer-s-disease-22108203","doi":"10.1016/j.bbadis.2011.11.005","journal":"Biochimica et biophysica acta","n_participants":null,"pmid":"22108203","source_url":"https://pubmed.ncbi.nlm.nih.gov/22108203/","study_design":null,"title":"PET amyloid-beta imaging in preclinical Alzheimer's disease","title_match":false,"year":2012},{"alzhub_score":44,"alzhub_url":"https://alzhub.org/study/vascular-dementia-distinguishing-characteristics-treatment-and-12801386","doi":"10.1046/j.1532-5415.5155.x","journal":"Journal of the American Geriatrics Society","n_participants":null,"pmid":"12801386","source_url":"https://pubmed.ncbi.nlm.nih.gov/12801386/","study_design":null,"title":"Vascular dementia: distinguishing characteristics, treatment, and prevention","title_match":false,"year":2003},{"alzhub_score":63,"alzhub_url":"https://alzhub.org/study/folic-acid-with-or-without-vitamin-b12-for-the-prevention-and-18843658","doi":"10.1002/14651858.cd004514.pub2","journal":"The Cochrane database of systematic reviews","n_participants":null,"pmid":"18843658","source_url":"https://pubmed.ncbi.nlm.nih.gov/18843658/","study_design":null,"title":"Folic acid with or without vitamin B12 for the prevention and treatment of healthy elderly and demented people","title_match":false,"year":2008},{"alzhub_score":64,"alzhub_url":"https://alzhub.org/study/diagnosis-and-management-of-dementia-with-lewy-bodies-third-report-of-16237129","doi":"10.1212/01.wnl.0000187889.17253.b1","journal":"Neurology","n_participants":null,"pmid":"16237129","source_url":"https://pubmed.ncbi.nlm.nih.gov/16237129/","study_design":null,"title":"Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium","title_match":false,"year":2005},{"alzhub_score":57,"alzhub_url":"https://alzhub.org/study/csf-markers-for-incipient-alzheimer-s-disease-14505582","doi":"10.1016/s1474-4422(03)00530-1","journal":"The Lancet. Neurology","n_participants":null,"pmid":"14505582","source_url":"https://pubmed.ncbi.nlm.nih.gov/14505582/","study_design":null,"title":"CSF markers for incipient Alzheimer's disease","title_match":false,"year":2003},{"alzhub_score":78,"alzhub_url":"https://alzhub.org/study/rivastigmine-for-dementia-associated-with-parkinson-s-disease-15590953","doi":"10.1056/nejmoa041470","journal":"The New England journal of medicine","n_participants":541,"pmid":"15590953","source_url":"https://pubmed.ncbi.nlm.nih.gov/15590953/","study_design":null,"title":"Rivastigmine for dementia associated with Parkinson's disease","title_match":true,"year":2004},{"alzhub_score":56,"alzhub_url":"https://alzhub.org/study/mild-cognitive-impairment-can-be-distinguished-from-alzheimer-disease-14732621","doi":"10.1001/archneur.61.1.59","journal":"Archives of neurology","n_participants":769,"pmid":"14732621","source_url":"https://pubmed.ncbi.nlm.nih.gov/14732621/","study_design":null,"title":"Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials","title_match":false,"year":2004},{"alzhub_score":75,"alzhub_url":"https://alzhub.org/study/efficacy-of-rivastigmine-in-dementia-with-lewy-bodies-a-randomised-11145488","doi":"10.1016/s0140-6736(00)03399-7","journal":"Lancet (London, England)","n_participants":120,"pmid":"11145488","source_url":"https://pubmed.ncbi.nlm.nih.gov/11145488/","study_design":null,"title":"Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study","title_match":true,"year":2000},{"alzhub_score":68,"alzhub_url":"https://alzhub.org/study/effectiveness-of-cholinesterase-inhibitors-and-memantine-for-treating-18316756","doi":"10.7326/0003-4819-148-5-200803040-00009","journal":"Annals of internal medicine","n_participants":null,"pmid":"18316756","source_url":"https://pubmed.ncbi.nlm.nih.gov/18316756/","study_design":null,"title":"Effectiveness of cholinesterase inhibitors and memantine for treating dementia: evidence review for a clinical practice guideline","title_match":true,"year":2008},{"alzhub_score":73,"alzhub_url":"https://alzhub.org/study/efficacy-of-galantamine-in-probable-vascular-dementia-and-alzheimer-s-11965273","doi":"10.1016/s0140-6736(02)08267-3","journal":"Lancet (London, England)","n_participants":396,"pmid":"11965273","source_url":"https://pubmed.ncbi.nlm.nih.gov/11965273/","study_design":null,"title":"Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomised trial","title_match":true,"year":2002},{"alzhub_score":70,"alzhub_url":"https://alzhub.org/study/non-degenerative-mild-cognitive-impairment-in-elderly-people-and-use-16452102","doi":"10.1136/bmj.38740.439664.de","journal":"BMJ (Clinical research ed.)","n_participants":372,"pmid":"16452102","source_url":"https://pubmed.ncbi.nlm.nih.gov/16452102/","study_design":"cohort study","title":"Non-degenerative mild cognitive impairment in elderly people and use of anticholinergic drugs: longitudinal cohort study","title_match":false,"year":2006},{"alzhub_score":54,"alzhub_url":"https://alzhub.org/study/cognitive-impairment-in-patients-with-parkinson-s-disease-diagnosis-22814541","doi":"10.1016/s1474-4422(12)70152-7","journal":"The Lancet. Neurology","n_participants":null,"pmid":"22814541","source_url":"https://pubmed.ncbi.nlm.nih.gov/22814541/","study_design":null,"title":"Cognitive impairment in patients with Parkinson's disease: diagnosis, biomarkers, and treatment","title_match":false,"year":2012},{"alzhub_score":67,"alzhub_url":"https://alzhub.org/study/a-1-year-placebo-controlled-preservation-of-function-survival-study-11502917","doi":"10.1212/wnl.57.3.481","journal":"Neurology","n_participants":null,"pmid":"11502917","source_url":"https://pubmed.ncbi.nlm.nih.gov/11502917/","study_design":null,"title":"A 1-year, placebo-controlled preservation of function survival study of donepezil in AD patients","title_match":true,"year":2001},{"alzhub_score":62,"alzhub_url":"https://alzhub.org/study/screening-for-cognitive-impairment-in-older-adults-a-systematic-24145578","doi":"10.7326/0003-4819-159-9-201311050-00730","journal":"Annals of internal medicine","n_participants":null,"pmid":"24145578","source_url":"https://pubmed.ncbi.nlm.nih.gov/24145578/","study_design":null,"title":"Screening for cognitive impairment in older adults: A systematic review for the U.S. Preventive Services Task Force","title_match":false,"year":2013},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/beneficial-effect-of-repetitive-transcranial-magnetic-stimulation-21246222","doi":"10.1007/s00702-010-0578-1","journal":"Journal of neural transmission (Vienna, Austria : 1996)","n_participants":null,"pmid":"21246222","source_url":"https://pubmed.ncbi.nlm.nih.gov/21246222/","study_design":null,"title":"Beneficial effect of repetitive transcranial magnetic stimulation combined with cognitive training for the treatment of Alzheimer's disease: a proof of concept study","title_match":false,"year":2011},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/potential-impact-of-amyloid-imaging-on-diagnosis-and-intended-23203162","doi":"10.1097/wad.0b013e318279d02a","journal":"Alzheimer disease and associated disorders","n_participants":229,"pmid":"23203162","source_url":"https://pubmed.ncbi.nlm.nih.gov/23203162/","study_design":null,"title":"Potential impact of amyloid imaging on diagnosis and intended management in patients with progressive cognitive decline","title_match":false,"year":2013},{"alzhub_score":51,"alzhub_url":"https://alzhub.org/study/periventricular-white-matter-hyperintensities-increase-the-likelihood-18825439","doi":"10.1007/s00415-008-0874-y","journal":"Journal of neurology","n_participants":null,"pmid":"18825439","source_url":"https://pubmed.ncbi.nlm.nih.gov/18825439/","study_design":null,"title":"Periventricular white matter hyperintensities increase the likelihood of progression from amnestic mild cognitive impairment to dementia","title_match":false,"year":2008},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/dementia-with-lewy-bodies-12567332","doi":"10.1053/scnp.2003.50006","journal":"Seminars in clinical neuropsychiatry","n_participants":null,"pmid":"12567332","source_url":"https://pubmed.ncbi.nlm.nih.gov/12567332/","study_design":null,"title":"Dementia with Lewy bodies","title_match":false,"year":2003},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/strategic-subcortical-hyperintensities-in-cholinergic-pathways-and-17296844","doi":"10.1001/archneur.64.2.266","journal":"Archives of neurology","n_participants":null,"pmid":"17296844","source_url":"https://pubmed.ncbi.nlm.nih.gov/17296844/","study_design":"cohort study","title":"Strategic subcortical hyperintensities in cholinergic pathways and executive function decline in treated Alzheimer patients","title_match":false,"year":2007},{"alzhub_score":63,"alzhub_url":"https://alzhub.org/study/memantine-in-moderate-to-severe-alzheimer-s-disease-12672860","doi":"10.1056/nejmoa013128","journal":"The New England journal of medicine","n_participants":null,"pmid":"12672860","source_url":"https://pubmed.ncbi.nlm.nih.gov/12672860/","study_design":null,"title":"Memantine in moderate-to-severe Alzheimer's disease","title_match":true,"year":2003},{"alzhub_score":74,"alzhub_url":"https://alzhub.org/study/galantamine-in-ad-a-6-month-randomized-placebo-controlled-trial-with-10881250","doi":"10.1212/wnl.54.12.2261","journal":"Neurology","n_participants":636,"pmid":"10881250","source_url":"https://pubmed.ncbi.nlm.nih.gov/10881250/","study_design":"open-label trial","title":"Galantamine in AD: A 6-month randomized, placebo-controlled trial with a 6-month extension. The Galantamine USA-1 Study Group","title_match":true,"year":2000},{"alzhub_score":47,"alzhub_url":"https://alzhub.org/study/therapeutics-of-alzheimer-s-disease-past-present-and-future-23891641","doi":"10.1016/j.neuropharm.2013.07.004","journal":"Neuropharmacology","n_participants":null,"pmid":"23891641","source_url":"https://pubmed.ncbi.nlm.nih.gov/23891641/","study_design":null,"title":"Therapeutics of Alzheimer's disease: Past, present and future","title_match":false,"year":2014},{"alzhub_score":59,"alzhub_url":"https://alzhub.org/study/practice-parameter-management-of-dementia-an-evidence-based-review-11342679","doi":"10.1212/wnl.56.9.1154","journal":"Neurology","n_participants":null,"pmid":"11342679","source_url":"https://pubmed.ncbi.nlm.nih.gov/11342679/","study_design":null,"title":"Practice parameter: management of dementia (an evidence-based review) [RETIRED]. Report of the Quality Standards Subcommittee of the American Academy of Neurology","title_match":false,"year":2001},{"alzhub_score":74,"alzhub_url":"https://alzhub.org/study/a-24-week-randomized-double-blind-study-of-donepezil-in-moderate-to-11524468","doi":"10.1212/wnl.57.4.613","journal":"Neurology","n_participants":144,"pmid":"11524468","source_url":"https://pubmed.ncbi.nlm.nih.gov/11524468/","study_design":null,"title":"A 24-week, randomized, double-blind study of donepezil in moderate to severe Alzheimer's disease","title_match":true,"year":2001},{"alzhub_score":62,"alzhub_url":"https://alzhub.org/study/the-effects-of-donepezil-in-alzheimer-s-disease-results-from-a-10325453","doi":"10.1159/000017126","journal":"Dementia and geriatric cognitive disorders","n_participants":null,"pmid":"10325453","source_url":"https://pubmed.ncbi.nlm.nih.gov/10325453/","study_design":null,"title":"The effects of donepezil in Alzheimer's disease - results from a multinational trial","title_match":true,"year":1999},{"alzhub_score":64,"alzhub_url":"https://alzhub.org/study/efficacy-and-safety-of-galantamine-in-patients-with-mild-to-moderate-11110737","doi":"10.1136/bmj.321.7274.1445","journal":"BMJ (Clinical research ed.)","n_participants":653,"pmid":"11110737","source_url":"https://pubmed.ncbi.nlm.nih.gov/11110737/","study_design":null,"title":"Efficacy and safety of galantamine in patients with mild to moderate Alzheimer's disease: multicentre randomised controlled trial. Galantamine International-1 Study Group","title_match":true,"year":2000},{"alzhub_score":71,"alzhub_url":"https://alzhub.org/study/memantine-for-patients-with-parkinson-s-disease-dementia-or-dementia-20729148","doi":"10.1016/s1474-4422(10)70194-0","journal":"The Lancet. Neurology","n_participants":199,"pmid":"20729148","source_url":"https://pubmed.ncbi.nlm.nih.gov/20729148/","study_design":null,"title":"Memantine for patients with Parkinson's disease dementia or dementia with Lewy bodies: a randomised, double-blind, placebo-controlled trial","title_match":true,"year":2010},{"alzhub_score":69,"alzhub_url":"https://alzhub.org/study/rofecoxib-no-effect-on-alzheimer-s-disease-in-a-1-year-randomized-14718699","doi":"10.1212/wnl.62.1.66","journal":"Neurology","n_participants":692,"pmid":"14718699","source_url":"https://pubmed.ncbi.nlm.nih.gov/14718699/","study_design":null,"title":"Rofecoxib: no effect on Alzheimer's disease in a 1-year, randomized, blinded, controlled study","title_match":false,"year":2004},{"alzhub_score":70,"alzhub_url":"https://alzhub.org/study/donepezil-is-associated-with-delayed-nursing-home-placement-in-12834513","doi":"10.1046/j.1365-2389.2003.51306.x","journal":"Journal of the American Geriatrics Society","n_participants":1115,"pmid":"12834513","source_url":"https://pubmed.ncbi.nlm.nih.gov/12834513/","study_design":"open-label trial","title":"Donepezil is associated with delayed nursing home placement in patients with Alzheimer's disease","title_match":true,"year":2003},{"alzhub_score":79,"alzhub_url":"https://alzhub.org/study/donepezil-for-dementia-due-to-alzheimer-s-disease-29923184","doi":"10.1002/14651858.cd001190.pub3","journal":"The Cochrane database of systematic reviews","n_participants":8257,"pmid":"29923184","source_url":"https://pubmed.ncbi.nlm.nih.gov/29923184/","study_design":"meta-analysis","title":"Donepezil for dementia due to Alzheimer's disease","title_match":true,"year":2018},{"alzhub_score":44,"alzhub_url":"https://alzhub.org/study/galantamine-a-novel-cholinergic-drug-with-a-unique-dual-mode-of-12177686","doi":"10.1111/j.1527-3458.2002.tb00221.x","journal":"CNS drug reviews","n_participants":null,"pmid":"12177686","source_url":"https://pubmed.ncbi.nlm.nih.gov/12177686/","study_design":null,"title":"Galantamine--a novel cholinergic drug with a unique dual mode of action for the treatment of patients with Alzheimer's disease","title_match":true,"year":2002},{"alzhub_score":72,"alzhub_url":"https://alzhub.org/study/donepezil-for-dementia-with-lewy-bodies-a-randomized-placebo-22829268","doi":"10.1002/ana.23557","journal":"Annals of neurology","n_participants":35,"pmid":"22829268","source_url":"https://pubmed.ncbi.nlm.nih.gov/22829268/","study_design":"clinical trial","title":"Donepezil for dementia with Lewy bodies: a randomized, placebo-controlled trial","title_match":true,"year":2012},{"alzhub_score":46,"alzhub_url":"https://alzhub.org/study/cognitive-dysfunction-and-dementia-in-parkinson-s-disease-15480840","doi":"10.1007/s00702-004-0168-1","journal":"Journal of neural transmission (Vienna, Austria : 1996)","n_participants":null,"pmid":"15480840","source_url":"https://pubmed.ncbi.nlm.nih.gov/15480840/","study_design":null,"title":"Cognitive dysfunction and dementia in Parkinson's disease","title_match":false,"year":2004},{"alzhub_score":66,"alzhub_url":"https://alzhub.org/study/pharmacological-management-of-lewy-body-dementia-a-systematic-review-26085043","doi":"10.1176/appi.ajp.2015.14121582","journal":"The American journal of psychiatry","n_participants":null,"pmid":"26085043","source_url":"https://pubmed.ncbi.nlm.nih.gov/26085043/","study_design":"meta-analysis","title":"Pharmacological Management of Lewy Body Dementia: A Systematic Review and Meta-Analysis","title_match":false,"year":2015},{"alzhub_score":71,"alzhub_url":"https://alzhub.org/study/metrifonate-benefits-cognitive-behavioral-and-global-function-in-9595967","doi":"10.1212/wnl.50.5.1222","journal":"Neurology","n_participants":24,"pmid":"9595967","source_url":"https://pubmed.ncbi.nlm.nih.gov/9595967/","study_design":null,"title":"Metrifonate benefits cognitive, behavioral, and global function in patients with Alzheimer's disease","title_match":false,"year":1998},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/activities-of-daily-living-in-patients-with-dementia-clinical-15521790","doi":"10.2165/00023210-200418130-00003","journal":"CNS drugs","n_participants":null,"pmid":"15521790","source_url":"https://pubmed.ncbi.nlm.nih.gov/15521790/","study_design":null,"title":"Activities of daily living in patients with dementia: clinical relevance, methods of assessment and effects of treatment","title_match":false,"year":2004},{"alzhub_score":64,"alzhub_url":"https://alzhub.org/study/efficacy-of-donepezil-on-maintenance-of-activities-of-daily-living-in-12757558","doi":"10.1046/j.1365-2389.2003.51260.x","journal":"Journal of the American Geriatrics Society","n_participants":null,"pmid":"12757558","source_url":"https://pubmed.ncbi.nlm.nih.gov/12757558/","study_design":null,"title":"Efficacy of donepezil on maintenance of activities of daily living in patients with moderate to severe Alzheimer's disease and the effect on caregiver burden","title_match":true,"year":2003},{"alzhub_score":67,"alzhub_url":"https://alzhub.org/study/a-systematic-review-and-meta-analysis-of-ethnic-differences-in-use-of-20224516","doi":"10.1097/jgp.0b013e3181bf9caf","journal":"The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry","n_participants":2090,"pmid":"20224516","source_url":"https://pubmed.ncbi.nlm.nih.gov/20224516/","study_design":"systematic review","title":"A systematic review and meta-analysis of ethnic differences in use of dementia treatment, care, and research","title_match":false,"year":2010},{"alzhub_score":58,"alzhub_url":"https://alzhub.org/study/detection-and-management-of-cognitive-impairment-in-primary-care-the-15450043","doi":"10.1111/j.1532-5415.2004.52459.x","journal":"Journal of the American Geriatrics Society","n_participants":1107,"pmid":"15450043","source_url":"https://pubmed.ncbi.nlm.nih.gov/15450043/","study_design":"cross-sectional","title":"Detection and management of cognitive impairment in primary care: The Steel Valley Seniors Survey","title_match":false,"year":2004},{"alzhub_score":59,"alzhub_url":"https://alzhub.org/study/racial-ethnic-disparities-in-medication-use-among-veterans-with-19193586","doi":"10.1345/aph.1l368","journal":"The Annals of pharmacotherapy","n_participants":56561,"pmid":"19193586","source_url":"https://pubmed.ncbi.nlm.nih.gov/19193586/","study_design":"cohort study","title":"Racial/ethnic disparities in medication use among veterans with hypertension and dementia: a national cohort study","title_match":false,"year":2009},{"alzhub_score":49,"alzhub_url":"https://alzhub.org/study/dementia-associated-with-parkinson-s-disease-12849211","doi":"10.1016/s1474-4422(03)00351-x","journal":"The Lancet. Neurology","n_participants":null,"pmid":"12849211","source_url":"https://pubmed.ncbi.nlm.nih.gov/12849211/","study_design":null,"title":"Dementia associated with Parkinson's disease","title_match":false,"year":2003},{"alzhub_score":51,"alzhub_url":"https://alzhub.org/study/state-of-the-science-on-mild-cognitive-impairment-mci-30651152","doi":"10.1017/s1092852918001347","journal":"CNS spectrums","n_participants":null,"pmid":"30651152","source_url":"https://pubmed.ncbi.nlm.nih.gov/30651152/","study_design":null,"title":"State of the science on mild cognitive impairment (MCI)","title_match":false,"year":2019},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/frontotemporal-lobar-degeneration-epidemiology-pathology-diagnosis-22950490","doi":"10.2165/11640070-000000000-00000","journal":"CNS drugs","n_participants":null,"pmid":"22950490","source_url":"https://pubmed.ncbi.nlm.nih.gov/22950490/","study_design":null,"title":"Frontotemporal lobar degeneration: epidemiology, pathology, diagnosis and management","title_match":false,"year":2012},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/rivastigmine-for-the-treatment-of-dementia-and-visual-hallucinations-12240787","doi":"10.1185/030079902125000813","journal":"Current medical research and opinion","n_participants":null,"pmid":"12240787","source_url":"https://pubmed.ncbi.nlm.nih.gov/12240787/","study_design":null,"title":"Rivastigmine for the treatment of dementia and visual hallucinations associated with Parkinson's disease: a case series","title_match":true,"year":2002},{"alzhub_score":42,"alzhub_url":"https://alzhub.org/study/an-update-on-medical-and-surgical-treatments-of-parkinson-s-disease-34221546","doi":"10.14336/ad.2020.1225","journal":"Aging and disease","n_participants":null,"pmid":"34221546","source_url":"https://pubmed.ncbi.nlm.nih.gov/34221546/","study_design":null,"title":"An Update on Medical and Surgical Treatments of Parkinson's Disease","title_match":false,"year":2021},{"alzhub_score":58,"alzhub_url":"https://alzhub.org/study/management-of-cognitive-determinants-in-senile-dementia-of-alzheimer-25316430","doi":"10.1007/s40261-014-0235-9","journal":"Clinical drug investigation","n_participants":null,"pmid":"25316430","source_url":"https://pubmed.ncbi.nlm.nih.gov/25316430/","study_design":null,"title":"Management of cognitive determinants in senile dementia of Alzheimer's type: therapeutic potential of a novel polyherbal drug product","title_match":false,"year":2014},{"alzhub_score":31,"alzhub_url":"https://alzhub.org/study/frontotemporal-dementia-a-review-for-primary-care-physicians-21121521","doi":null,"journal":"American family physician","n_participants":null,"pmid":"21121521","source_url":"https://pubmed.ncbi.nlm.nih.gov/21121521/","study_design":null,"title":"Frontotemporal dementia: a review for primary care physicians","title_match":false,"year":2010},{"alzhub_score":59,"alzhub_url":"https://alzhub.org/study/pharmacological-treatment-of-parkinson-disease-a-review-24756517","doi":"10.1001/jama.2014.3654","journal":"JAMA","n_participants":null,"pmid":"24756517","source_url":"https://pubmed.ncbi.nlm.nih.gov/24756517/","study_design":null,"title":"Pharmacological treatment of Parkinson disease: a review","title_match":false,"year":2014},{"alzhub_score":50,"alzhub_url":"https://alzhub.org/study/parkinson-s-disease-the-quintessential-neuropsychiatric-disorder-21626547","doi":"10.1002/mds.23664","journal":"Movement disorders : official journal of the Movement Disorder Society","n_participants":null,"pmid":"21626547","source_url":"https://pubmed.ncbi.nlm.nih.gov/21626547/","study_design":null,"title":"Parkinson's disease: the quintessential neuropsychiatric disorder","title_match":false,"year":2011},{"alzhub_score":65,"alzhub_url":"https://alzhub.org/study/in-vivo-staging-of-pathology-in-rem-sleep-behaviour-disorder-a-29866443","doi":"10.1016/s1474-4422(18)30162-5","journal":"The Lancet. Neurology","n_participants":22,"pmid":"29866443","source_url":"https://pubmed.ncbi.nlm.nih.gov/29866443/","study_design":"case-control study","title":"In-vivo staging of pathology in REM sleep behaviour disorder: a multimodality imaging case-control study","title_match":false,"year":2018},{"alzhub_score":49,"alzhub_url":"https://alzhub.org/study/hallucinations-in-parkinson-disease-19498436","doi":"10.1038/nrneurol.2009.62","journal":"Nature reviews. Neurology","n_participants":null,"pmid":"19498436","source_url":"https://pubmed.ncbi.nlm.nih.gov/19498436/","study_design":"cross-sectional","title":"Hallucinations in Parkinson disease","title_match":false,"year":2009},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/cholinesterase-inhibitors-new-roles-and-therapeutic-alternatives-15304240","doi":"10.1016/j.phrs.2003.11.017","journal":"Pharmacological research","n_participants":null,"pmid":"15304240","source_url":"https://pubmed.ncbi.nlm.nih.gov/15304240/","study_design":null,"title":"Cholinesterase inhibitors: new roles and therapeutic alternatives","title_match":true,"year":2004},{"alzhub_score":42,"alzhub_url":"https://alzhub.org/study/down-syndrome-and-alzheimer-disease-response-to-donepezil-12117361","doi":"10.1001/archneur.59.7.1133","journal":"Archives of neurology","n_participants":null,"pmid":"12117361","source_url":"https://pubmed.ncbi.nlm.nih.gov/12117361/","study_design":null,"title":"Down syndrome and Alzheimer disease: response to donepezil","title_match":true,"year":2002},{"alzhub_score":44,"alzhub_url":"https://alzhub.org/study/cholinesterase-inhibitor-therapy-stabilizes-symptoms-of-alzheimer-10850724","doi":"10.1097/00002093-200000001-00002","journal":"Alzheimer disease and associated disorders","n_participants":8000,"pmid":"10850724","source_url":"https://pubmed.ncbi.nlm.nih.gov/10850724/","study_design":null,"title":"Cholinesterase inhibitor therapy stabilizes symptoms of Alzheimer disease","title_match":true,"year":2000},{"alzhub_score":39,"alzhub_url":"https://alzhub.org/study/therapeutic-approaches-in-the-improvement-of-cognitive-performance-in-22541285","doi":"10.1016/b978-0-444-54299-1.00001-7","journal":"Progress in brain research","n_participants":null,"pmid":"22541285","source_url":"https://pubmed.ncbi.nlm.nih.gov/22541285/","study_design":null,"title":"Therapeutic approaches in the improvement of cognitive performance in Down syndrome: past, present, and future","title_match":false,"year":2012},{"alzhub_score":35,"alzhub_url":"https://alzhub.org/study/relevance-of-donepezil-in-enhancing-learning-and-memory-in-special-17221321","doi":"10.1007/s10803-006-0322-8","journal":"Journal of autism and developmental disorders","n_participants":null,"pmid":"17221321","source_url":"https://pubmed.ncbi.nlm.nih.gov/17221321/","study_design":null,"title":"Relevance of donepezil in enhancing learning and memory in special populations: a review of the literature","title_match":true,"year":2007},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/cognitive-enhancement-by-pharmacological-and-behavioral-interventions-22898099","doi":"10.1016/j.bcp.2012.06.028","journal":"Biochemical pharmacology","n_participants":null,"pmid":"22898099","source_url":"https://pubmed.ncbi.nlm.nih.gov/22898099/","study_design":null,"title":"Cognitive enhancement by pharmacological and behavioral interventions: the murine Down syndrome model","title_match":false,"year":2012},{"alzhub_score":34,"alzhub_url":"https://alzhub.org/study/the-glutamatergic-hypothesis-for-down-syndrome-the-potential-use-of-n-24152324","doi":"10.2174/18715273113126660183","journal":"CNS & neurological disorders drug targets","n_participants":null,"pmid":"24152324","source_url":"https://pubmed.ncbi.nlm.nih.gov/24152324/","study_design":null,"title":"The glutamatergic hypothesis for Down syndrome: the potential use of N-methyl-D-aspartate receptor antagonists to enhance cognition and decelerate neurodegeneration","title_match":false,"year":2014},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/present-and-future-of-alzheimer-therapy-10961434","doi":"10.1007/978-3-7091-6781-6_24","journal":"Journal of neural transmission. Supplementum","n_participants":8000,"pmid":"10961434","source_url":"https://pubmed.ncbi.nlm.nih.gov/10961434/","study_design":null,"title":"Present and future of Alzheimer therapy","title_match":false,"year":2000},{"alzhub_score":46,"alzhub_url":"https://alzhub.org/study/review-cerebral-microvascular-pathology-in-ageing-and-20946471","doi":"10.1111/j.1365-2990.2010.01139.x","journal":"Neuropathology and applied neurobiology","n_participants":null,"pmid":"20946471","source_url":"https://pubmed.ncbi.nlm.nih.gov/20946471/","study_design":null,"title":"Review: cerebral microvascular pathology in ageing and neurodegeneration","title_match":false,"year":2011},{"alzhub_score":69,"alzhub_url":"https://alzhub.org/study/vitamin-e-and-donepezil-for-the-treatment-of-mild-cognitive-impairment-15829527","doi":"10.1056/nejmoa050151","journal":"The New England journal of medicine","n_participants":769,"pmid":"15829527","source_url":"https://pubmed.ncbi.nlm.nih.gov/15829527/","study_design":null,"title":"Vitamin E and donepezil for the treatment of mild cognitive impairment","title_match":true,"year":2005},{"alzhub_score":73,"alzhub_url":"https://alzhub.org/study/effect-of-rivastigmine-on-delay-to-diagnosis-of-alzheimer-s-disease-17509485","doi":"10.1016/s1474-4422(07)70109-6","journal":"The Lancet. Neurology","n_participants":null,"pmid":"17509485","source_url":"https://pubmed.ncbi.nlm.nih.gov/17509485/","study_design":null,"title":"Effect of rivastigmine on delay to diagnosis of Alzheimer's disease from mild cognitive impairment: the InDDEx study","title_match":true,"year":2007},{"alzhub_score":66,"alzhub_url":"https://alzhub.org/study/adcoms-a-composite-clinical-outcome-for-prodromal-alzheimer-s-disease-27010616","doi":"10.1136/jnnp-2015-312383","journal":"Journal of neurology, neurosurgery, and psychiatry","n_participants":null,"pmid":"27010616","source_url":"https://pubmed.ncbi.nlm.nih.gov/27010616/","study_design":"longitudinal study","title":"ADCOMS: a composite clinical outcome for prodromal Alzheimer's disease trials","title_match":false,"year":2016},{"alzhub_score":63,"alzhub_url":"https://alzhub.org/study/qualitative-estimates-of-medial-temporal-atrophy-as-a-predictor-of-17210817","doi":"10.1001/archneur.64.1.108","journal":"Archives of neurology","n_participants":190,"pmid":"17210817","source_url":"https://pubmed.ncbi.nlm.nih.gov/17210817/","study_design":null,"title":"Qualitative estimates of medial temporal atrophy as a predictor of progression from mild cognitive impairment to dementia","title_match":false,"year":2007},{"alzhub_score":62,"alzhub_url":"https://alzhub.org/study/efficacy-of-cognitive-rehabilitation-in-patients-with-mild-cognitive-17117398","doi":"10.1002/gps.1681","journal":"International journal of geriatric psychiatry","n_participants":59,"pmid":"17117398","source_url":"https://pubmed.ncbi.nlm.nih.gov/17117398/","study_design":"longitudinal study","title":"Efficacy of cognitive rehabilitation in patients with mild cognitive impairment treated with cholinesterase inhibitors","title_match":true,"year":2007},{"alzhub_score":50,"alzhub_url":"https://alzhub.org/study/mild-cognitive-impairment-an-opportunity-to-identify-patients-at-high-16990077","doi":"10.1016/j.clinthera.2006.07.006","journal":"Clinical therapeutics","n_participants":769,"pmid":"16990077","source_url":"https://pubmed.ncbi.nlm.nih.gov/16990077/","study_design":null,"title":"Mild cognitive impairment: an opportunity to identify patients at high risk for progression to Alzheimer's disease","title_match":false,"year":2006},{"alzhub_score":70,"alzhub_url":"https://alzhub.org/study/maintenance-treatment-of-depression-in-old-age-a-randomized-double-21199965","doi":"10.1001/archgenpsychiatry.2010.184","journal":"Archives of general psychiatry","n_participants":73,"pmid":"21199965","source_url":"https://pubmed.ncbi.nlm.nih.gov/21199965/","study_design":null,"title":"Maintenance treatment of depression in old age: a randomized, double-blind, placebo-controlled evaluation of the efficacy and safety of donepezil combined with antidepressant pharmacotherapy","title_match":true,"year":2011},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/mild-cognitive-impairment-16085780","doi":"10.1176/appi.ajgp.13.8.645","journal":"The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry","n_participants":null,"pmid":"16085780","source_url":"https://pubmed.ncbi.nlm.nih.gov/16085780/","study_design":null,"title":"Mild cognitive impairment","title_match":false,"year":2005},{"alzhub_score":67,"alzhub_url":"https://alzhub.org/study/donepezil-delays-progression-to-ad-in-mci-subjects-with-depressive-19528519","doi":"10.1212/wnl.0b013e3181aa52d3","journal":"Neurology","n_participants":208,"pmid":"19528519","source_url":"https://pubmed.ncbi.nlm.nih.gov/19528519/","study_design":null,"title":"Donepezil delays progression to AD in MCI subjects with depressive symptoms","title_match":true,"year":2009},{"alzhub_score":71,"alzhub_url":"https://alzhub.org/study/pharmacological-and-non-pharmacological-interventions-to-enhance-33289311","doi":"10.1111/jsr.13229","journal":"Journal of sleep research","n_participants":1056,"pmid":"33289311","source_url":"https://pubmed.ncbi.nlm.nih.gov/33289311/","study_design":"systematic review","title":"Pharmacological and non-pharmacological interventions to enhance sleep in mild cognitive impairment and mild Alzheimer's disease: A systematic review","title_match":false,"year":2021},{"alzhub_score":63,"alzhub_url":"https://alzhub.org/study/longitudinal-mri-findings-from-the-vitamin-e-and-donepezil-treatment-17452062","doi":"10.1016/j.neurobiolaging.2007.03.004","journal":"Neurobiology of aging","n_participants":131,"pmid":"17452062","source_url":"https://pubmed.ncbi.nlm.nih.gov/17452062/","study_design":null,"title":"Longitudinal MRI findings from the vitamin E and donepezil treatment study for MCI","title_match":true,"year":2008},{"alzhub_score":72,"alzhub_url":"https://alzhub.org/study/cholinesterase-inhibitors-for-mild-cognitive-impairment-22972133","doi":"10.1002/14651858.cd009132.pub2","journal":"The Cochrane database of systematic reviews","n_participants":5149,"pmid":"22972133","source_url":"https://pubmed.ncbi.nlm.nih.gov/22972133/","study_design":"meta-analysis","title":"Cholinesterase inhibitors for mild cognitive impairment","title_match":true,"year":2012},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/progress-in-studies-of-huperzine-a-a-natural-cholinesterase-inhibitor-16364207","doi":"10.1111/j.1745-7254.2006.00255.x","journal":"Acta pharmacologica Sinica","n_participants":null,"pmid":"16364207","source_url":"https://pubmed.ncbi.nlm.nih.gov/16364207/","study_design":null,"title":"Progress in studies of huperzine A, a natural cholinesterase inhibitor from Chinese herbal medicine","title_match":true,"year":2006},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/multi-target-directed-coumarin-derivatives-hache-and-bace1-inhibitors-17998161","doi":"10.1016/j.bmcl.2007.09.100","journal":"Bioorganic & medicinal chemistry letters","n_participants":null,"pmid":"17998161","source_url":"https://pubmed.ncbi.nlm.nih.gov/17998161/","study_design":null,"title":"Multi-target-directed coumarin derivatives: hAChE and BACE1 inhibitors as potential anti-Alzheimer compounds","title_match":false,"year":2008},{"alzhub_score":39,"alzhub_url":"https://alzhub.org/study/alzheimer-s-disease-and-oxidative-stress-a-review-24059239","doi":"10.2174/09298673113206660258","journal":"Current medicinal chemistry","n_participants":null,"pmid":"24059239","source_url":"https://pubmed.ncbi.nlm.nih.gov/24059239/","study_design":null,"title":"Alzheimer\u00b4s disease and oxidative stress: a review","title_match":false,"year":2014},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/mechanisms-behind-the-neuroprotective-actions-of-cholinesterase-16772751","doi":"10.1097/01.wad.0000213804.59187.2d","journal":"Alzheimer disease and associated disorders","n_participants":null,"pmid":"16772751","source_url":"https://pubmed.ncbi.nlm.nih.gov/16772751/","study_design":null,"title":"Mechanisms behind the neuroprotective actions of cholinesterase inhibitors in Alzheimer disease","title_match":true,"year":2006},{"alzhub_score":50,"alzhub_url":"https://alzhub.org/study/alzheimer-s-disease-recent-treatment-strategies-32941929","doi":"10.1016/j.ejphar.2020.173554","journal":"European journal of pharmacology","n_participants":null,"pmid":"32941929","source_url":"https://pubmed.ncbi.nlm.nih.gov/32941929/","study_design":null,"title":"Alzheimer's disease: Recent treatment strategies","title_match":false,"year":2020},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/new-and-emerging-drug-therapies-for-alzheimer-disease-38962384","doi":"10.18773/austprescr.2024.021","journal":"Australian prescriber","n_participants":null,"pmid":"38962384","source_url":"https://pubmed.ncbi.nlm.nih.gov/38962384/","study_design":null,"title":"New and emerging drug therapies for Alzheimer disease","title_match":false,"year":2024},{"alzhub_score":30,"alzhub_url":"https://alzhub.org/study/the-differential-diagnosis-and-treatment-of-mild-cognitive-impairment-36576369","doi":"10.4088/jcp.bg21120com4","journal":"The Journal of clinical psychiatry","n_participants":null,"pmid":"36576369","source_url":"https://pubmed.ncbi.nlm.nih.gov/36576369/","study_design":null,"title":"The Differential Diagnosis and Treatment of Mild Cognitive Impairment and Alzheimer Disease","title_match":false,"year":2022},{"alzhub_score":39,"alzhub_url":"https://alzhub.org/study/incidence-of-amyloid-related-imaging-abnormalities-and-health-41885326","doi":"10.18553/jmcp.2026.32.4.470","journal":"Journal of managed care & specialty pharmacy","n_participants":240,"pmid":"41885326","source_url":"https://pubmed.ncbi.nlm.nih.gov/41885326/","study_design":null,"title":"Incidence of amyloid-related imaging abnormalities and health resource utilization in patients with Alzheimer disease receiving monoclonal antibody treatments: A real-world evidence study","title_match":false,"year":2026},{"alzhub_score":27,"alzhub_url":"https://alzhub.org/study/acquired-risk-factors-that-influence-risk-for-dementia-and-possibly-38986163","doi":null,"journal":"South Dakota medicine : the journal of the South Dakota State Medical Association","n_participants":null,"pmid":"38986163","source_url":"https://pubmed.ncbi.nlm.nih.gov/38986163/","study_design":null,"title":"Acquired Risk Factors that Influence Risk for Dementia and Possibly Alzheimer Disease","title_match":false,"year":2024},{"alzhub_score":77,"alzhub_url":"https://alzhub.org/study/a-24-week-double-blind-placebo-controlled-trial-of-donepezil-in-9443470","doi":"10.1212/wnl.50.1.136","journal":"Neurology","n_participants":162,"pmid":"9443470","source_url":"https://pubmed.ncbi.nlm.nih.gov/9443470/","study_design":null,"title":"A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Donepezil Study Group","title_match":true,"year":1998},{"alzhub_score":72,"alzhub_url":"https://alzhub.org/study/cholinesterase-inhibitors-for-alzheimer-s-disease-16437532","doi":"10.1002/14651858.cd005593","journal":"The Cochrane database of systematic reviews","n_participants":null,"pmid":"16437532","source_url":"https://pubmed.ncbi.nlm.nih.gov/16437532/","study_design":null,"title":"Cholinesterase inhibitors for Alzheimer's disease","title_match":true,"year":2006},{"alzhub_score":65,"alzhub_url":"https://alzhub.org/study/efficacy-and-safety-of-memantine-in-patients-with-mild-to-moderate-12105362","doi":"10.1161/01.str.0000020094.08790.49","journal":"Stroke","n_participants":321,"pmid":"12105362","source_url":"https://pubmed.ncbi.nlm.nih.gov/12105362/","study_design":null,"title":"Efficacy and safety of memantine in patients with mild to moderate vascular dementia: a randomized, placebo-controlled trial (MMM 300)","title_match":true,"year":2002},{"alzhub_score":66,"alzhub_url":"https://alzhub.org/study/a-randomized-double-blind-placebo-controlled-study-of-the-efficacy-11843990","doi":"10.1111/j.1532-5415.2001.49266.x","journal":"Journal of the American Geriatrics Society","n_participants":null,"pmid":"11843990","source_url":"https://pubmed.ncbi.nlm.nih.gov/11843990/","study_design":null,"title":"A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting","title_match":true,"year":2001},{"alzhub_score":65,"alzhub_url":"https://alzhub.org/study/a-double-blind-placebo-controlled-multicentre-study-of-memantine-in-12409683","doi":"10.1097/00004850-200211000-00005","journal":"International clinical psychopharmacology","n_participants":579,"pmid":"12409683","source_url":"https://pubmed.ncbi.nlm.nih.gov/12409683/","study_design":"randomized controlled trial","title":"A double-blind, placebo-controlled multicentre study of memantine in mild to moderate vascular dementia (MMM500)","title_match":true,"year":2002},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/the-effectiveness-and-cost-effectiveness-of-donepezil-galantamine-22541366","doi":"10.3310/hta16210","journal":"Health technology assessment (Winchester, England)","n_participants":null,"pmid":"22541366","source_url":"https://pubmed.ncbi.nlm.nih.gov/22541366/","study_design":"systematic review","title":"The effectiveness and cost-effectiveness of donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's disease (review of Technology Appraisal No. 111): a systematic review and economic model","title_match":true,"year":2012},{"alzhub_score":74,"alzhub_url":"https://alzhub.org/study/cholinesterase-inhibitors-for-dementia-with-lewy-bodies-parkinson-s-22419314","doi":"10.1002/14651858.cd006504.pub2","journal":"The Cochrane database of systematic reviews","n_participants":1236,"pmid":"22419314","source_url":"https://pubmed.ncbi.nlm.nih.gov/22419314/","study_design":null,"title":"Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease","title_match":true,"year":2012},{"alzhub_score":50,"alzhub_url":"https://alzhub.org/study/cholinesterase-inhibitor-treatment-alters-the-natural-history-of-11861686","doi":"10.1136/jnnp.72.3.310","journal":"Journal of neurology, neurosurgery, and psychiatry","n_participants":135,"pmid":"11861686","source_url":"https://pubmed.ncbi.nlm.nih.gov/11861686/","study_design":null,"title":"Cholinesterase inhibitor treatment alters the natural history of Alzheimer's disease","title_match":true,"year":2002},{"alzhub_score":66,"alzhub_url":"https://alzhub.org/study/long-term-efficacy-and-safety-of-donepezil-in-the-treatment-of-10793322","doi":"10.1016/s0924-977x(00)00067-5","journal":"European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology","n_participants":133,"pmid":"10793322","source_url":"https://pubmed.ncbi.nlm.nih.gov/10793322/","study_design":"open-label trial","title":"Long-term efficacy and safety of donepezil in the treatment of Alzheimer's disease: final analysis of a US multicentre open-label study","title_match":true,"year":2000},{"alzhub_score":66,"alzhub_url":"https://alzhub.org/study/efficacy-and-safety-of-cholinesterase-inhibitors-and-memantine-in-24828899","doi":"10.1136/jnnp-2014-307659","journal":"Journal of neurology, neurosurgery, and psychiatry","n_participants":null,"pmid":"24828899","source_url":"https://pubmed.ncbi.nlm.nih.gov/24828899/","study_design":"meta-analysis","title":"Efficacy and safety of cholinesterase inhibitors and memantine in cognitive impairment in Parkinson's disease, Parkinson's disease dementia, and dementia with Lewy bodies: systematic review with meta-analysis and trial sequential analysis","title_match":true,"year":2015},{"alzhub_score":65,"alzhub_url":"https://alzhub.org/study/long-term-efficacy-and-safety-of-donepezil-in-the-treatment-of-9452942","doi":"10.1016/s0924-977x(97)00079-5","journal":"European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology","n_participants":133,"pmid":"9452942","source_url":"https://pubmed.ncbi.nlm.nih.gov/9452942/","study_design":"open-label trial","title":"Long-term efficacy and safety of donepezil in the treatment of Alzheimer's disease: an interim analysis of the results of a US multicentre open label extension study","title_match":true,"year":1998},{"alzhub_score":65,"alzhub_url":"https://alzhub.org/study/effects-of-rivastigmine-in-patients-with-and-without-visual-16960863","doi":"10.1002/mds.21077","journal":"Movement disorders : official journal of the Movement Disorder Society","n_participants":188,"pmid":"16960863","source_url":"https://pubmed.ncbi.nlm.nih.gov/16960863/","study_design":null,"title":"Effects of rivastigmine in patients with and without visual hallucinations in dementia associated with Parkinson's disease","title_match":true,"year":2006},{"alzhub_score":71,"alzhub_url":"https://alzhub.org/study/donepezil-in-patients-with-subcortical-vascular-cognitive-impairment-18296124","doi":"10.1016/s1474-4422(08)70046-2","journal":"The Lancet. Neurology","n_participants":86,"pmid":"18296124","source_url":"https://pubmed.ncbi.nlm.nih.gov/18296124/","study_design":null,"title":"Donepezil in patients with subcortical vascular cognitive impairment: a randomised double-blind trial in CADASIL","title_match":true,"year":2008},{"alzhub_score":64,"alzhub_url":"https://alzhub.org/study/rosiglitazone-does-not-improve-cognition-or-global-function-when-used-21592048","doi":"10.2174/156720511796391935","journal":"Current Alzheimer research","n_participants":1496,"pmid":"21592048","source_url":"https://pubmed.ncbi.nlm.nih.gov/21592048/","study_design":"clinical trial","title":"Rosiglitazone does not improve cognition or global function when used as adjunctive therapy to AChE inhibitors in mild-to-moderate Alzheimer's disease: two phase 3 studies","title_match":false,"year":2011},{"alzhub_score":72,"alzhub_url":"https://alzhub.org/study/galantamine-for-alzheimer-s-disease-and-mild-cognitive-impairment-16437436","doi":"10.1002/14651858.cd001747.pub3","journal":"The Cochrane database of systematic reviews","n_participants":6805,"pmid":"16437436","source_url":"https://pubmed.ncbi.nlm.nih.gov/16437436/","study_design":null,"title":"Galantamine for Alzheimer's disease and mild cognitive impairment","title_match":true,"year":2006},{"alzhub_score":77,"alzhub_url":"https://alzhub.org/study/effects-of-a-combined-transcranial-magnetic-stimulation-tms-and-31879235","doi":"10.1016/j.jalz.2019.08.197","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":131,"pmid":"31879235","source_url":"https://pubmed.ncbi.nlm.nih.gov/31879235/","study_design":null,"title":"Effects of a combined transcranial magnetic stimulation (TMS) and cognitive training intervention in patients with Alzheimer's disease","title_match":false,"year":2020},{"alzhub_score":69,"alzhub_url":"https://alzhub.org/study/galantamine-treatment-of-vascular-dementia-a-randomized-trial-17664404","doi":"10.1212/01.wnl.0000266625.31615.f6","journal":"Neurology","n_participants":788,"pmid":"17664404","source_url":"https://pubmed.ncbi.nlm.nih.gov/17664404/","study_design":null,"title":"Galantamine treatment of vascular dementia: a randomized trial","title_match":true,"year":2007},{"alzhub_score":73,"alzhub_url":"https://alzhub.org/study/rivastigmine-for-alzheimer-s-disease-25858345","doi":"10.1002/14651858.cd001191.pub3","journal":"The Cochrane database of systematic reviews","n_participants":3232,"pmid":"25858345","source_url":"https://pubmed.ncbi.nlm.nih.gov/25858345/","study_design":null,"title":"Rivastigmine for Alzheimer's disease","title_match":true,"year":2015},{"alzhub_score":70,"alzhub_url":"https://alzhub.org/study/donepezil-in-parkinson-s-disease-dementia-a-randomized-double-blind-22915447","doi":"10.1002/mds.25098","journal":"Movement disorders : official journal of the Movement Disorder Society","n_participants":550,"pmid":"22915447","source_url":"https://pubmed.ncbi.nlm.nih.gov/22915447/","study_design":null,"title":"Donepezil in Parkinson's disease dementia: a randomized, double-blind efficacy and safety study","title_match":true,"year":2012},{"alzhub_score":58,"alzhub_url":"https://alzhub.org/study/clinical-efficacy-and-safety-of-donepezil-on-cognitive-and-global-11044775","doi":"10.1159/000017259","journal":"Dementia and geriatric cognitive disorders","n_participants":228,"pmid":"11044775","source_url":"https://pubmed.ncbi.nlm.nih.gov/11044775/","study_design":null,"title":"Clinical efficacy and safety of donepezil on cognitive and global function in patients with Alzheimer's disease. A 24-week, multicenter, double-blind, placebo-controlled study in Japan. E2020 Study Group","title_match":true,"year":2000},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/persistent-treatment-with-cholinesterase-inhibitors-and-or-memantine-19845950","doi":"10.1186/alzrt7","journal":"Alzheimer's research & therapy","n_participants":null,"pmid":"19845950","source_url":"https://pubmed.ncbi.nlm.nih.gov/19845950/","study_design":null,"title":"Persistent treatment with cholinesterase inhibitors and/or memantine slows clinical progression of Alzheimer disease","title_match":true,"year":2009},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/cognitive-psychiatric-and-motor-response-to-galantamine-in-parkinson-14533126","doi":"10.1002/gps.949","journal":"International journal of geriatric psychiatry","n_participants":null,"pmid":"14533126","source_url":"https://pubmed.ncbi.nlm.nih.gov/14533126/","study_design":"open-label trial","title":"Cognitive, psychiatric and motor response to galantamine in Parkinson's disease with dementia","title_match":true,"year":2003},{"alzhub_score":65,"alzhub_url":"https://alzhub.org/study/long-term-effects-of-cholinesterase-inhibitors-on-cognitive-decline-33741639","doi":"10.1212/wnl.0000000000011832","journal":"Neurology","n_participants":11652,"pmid":"33741639","source_url":"https://pubmed.ncbi.nlm.nih.gov/33741639/","study_design":null,"title":"Long-term Effects of Cholinesterase Inhibitors on Cognitive Decline and Mortality","title_match":true,"year":2021},{"alzhub_score":77,"alzhub_url":"https://alzhub.org/study/cholinesterase-inhibitors-for-vascular-dementia-and-other-vascular-33704781","doi":"10.1002/14651858.cd013306.pub2","journal":"The Cochrane database of systematic reviews","n_participants":2193,"pmid":"33704781","source_url":"https://pubmed.ncbi.nlm.nih.gov/33704781/","study_design":"meta-analysis","title":"Cholinesterase inhibitors for vascular dementia and other vascular cognitive impairments: a network meta-analysis","title_match":true,"year":2021},{"alzhub_score":59,"alzhub_url":"https://alzhub.org/study/a-systematic-review-and-meta-analysis-of-the-effectiveness-of-29734182","doi":"10.1159/000486546","journal":"Dementia and geriatric cognitive disorders","n_participants":null,"pmid":"29734182","source_url":"https://pubmed.ncbi.nlm.nih.gov/29734182/","study_design":"systematic review","title":"A Systematic Review and Meta-Analysis of the Effectiveness of Acetylcholinesterase Inhibitors and Memantine in Treating the Cognitive Symptoms of Dementia","title_match":true,"year":2018},{"alzhub_score":64,"alzhub_url":"https://alzhub.org/study/attainment-of-treatment-goals-by-people-with-alzheimer-s-disease-16554498","doi":"10.1503/cmaj.051432","journal":"CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne","n_participants":159,"pmid":"16554498","source_url":"https://pubmed.ncbi.nlm.nih.gov/16554498/","study_design":"randomized controlled trial","title":"Attainment of treatment goals by people with Alzheimer's disease receiving galantamine: a randomized controlled trial","title_match":true,"year":2006},{"alzhub_score":61,"alzhub_url":"https://alzhub.org/study/treatment-with-cholinesterase-inhibitors-and-memantine-of-patients-in-21220675","doi":"10.1001/archneurol.2010.343","journal":"Archives of neurology","n_participants":177,"pmid":"21220675","source_url":"https://pubmed.ncbi.nlm.nih.gov/21220675/","study_design":"cohort study","title":"Treatment with cholinesterase inhibitors and memantine of patients in the Alzheimer's Disease Neuroimaging Initiative","title_match":true,"year":2011},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/alpha-lipoic-acid-as-a-new-treatment-option-for-alzheimer-corrected-11395173","doi":"10.1016/s0167-4943(01)00104-2","journal":"Archives of gerontology and geriatrics","n_participants":null,"pmid":"11395173","source_url":"https://pubmed.ncbi.nlm.nih.gov/11395173/","study_design":null,"title":"Alpha-lipoic acid as a new treatment option for Alzheimer [corrected] type dementia","title_match":false,"year":2001},{"alzhub_score":60,"alzhub_url":"https://alzhub.org/study/reality-orientation-therapy-combined-with-cholinesterase-inhibitors-16260821","doi":"10.1192/bjp.187.5.450","journal":"The British journal of psychiatry : the journal of mental science","n_participants":156,"pmid":"16260821","source_url":"https://pubmed.ncbi.nlm.nih.gov/16260821/","study_design":null,"title":"Reality orientation therapy combined with cholinesterase inhibitors in Alzheimer's disease: randomised controlled trial","title_match":true,"year":2005},{"alzhub_score":76,"alzhub_url":"https://alzhub.org/study/masitinib-for-mild-to-moderate-alzheimer-s-disease-results-from-a-36849969","doi":"10.1186/s13195-023-01169-x","journal":"Alzheimer's research & therapy","n_participants":182,"pmid":"36849969","source_url":"https://pubmed.ncbi.nlm.nih.gov/36849969/","study_design":null,"title":"Masitinib for mild-to-moderate Alzheimer's disease: results from a randomized, placebo-controlled, phase 3, clinical trial","title_match":false,"year":2023},{"alzhub_score":53,"alzhub_url":"https://alzhub.org/study/cholinesterase-inhibitors-may-not-benefit-mild-cognitive-impairment-30633043","doi":"10.1097/wad.0000000000000291","journal":"Alzheimer disease and associated disorders","n_participants":2242,"pmid":"30633043","source_url":"https://pubmed.ncbi.nlm.nih.gov/30633043/","study_design":null,"title":"Cholinesterase Inhibitors May Not Benefit Mild Cognitive Impairment and Mild Alzheimer Disease Dementia","title_match":true,"year":2019},{"alzhub_score":53,"alzhub_url":"https://alzhub.org/study/basal-forebrain-volume-but-not-hippocampal-volume-is-a-predictor-of-30158893","doi":"10.3389/fneur.2018.00642","journal":"Frontiers in neurology","n_participants":124,"pmid":"30158893","source_url":"https://pubmed.ncbi.nlm.nih.gov/30158893/","study_design":null,"title":"Basal Forebrain Volume, but Not Hippocampal Volume, Is a Predictor of Global Cognitive Decline in Patients With Alzheimer's Disease Treated With Cholinesterase Inhibitors","title_match":true,"year":2018},{"alzhub_score":70,"alzhub_url":"https://alzhub.org/study/clinical-trials-and-late-stage-drug-development-for-alzheimer-s-24605808","doi":"10.1111/joim.12191","journal":"Journal of internal medicine","n_participants":null,"pmid":"24605808","source_url":"https://pubmed.ncbi.nlm.nih.gov/24605808/","study_design":"meta-analysis","title":"Clinical trials and late-stage drug development for Alzheimer's disease: an appraisal from 1984 to 2014","title_match":false,"year":2014},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/clinical-trials-of-new-drugs-for-alzheimer-disease-31906949","doi":"10.1186/s12929-019-0609-7","journal":"Journal of biomedical science","n_participants":null,"pmid":"31906949","source_url":"https://pubmed.ncbi.nlm.nih.gov/31906949/","study_design":null,"title":"Clinical trials of new drugs for Alzheimer disease","title_match":false,"year":2020},{"alzhub_score":27,"alzhub_url":"https://alzhub.org/study/few-alzheimers-patients-get-state-of-art-care-d4990f60","doi":"10.1176/pn.36.8.0042","journal":"Psychiatric News","n_participants":125,"pmid":null,"source_url":"https://doi.org/10.1176/pn.36.8.0042","study_design":null,"title":"Few Alzheimer\u2019s Patients Get State-of-Art Care","title_match":false,"year":2001},{"alzhub_score":50,"alzhub_url":"https://alzhub.org/study/entering-and-exiting-the-medicare-part-d-coverage-gap-role-of-20217267","doi":"10.1007/s11606-010-1300-6","journal":"Journal of General Internal Medicine","n_participants":287713,"pmid":"20217267","source_url":"https://pubmed.ncbi.nlm.nih.gov/20217267/","study_design":null,"title":"Entering and Exiting the Medicare Part D Coverage Gap: Role of Comorbidities and Demographics","title_match":false,"year":2010},{"alzhub_score":37,"alzhub_url":"https://alzhub.org/study/the-impact-of-medicare-prescription-drug-coverage-on-the-use-of-23621892","doi":"10.1186/1471-2318-13-37","journal":"BMC Geriatrics","n_participants":null,"pmid":"23621892","source_url":"https://pubmed.ncbi.nlm.nih.gov/23621892/","study_design":null,"title":"The impact of Medicare prescription drug coverage on the use of antidementia drugs","title_match":false,"year":2013},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/appeals-system-and-its-outcomes-in-national-health-insurance-in-taiwan-16507607","doi":"10.1345/aph.1g437","journal":"Annals of Pharmacotherapy","n_participants":12237,"pmid":"16507607","source_url":"https://pubmed.ncbi.nlm.nih.gov/16507607/","study_design":null,"title":"Appeals System and Its Outcomes in National Health Insurance in Taiwan","title_match":false,"year":2006},{"alzhub_score":26,"alzhub_url":"https://alzhub.org/study/concomitant-cholinesterase-inhibitor-and-anticholinergic-drug-use-26f00cc1","doi":"10.1093/geroni/igaa057.842","journal":"Innovation in Aging","n_participants":null,"pmid":null,"source_url":"https://doi.org/10.1093/geroni/igaa057.842","study_design":null,"title":"Concomitant Cholinesterase Inhibitor and Anticholinergic Drug Use Among Older Adults With Dementia","title_match":true,"year":2020},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/p3401-impact-of-prescription-drug-coverage-on-use-of-antidementia-a1fc4a91","doi":"10.1016/j.jalz.2011.05.1844","journal":"Alzheimer s & Dementia","n_participants":35102,"pmid":null,"source_url":"https://doi.org/10.1016/j.jalz.2011.05.1844","study_design":"cohort study","title":"P3\u2010401: Impact of prescription drug coverage on use of anti\u2010dementia drugs","title_match":false,"year":2011},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/p3429-response-to-cholinesterase-inhibitor-medication-at-first-5ee8585a","doi":"10.1016/j.jalz.2010.05.1972","journal":"Alzheimer s & Dementia","n_participants":2678,"pmid":null,"source_url":"https://doi.org/10.1016/j.jalz.2010.05.1972","study_design":null,"title":"P3\u2010429: Response to cholinesterase inhibitor medication at first renewal in a Canadian provincial drug coverage initiative: the British Columbia Alzheimer's Drug Therapy Initiative (BC ADTI) experience","title_match":true,"year":2010},{"alzhub_score":44,"alzhub_url":"https://alzhub.org/study/primary-care-physicians-dementia-care-practices-evidence-of-19597058","doi":"10.1093/geront/gnp106","journal":"The Gerontologist","n_participants":422,"pmid":"19597058","source_url":"https://pubmed.ncbi.nlm.nih.gov/19597058/","study_design":"cross-sectional","title":"Primary Care Physicians' Dementia Care Practices: Evidence of Geographic Variation","title_match":false,"year":2009},{"alzhub_score":49,"alzhub_url":"https://alzhub.org/study/geographic-variation-of-antidementia-and-antipsychotic-medication-use-38833712","doi":"10.1097/mlr.0000000000002016","journal":"Medical Care","n_participants":9735,"pmid":"38833712","source_url":"https://pubmed.ncbi.nlm.nih.gov/38833712/","study_design":null,"title":"Geographic Variation of Antidementia and Antipsychotic Medication Use Among US Nursing Home Residents With Dementia","title_match":false,"year":2024},{"alzhub_score":58,"alzhub_url":"https://alzhub.org/study/using-data-linkage-for-national-surveillance-of-clinical-quality-34021203","doi":"10.1038/s41598-021-89646-x","journal":"Scientific Reports","n_participants":373695,"pmid":"34021203","source_url":"https://pubmed.ncbi.nlm.nih.gov/34021203/","study_design":"cohort study","title":"Using data linkage for national surveillance of clinical quality indicators for dementia care among Australian aged care users","title_match":false,"year":2021},{"alzhub_score":31,"alzhub_url":"https://alzhub.org/study/dementia-care-in-diverse-older-adults-in-the-deep-south-and-the-rest-3ac95d77","doi":"10.1002/alz.054038","journal":"Alzheimer s & Dementia","n_participants":null,"pmid":null,"source_url":"https://doi.org/10.1002/alz.054038","study_design":null,"title":"Dementia care in diverse older adults in the Deep South and the rest of the United States","title_match":false,"year":2021},{"alzhub_score":29,"alzhub_url":"https://alzhub.org/study/perspectivas-futuras-do-tratamento-farmacologico-para-doenca-de-f5f86458","doi":"10.55892/jrg.v8i18.2025","journal":"Revista JRG de Estudos Acad\u00eamicos","n_participants":null,"pmid":null,"source_url":"https://doi.org/10.55892/jrg.v8i18.2025","study_design":null,"title":"Perspectivas futuras do tratamento farmacol\u00f3gico para doen\u00e7a de Alzheimer: uma revis\u00e3o integrativa","title_match":false,"year":2025},{"alzhub_score":27,"alzhub_url":"https://alzhub.org/study/novel-drug-delivery-system-a-pandora-box-for-the-manage-ment-of-f13bd11e","doi":"10.4238/0fganh12","journal":"Genetics and Molecular Research","n_participants":null,"pmid":null,"source_url":"https://doi.org/10.4238/0fganh12","study_design":null,"title":"NOVEL DRUG DELIVERY SYSTEM: A PANDORA BOX FOR THE MANAGE MENT OF ALZHEIMER NOVEL DRUG DELIVERY IN ALZHEIMER","title_match":false,"year":2026},{"alzhub_score":26,"alzhub_url":"https://alzhub.org/study/exploring-the-pathogenesis-of-alzheimer-disease-in-basal-forebrain-521df110","doi":"10.25258/ijddt.16.32s.128","journal":"International Journal of Drug Delivery Technology","n_participants":null,"pmid":null,"source_url":"https://doi.org/10.25258/ijddt.16.32s.128","study_design":null,"title":"Exploring the Pathogenesis of Alzheimer Disease in Basal Forebrain Cholinergic Neurons and Converging Insights from Alternative Hypothesis","title_match":false,"year":2026},{"alzhub_score":27,"alzhub_url":"https://alzhub.org/study/alzheimer-disease-an-integrated-multidisciplinary-perspective-on-2448a12c","doi":"10.64483/202522763","journal":"Saudi Journal of Medicine and Public Health","n_participants":null,"pmid":null,"source_url":"https://doi.org/10.64483/202522763","study_design":"narrative review","title":"Alzheimer Disease: An Integrated Multidisciplinary Perspective on Pathophysiology, Diagnosis, Management, and Contemporary Therapeutic Advances for Pharmacists, Neurologists, Nurses, Health Information Professionals, and Healthcare Assistants","title_match":false,"year":2025},{"alzhub_score":28,"alzhub_url":"https://alzhub.org/study/neuropharmacology-of-alzheimer-disease-92336d40","doi":"10.5281/zenodo.17711756","journal":"Zenodo (CERN European Organization for Nuclear Research)","n_participants":null,"pmid":null,"source_url":"https://doi.org/10.5281/zenodo.17711756","study_design":null,"title":"Neuropharmacology of Alzheimer Disease","title_match":false,"year":2025},{"alzhub_score":39,"alzhub_url":"https://alzhub.org/study/neuropharmacology-of-alzheimer-disease-0c60ebd5","doi":"10.5281/zenodo.17711757","journal":"Zenodo (CERN European Organization for Nuclear Research)","n_participants":null,"pmid":null,"source_url":"https://doi.org/10.5281/zenodo.17711757","study_design":null,"title":"Neuropharmacology of Alzheimer Disease","title_match":false,"year":2025},{"alzhub_score":31,"alzhub_url":"https://alzhub.org/study/endogenous-lithium-levels-and-alzheimer-disease-41784383","doi":"10.1093/clinchem/hvaf174","journal":"Clinical Chemistry","n_participants":null,"pmid":"41784383","source_url":"https://pubmed.ncbi.nlm.nih.gov/41784383/","study_design":null,"title":"Endogenous Lithium Levels and Alzheimer Disease","title_match":false,"year":2025},{"alzhub_score":29,"alzhub_url":"https://alzhub.org/study/comprehensive-review-on-alzheimer-disease-causes-risk-factors-837ee353","doi":"10.5281/zenodo.18509182","journal":"Zenodo (CERN European Organization for Nuclear Research)","n_participants":null,"pmid":null,"source_url":"https://doi.org/10.5281/zenodo.18509182","study_design":null,"title":"Comprehensive Review on Alzheimer Disease: Causes, Risk Factors, Pathology, Mechanisms","title_match":false,"year":2026},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/comprehensive-review-on-alzheimer-disease-causes-risk-factors-54d0f1d7","doi":"10.5281/zenodo.18509183","journal":"Zenodo (CERN European Organization for Nuclear Research)","n_participants":null,"pmid":null,"source_url":"https://doi.org/10.5281/zenodo.18509183","study_design":null,"title":"Comprehensive Review on Alzheimer Disease: Causes, Risk Factors, Pathology, Mechanisms","title_match":false,"year":2026},{"alzhub_score":28,"alzhub_url":"https://alzhub.org/study/druggable-pathophysiologic-targets-in-alzheimer-disease-from-amyloid-42564518","doi":"10.12779/dnd.2026.25.3.152","journal":"Dementia and Neurocognitive Disorders","n_participants":null,"pmid":"42564518","source_url":"https://pubmed.ncbi.nlm.nih.gov/42564518/","study_design":null,"title":"Druggable Pathophysiologic Targets in Alzheimer Disease: From Amyloid and Tau to Biomarker-Guided Multimodal Therapy","title_match":false,"year":2026},{"alzhub_score":27,"alzhub_url":"https://alzhub.org/study/redefining-alzheimers-disease-through-modern-biotechnology-from-92541794","doi":"10.65035/w1y9ey43","journal":"Journal of medical & health sciences review.","n_participants":null,"pmid":null,"source_url":"https://doi.org/10.65035/w1y9ey43","study_design":null,"title":"REDEFINING ALZHEIMER\u2019S DISEASE THROUGH MODERN BIOTECHNOLOGY; FROM MOLECULAR PATHOGENESIS TO INNOVATIVE THERAPEUTICS AND DIAGNOSTIC FRONTIERS","title_match":false,"year":2025},{"alzhub_score":27,"alzhub_url":"https://alzhub.org/study/alzheimers-disease-pathophysiology-current-and-emerging-therapeutic-411be862","doi":"10.18231/j.ctppc.39626.1776405949","journal":"Current Trends in Pharmacy and Pharmaceutical Chemistry","n_participants":null,"pmid":null,"source_url":"https://doi.org/10.18231/j.ctppc.39626.1776405949","study_design":null,"title":"Alzheimer\u2019s disease: Pathophysiology, current and emerging therapeutic approaches for Alzheimer\u2019s disease","title_match":false,"year":2026},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/clinical-practice-guidelines-for-dementia-recommendations-for-the-39944528","doi":"10.12779/dnd.2025.24.1.24","journal":"Dementia and Neurocognitive Disorders","n_participants":null,"pmid":"39944528","source_url":"https://pubmed.ncbi.nlm.nih.gov/39944528/","study_design":null,"title":"Clinical Practice Guidelines for Dementia: Recommendations for the Pharmacological Treatment of Behavioral and Psychological Symptoms","title_match":false,"year":2025},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/cholinesterase-inhibitors-for-patients-with-dementia-patterns-of-41527747","doi":"10.1177/13872877251411418","journal":"Journal of Alzheimer s Disease","n_participants":null,"pmid":"41527747","source_url":"https://pubmed.ncbi.nlm.nih.gov/41527747/","study_design":null,"title":"Cholinesterase inhibitors for patients with dementia: Patterns of prescribing and disparities in treatment","title_match":true,"year":2026},{"alzhub_score":42,"alzhub_url":"https://alzhub.org/study/disparity-of-prescribed-psychotropics-in-alzheimers-disease-with-eff6a280","doi":"10.3390/pharma5010001","journal":"Pharmacoepidemiology","n_participants":6237,"pmid":null,"source_url":"https://doi.org/10.3390/pharma5010001","study_design":null,"title":"Disparity of Prescribed Psychotropics in Alzheimer\u2019s Disease with Neuropsychiatric Symptoms","title_match":false,"year":2025},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/vascular-cognitive-impairment-and-dementia-prevention-treatments-41554956","doi":"10.1038/s41386-026-02331-3","journal":"Neuropsychopharmacology","n_participants":null,"pmid":"41554956","source_url":"https://pubmed.ncbi.nlm.nih.gov/41554956/","study_design":null,"title":"Vascular cognitive impairment and dementia: Prevention, treatments, mechanisms and management options for the future","title_match":false,"year":2026},{"alzhub_score":46,"alzhub_url":"https://alzhub.org/study/dementia-in-a-resourceconstrained-subsaharan-african-setting-a-40110607","doi":"10.1002/alz.14538","journal":"Alzheimer s & Dementia","n_participants":null,"pmid":"40110607","source_url":"https://pubmed.ncbi.nlm.nih.gov/40110607/","study_design":null,"title":"Dementia in a resource\u2010constrained sub\u2010Saharan African setting: A comprehensive retrospective analysis of prevalence, risk factors, and management at the only neuropsychiatric facility in Northeastern Nigeria","title_match":false,"year":2025},{"alzhub_score":28,"alzhub_url":"https://alzhub.org/study/diabetes-and-dementia-current-data-ea341fb6","doi":"10.22141/2224-0721.21.2.2025.1521","journal":"INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine)","n_participants":null,"pmid":null,"source_url":"https://doi.org/10.22141/2224-0721.21.2.2025.1521","study_design":null,"title":"Diabetes and dementia: current data","title_match":false,"year":2025},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/current-strategies-in-the-management-of-dementia-with-lewy-bodies-and-40598239","doi":"10.1186/s13024-025-00856-7","journal":"Molecular Neurodegeneration","n_participants":null,"pmid":"40598239","source_url":"https://pubmed.ncbi.nlm.nih.gov/40598239/","study_design":null,"title":"Current strategies in the management of dementia with lewy bodies and future directions based on disease pathophysiology","title_match":false,"year":2025},{"alzhub_score":42,"alzhub_url":"https://alzhub.org/study/the-patient-pathway-for-mild-cognitive-impairment-due-to-alzheimers-40483260","doi":"10.1016/j.tjpad.2025.100215","journal":"The Journal of Prevention of Alzheimer s Disease","n_participants":31,"pmid":"40483260","source_url":"https://pubmed.ncbi.nlm.nih.gov/40483260/","study_design":null,"title":"The patient pathway for mild cognitive impairment due to Alzheimer\u2019s disease in Asia: Current practices, barriers, and expert recommendations for optimization","title_match":false,"year":2025},{"alzhub_score":49,"alzhub_url":"https://alzhub.org/study/the-impact-of-cholinesterase-inhibitors-on-cognitive-trajectories-in-41568736","doi":"10.1002/alz.70193","journal":"Alzheimer s & Dementia","n_participants":null,"pmid":"41568736","source_url":"https://pubmed.ncbi.nlm.nih.gov/41568736/","study_design":"longitudinal study","title":"The impact of cholinesterase inhibitors on cognitive trajectories in mild cognitive impairment patients based on amyloid beta status","title_match":true,"year":2025},{"alzhub_score":33,"alzhub_url":"https://alzhub.org/study/developments-on-bace-1-inhibitors-as-antialzheimer-agents-a-41838033","doi":"10.1002/ardp.70220","journal":"Archiv der Pharmazie","n_participants":null,"pmid":"41838033","source_url":"https://pubmed.ncbi.nlm.nih.gov/41838033/","study_design":null,"title":"Developments on BACE 1 Inhibitors as Anti\u2010Alzheimer Agents: A Perspective on Medicinal Chemistry\u2010Based Advances","title_match":false,"year":2026},{"alzhub_score":42,"alzhub_url":"https://alzhub.org/study/effectiveness-of-acetylcholinesterase-inhibitors-and-memantine-in-41396413","doi":"10.1007/s11357-025-02052-3","journal":"GeroScience","n_participants":703,"pmid":"41396413","source_url":"https://pubmed.ncbi.nlm.nih.gov/41396413/","study_design":null,"title":"Effectiveness of acetylcholinesterase inhibitors and memantine in patients affected by severe dementia","title_match":true,"year":2025},{"alzhub_score":61,"alzhub_url":"https://alzhub.org/study/sex-differences-in-amyloid-pet-in-a-large-realworld-sample-from-the-40415175","doi":"10.1002/alz.70304","journal":"Alzheimer s & Dementia","n_participants":10361,"pmid":"40415175","source_url":"https://pubmed.ncbi.nlm.nih.gov/40415175/","study_design":null,"title":"Sex differences in amyloid PET in a large, real\u2010world sample from the Imaging Dementia\u2013Evidence for Amyloid Scanning (IDEAS) Study","title_match":false,"year":2025},{"alzhub_score":54,"alzhub_url":"https://alzhub.org/study/cognitive-impairment-dementia-and-depression-in-older-adults-41682879","doi":"10.3390/jcm15031198","journal":"Journal of Clinical Medicine","n_participants":null,"pmid":"41682879","source_url":"https://pubmed.ncbi.nlm.nih.gov/41682879/","study_design":"cohort study","title":"Cognitive Impairment, Dementia and Depression in Older Adults","title_match":false,"year":2026},{"alzhub_score":39,"alzhub_url":"https://alzhub.org/study/empagliflozin-and-memantine-combination-ameliorates-cognitive-40325262","doi":"10.1007/s10787-025-01755-5","journal":"Inflammopharmacology","n_participants":null,"pmid":"40325262","source_url":"https://pubmed.ncbi.nlm.nih.gov/40325262/","study_design":null,"title":"Empagliflozin and memantine combination ameliorates cognitive impairment in scopolamine + heavy metal mixture-induced Alzheimer\u2019s disease in rats: role of AMPK/mTOR, BDNF, BACE-1, neuroinflammation, and oxidative stress","title_match":true,"year":2025},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/benzoxazole-derivatives-as-dual-p38-mitogenactivated-protein-kinase-41047159","doi":"10.1002/cmdc.202500669","journal":"ChemMedChem","n_participants":31,"pmid":"41047159","source_url":"https://pubmed.ncbi.nlm.nih.gov/41047159/","study_design":null,"title":"Benzoxazole Derivatives as Dual p38\u03b1 Mitogen\u2010Activated Protein Kinase and Acetylcholinesterase Inhibitors: Design, Synthesis, and Evaluation for Alzheimer's Disease and Cancer Therapy","title_match":true,"year":2025},{"alzhub_score":32,"alzhub_url":"https://alzhub.org/study/a-review-on-recent-advances-in-alzheimer-s-disease-the-role-of-40717739","doi":"10.3934/neuroscience.2025006","journal":"AIMS neuroscience","n_participants":null,"pmid":"40717739","source_url":"https://pubmed.ncbi.nlm.nih.gov/40717739/","study_design":null,"title":"A review on recent advances in Alzheimer's disease: The role of synaptic plasticity","title_match":false,"year":2025},{"alzhub_score":49,"alzhub_url":"https://alzhub.org/study/a-2025-update-on-treatment-strategies-for-the-alzheimers-disease-40442885","doi":"10.1097/jcma.0000000000001252","journal":"Journal of the Chinese Medical Association","n_participants":null,"pmid":"40442885","source_url":"https://pubmed.ncbi.nlm.nih.gov/40442885/","study_design":null,"title":"A 2025 update on treatment strategies for the Alzheimer\u2019s disease spectrum","title_match":false,"year":2025},{"alzhub_score":44,"alzhub_url":"https://alzhub.org/study/acetylcholinesterase-inhibitors-and-the-risk-of-delirium-a-danish-42050692","doi":"10.1186/s13195-026-02060-1","journal":"Alzheimer s Research & Therapy","n_participants":45651,"pmid":"42050692","source_url":"https://pubmed.ncbi.nlm.nih.gov/42050692/","study_design":null,"title":"Acetylcholinesterase inhibitors and the risk of delirium \u2013 a Danish nationwide register-based cohort study","title_match":true,"year":2026},{"alzhub_score":51,"alzhub_url":"https://alzhub.org/study/continued-use-of-cholinesterase-inhibitors-and-memantine-in-hospice-40126467","doi":"10.1001/jamainternmed.2024.8579","journal":"JAMA Internal Medicine","n_participants":null,"pmid":"40126467","source_url":"https://pubmed.ncbi.nlm.nih.gov/40126467/","study_design":"cohort study","title":"Continued Use of Cholinesterase Inhibitors and Memantine in Hospice","title_match":true,"year":2025},{"alzhub_score":28,"alzhub_url":"https://alzhub.org/study/neuropalliative-care-in-dementia-41328935","doi":"10.1212/cont.0000000000001639","journal":"CONTINUUM Lifelong Learning in Neurology","n_participants":null,"pmid":"41328935","source_url":"https://pubmed.ncbi.nlm.nih.gov/41328935/","study_design":null,"title":"Neuropalliative Care in Dementia","title_match":false,"year":2025},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/pharmacotherapy-for-poststroke-cognitive-impairment-and-poststroke-40421258","doi":"10.1155/srat/6893801","journal":"Stroke Research and Treatment","n_participants":null,"pmid":"40421258","source_url":"https://pubmed.ncbi.nlm.nih.gov/40421258/","study_design":null,"title":"Pharmacotherapy for Poststroke Cognitive Impairment and Poststroke Cognitive Impairment With Dementia: A Review","title_match":false,"year":2025},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/long-term-effect-of-discontinuing-anticholinesterase-treatment-on-41732331","doi":"10.1016/j.lanepe.2026.101607","journal":"The Lancet regional health. Europe","n_participants":null,"pmid":"41732331","source_url":"https://pubmed.ncbi.nlm.nih.gov/41732331/","study_design":null,"title":"Long-term effect of discontinuing anticholinesterase treatment on cognitive decline and mortality in Alzheimer's disease in France: a quasi-experiment and target trial emulation study","title_match":false,"year":2026},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/rapid-health-technology-assessment-of-galantamine-for-the-treatment-40489822","doi":"10.1097/MD.0000000000042744","journal":"Medicine","n_participants":null,"pmid":"40489822","source_url":"https://pubmed.ncbi.nlm.nih.gov/40489822/","study_design":"systematic review","title":"Rapid health technology assessment of galantamine for the treatment of Alzheimer's disease: A review","title_match":true,"year":2025},{"alzhub_score":42,"alzhub_url":"https://alzhub.org/study/impact-of-modifications-to-antidementia-drug-reimbursement-in-france-38925159","doi":"10.1111/bcp.16143","journal":"British journal of clinical pharmacology","n_participants":120,"pmid":"38925159","source_url":"https://pubmed.ncbi.nlm.nih.gov/38925159/","study_design":null,"title":"Impact of modifications to antidementia drug reimbursement in France: Analysis of the FRA-DEM cohort","title_match":false,"year":2024},{"alzhub_score":30,"alzhub_url":"https://alzhub.org/study/analysis-of-japanese-nationwide-health-datasets-association-between-37439280","doi":"10.1515/sjpain-2023-0010","journal":"Scandinavian journal of pain","n_participants":null,"pmid":"37439280","source_url":"https://pubmed.ncbi.nlm.nih.gov/37439280/","study_design":null,"title":"Analysis of Japanese nationwide health datasets: association between lifestyle habits and prevalence of neuropathic pain and fibromyalgia with reference to dementia-related diseases and Parkinson's disease","title_match":false,"year":2023},{"alzhub_score":34,"alzhub_url":"https://alzhub.org/study/effectiveness-of-the-10-cm2-rivastigmine-patch-in-taiwanese-patients-34506009","doi":"10.1007/s12325-021-01893-6","journal":"Advances in therapy","n_participants":null,"pmid":"34506009","source_url":"https://pubmed.ncbi.nlm.nih.gov/34506009/","study_design":"open-label trial","title":"Effectiveness of the 10 cm2 Rivastigmine Patch in Taiwanese Patients with Mild-to-Moderate Alzheimer's Dementia: A 48-Week Real-World Observational Study","title_match":true,"year":2021},{"alzhub_score":44,"alzhub_url":"https://alzhub.org/study/alzheimer-s-disease-treated-patients-showed-different-patterns-for-23871825","doi":"10.1016/j.fct.2013.07.013","journal":"Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association","n_participants":null,"pmid":"23871825","source_url":"https://pubmed.ncbi.nlm.nih.gov/23871825/","study_design":null,"title":"Alzheimer's disease treated patients showed different patterns for oxidative stress and inflammation markers","title_match":false,"year":2013},{"alzhub_score":44,"alzhub_url":"https://alzhub.org/study/amyloid-precursor-protein-in-platelets-of-patients-with-alzheimer-11255448","doi":"10.1001/archneur.58.3.442","journal":"Archives of neurology","n_participants":30,"pmid":"11255448","source_url":"https://pubmed.ncbi.nlm.nih.gov/11255448/","study_design":"clinical trial","title":"Amyloid precursor protein in platelets of patients with Alzheimer disease: effect of acetylcholinesterase inhibitor treatment","title_match":true,"year":2001},{"alzhub_score":37,"alzhub_url":"https://alzhub.org/study/plasma-levels-of-abeta42-and-abeta40-in-alzheimer-patients-during-12218259","doi":"10.1159/000063605","journal":"Dementia and geriatric cognitive disorders","n_participants":null,"pmid":"12218259","source_url":"https://pubmed.ncbi.nlm.nih.gov/12218259/","study_design":"clinical trial","title":"Plasma levels of Abeta42 and Abeta40 in Alzheimer patients during treatment with the acetylcholinesterase inhibitor tacrine","title_match":true,"year":2002},{"alzhub_score":51,"alzhub_url":"https://alzhub.org/study/two-year-follow-up-of-amyloid-deposition-in-patients-with-alzheimer-s-16854944","doi":"10.1093/brain/awl178","journal":"Brain","n_participants":null,"pmid":"16854944","source_url":"https://pubmed.ncbi.nlm.nih.gov/16854944/","study_design":null,"title":"Two-year follow-up of amyloid deposition in patients with Alzheimer's disease","title_match":false,"year":2006},{"alzhub_score":72,"alzhub_url":"https://alzhub.org/study/memantine-for-dementia-12917950","doi":"10.1002/14651858.cd003154","journal":"The Cochrane database of systematic reviews","n_participants":null,"pmid":"12917950","source_url":"https://pubmed.ncbi.nlm.nih.gov/12917950/","study_design":null,"title":"Memantine for dementia","title_match":true,"year":2003},{"alzhub_score":83,"alzhub_url":"https://alzhub.org/study/donepezil-for-dementia-due-to-alzheimer-s-disease-16437430","doi":"10.1002/14651858.cd001190.pub2","journal":"The Cochrane database of systematic reviews","n_participants":5272,"pmid":"16437430","source_url":"https://pubmed.ncbi.nlm.nih.gov/16437430/","study_design":null,"title":"Donepezil for dementia due to Alzheimer's disease","title_match":true,"year":2006},{"alzhub_score":72,"alzhub_url":"https://alzhub.org/study/memantine-for-dementia-16625572","doi":"10.1002/14651858.cd003154.pub5","journal":"The Cochrane database of systematic reviews","n_participants":null,"pmid":"16625572","source_url":"https://pubmed.ncbi.nlm.nih.gov/16625572/","study_design":null,"title":"Memantine for dementia","title_match":true,"year":2006},{"alzhub_score":78,"alzhub_url":"https://alzhub.org/study/donepezil-for-dementia-due-to-alzheimer-s-disease-12917900","doi":"10.1002/14651858.cd001190","journal":"The Cochrane database of systematic reviews","n_participants":4365,"pmid":"12917900","source_url":"https://pubmed.ncbi.nlm.nih.gov/12917900/","study_design":null,"title":"Donepezil for dementia due to Alzheimer's disease","title_match":true,"year":2003},{"alzhub_score":78,"alzhub_url":"https://alzhub.org/study/rivastigmine-for-alzheimer-s-disease-11034705","doi":"10.1002/14651858.cd001191","journal":"The Cochrane database of systematic reviews","n_participants":3370,"pmid":"11034705","source_url":"https://pubmed.ncbi.nlm.nih.gov/11034705/","study_design":null,"title":"Rivastigmine for Alzheimer's disease","title_match":true,"year":2000},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/dementia-with-lewy-bodies-14693108","doi":"10.1016/s1474-4422(03)00619-7","journal":"The Lancet. Neurology","n_participants":null,"pmid":"14693108","source_url":"https://pubmed.ncbi.nlm.nih.gov/14693108/","study_design":null,"title":"Dementia with Lewy bodies","title_match":false,"year":2004},{"alzhub_score":47,"alzhub_url":"https://alzhub.org/study/pharmacological-treatment-and-prevention-of-cerebral-small-vessel-25727737","doi":"10.1111/ijs.12466","journal":"International journal of stroke : official journal of the International Stroke Society","n_participants":null,"pmid":"25727737","source_url":"https://pubmed.ncbi.nlm.nih.gov/25727737/","study_design":null,"title":"Pharmacological treatment and prevention of cerebral small vessel disease: a review of potential interventions","title_match":false,"year":2015},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/galantamine-induced-amyloid-beta-clearance-mediated-via-stimulation-20947502","doi":"10.1074/jbc.m110.142356","journal":"The Journal of biological chemistry","n_participants":null,"pmid":"20947502","source_url":"https://pubmed.ncbi.nlm.nih.gov/20947502/","study_design":null,"title":"Galantamine-induced amyloid-{beta} clearance mediated via stimulation of microglial nicotinic acetylcholine receptors","title_match":true,"year":2010},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/current-pharmacotherapy-for-alzheimer-s-disease-16409164","doi":"10.1146/annurev.med.57.121304.131442","journal":"Annual review of medicine","n_participants":null,"pmid":"16409164","source_url":"https://pubmed.ncbi.nlm.nih.gov/16409164/","study_design":null,"title":"Current pharmacotherapy for Alzheimer's disease","title_match":false,"year":2006},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/synuclein-oligomers-induce-glutamate-release-from-astrocytes-and-33483428","doi":"10.1523/jneurosci.1871-20.2020","journal":"The Journal of neuroscience : the official journal of the Society for Neuroscience","n_participants":null,"pmid":"33483428","source_url":"https://pubmed.ncbi.nlm.nih.gov/33483428/","study_design":null,"title":"\u03b1-Synuclein Oligomers Induce Glutamate Release from Astrocytes and Excessive Extrasynaptic NMDAR Activity in Neurons, Thus Contributing to Synapse Loss","title_match":false,"year":2021},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/calcium-flux-independent-nmda-receptor-activity-is-required-for-a-26086964","doi":"10.1038/cddis.2015.160","journal":"Cell death & disease","n_participants":null,"pmid":"26086964","source_url":"https://pubmed.ncbi.nlm.nih.gov/26086964/","study_design":null,"title":"Calcium flux-independent NMDA receptor activity is required for A\u03b2 oligomer-induced synaptic loss","title_match":false,"year":2015},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/small-molecule-therapeutics-for-tauopathy-in-alzheimer-s-disease-33139110","doi":"10.1016/j.ejmech.2020.112915","journal":"European journal of medicinal chemistry","n_participants":null,"pmid":"33139110","source_url":"https://pubmed.ncbi.nlm.nih.gov/33139110/","study_design":null,"title":"Small molecule therapeutics for tauopathy in Alzheimer's disease: Walking on the path of most resistance","title_match":false,"year":2021},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/alzheimer-s-disease-molecular-aspects-and-treatment-opportunities-37224884","doi":"10.1016/j.arr.2023.101960","journal":"Ageing research reviews","n_participants":null,"pmid":"37224884","source_url":"https://pubmed.ncbi.nlm.nih.gov/37224884/","study_design":null,"title":"Alzheimer's disease: Molecular aspects and treatment opportunities using herbal drugs","title_match":false,"year":2023},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/cognitive-impairment-in-parkinson-s-disease-and-dementia-with-lewy-26411499","doi":"10.1016/j.parkreldis.2015.09.034","journal":"Parkinsonism & related disorders","n_participants":null,"pmid":"26411499","source_url":"https://pubmed.ncbi.nlm.nih.gov/26411499/","study_design":null,"title":"Cognitive impairment in Parkinson's disease and dementia with Lewy bodies","title_match":false,"year":2016},{"alzhub_score":64,"alzhub_url":"https://alzhub.org/study/clinical-practice-with-anti-dementia-drugs-a-consensus-statement-from-17060346","doi":"10.1177/0269881106068299","journal":"Journal of psychopharmacology (Oxford, England)","n_participants":null,"pmid":"17060346","source_url":"https://pubmed.ncbi.nlm.nih.gov/17060346/","study_design":"meta-analysis","title":"Clinical practice with anti-dementia drugs: a consensus statement from British Association for Psychopharmacology","title_match":false,"year":2006},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/approach-to-cognitive-impairment-in-parkinson-s-disease-33205381","doi":"10.1007/s13311-020-00963-x","journal":"Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics","n_participants":null,"pmid":"33205381","source_url":"https://pubmed.ncbi.nlm.nih.gov/33205381/","study_design":null,"title":"Approach to Cognitive Impairment in Parkinson's Disease","title_match":false,"year":2020},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/a-practical-algorithm-for-managing-alzheimer-s-disease-what-when-and-25815358","doi":"10.1002/acn3.166","journal":"Annals of clinical and translational neurology","n_participants":null,"pmid":"25815358","source_url":"https://pubmed.ncbi.nlm.nih.gov/25815358/","study_design":null,"title":"A practical algorithm for managing Alzheimer's disease: what, when, and why?","title_match":false,"year":2015},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/insights-into-the-neuroprotective-effects-of-i-salvia-officinalis-i-l-35137748","doi":"10.1039/d1fo02988f","journal":"Food & function","n_participants":null,"pmid":"35137748","source_url":"https://pubmed.ncbi.nlm.nih.gov/35137748/","study_design":null,"title":"Insights into the neuroprotective effects of Salvia officinalis L. and Salvia microphylla Kunth in the memory impairment rat model","title_match":false,"year":2022},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/effects-of-cholinergic-drugs-and-cognitive-training-on-dementia-15084794","doi":"10.1159/000077735","journal":"Dementia and geriatric cognitive disorders","n_participants":null,"pmid":"15084794","source_url":"https://pubmed.ncbi.nlm.nih.gov/15084794/","study_design":null,"title":"Effects of cholinergic drugs and cognitive training on dementia","title_match":false,"year":2004},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/neuropsychological-rehabilitation-of-memory-deficits-and-activities-15517089","doi":"10.1590/s0100-879x2004001100018","journal":"Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas","n_participants":null,"pmid":"15517089","source_url":"https://pubmed.ncbi.nlm.nih.gov/15517089/","study_design":null,"title":"Neuropsychological rehabilitation of memory deficits and activities of daily living in patients with Alzheimer's disease: a pilot study","title_match":false,"year":2004},{"alzhub_score":78,"alzhub_url":"https://alzhub.org/study/psychosocial-interventions-for-alzheimer-s-disease-cognitive-symptoms-30086714","doi":"10.1186/s12877-018-0864-6","journal":"BMC geriatrics","n_participants":682,"pmid":"30086714","source_url":"https://pubmed.ncbi.nlm.nih.gov/30086714/","study_design":"meta-analysis","title":"Psychosocial interventions for Alzheimer's disease cognitive symptoms: a Bayesian network meta-analysis","title_match":false,"year":2018},{"alzhub_score":72,"alzhub_url":"https://alzhub.org/study/one-year-repeated-cycles-of-cognitive-training-ct-for-alzheimer-s-23784727","doi":"10.1007/s40520-013-0065-2","journal":"Aging clinical and experimental research","n_participants":16,"pmid":"23784727","source_url":"https://pubmed.ncbi.nlm.nih.gov/23784727/","study_design":"randomized controlled trial","title":"One-year repeated cycles of cognitive training (CT) for Alzheimer's disease","title_match":false,"year":2013},{"alzhub_score":78,"alzhub_url":"https://alzhub.org/study/rivastigmine-for-gait-stability-in-patients-with-parkinson-s-disease-26795874","doi":"10.1016/s1474-4422(15)00389-0","journal":"The Lancet. Neurology","n_participants":130,"pmid":"26795874","source_url":"https://pubmed.ncbi.nlm.nih.gov/26795874/","study_design":"clinical trial","title":"Rivastigmine for gait stability in patients with Parkinson's disease (ReSPonD): a randomised, double-blind, placebo-controlled, phase 2 trial","title_match":true,"year":2016},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/the-interplay-of-cholinergic-function-attention-and-falls-in-21898597","doi":"10.1002/mds.23932","journal":"Movement disorders : official journal of the Movement Disorder Society","n_participants":null,"pmid":"21898597","source_url":"https://pubmed.ncbi.nlm.nih.gov/21898597/","study_design":null,"title":"The interplay of cholinergic function, attention, and falls in Parkinson's disease","title_match":false,"year":2011},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/prior-pathology-in-the-basal-forebrain-cholinergic-system-predisposes-22553034","doi":"10.1523/jneurosci.4673-11.2012","journal":"The Journal of neuroscience : the official journal of the Society for Neuroscience","n_participants":null,"pmid":"22553034","source_url":"https://pubmed.ncbi.nlm.nih.gov/22553034/","study_design":null,"title":"Prior pathology in the basal forebrain cholinergic system predisposes to inflammation-induced working memory deficits: reconciling inflammatory and cholinergic hypotheses of delirium","title_match":false,"year":2012},{"alzhub_score":76,"alzhub_url":"https://alzhub.org/study/donepezil-in-the-prevention-and-treatment-of-post-surgical-delirium-16319303","doi":"10.1176/appi.ajgp.13.12.1100","journal":"The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry","n_participants":80,"pmid":"16319303","source_url":"https://pubmed.ncbi.nlm.nih.gov/16319303/","study_design":null,"title":"Donepezil in the prevention and treatment of post-surgical delirium","title_match":true,"year":2005},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/psychiatric-aspects-of-parkinson-s-disease-an-update-15258780","doi":"10.1007/s00415-004-0483-3","journal":"Journal of neurology","n_participants":null,"pmid":"15258780","source_url":"https://pubmed.ncbi.nlm.nih.gov/15258780/","study_design":null,"title":"Psychiatric aspects of Parkinson's disease--an update","title_match":false,"year":2004},{"alzhub_score":76,"alzhub_url":"https://alzhub.org/study/a-randomized-double-blind-placebo-controlled-trial-of-donepezil-17006875","doi":"10.1002/gps.1679","journal":"International journal of geriatric psychiatry","n_participants":95,"pmid":"17006875","source_url":"https://pubmed.ncbi.nlm.nih.gov/17006875/","study_design":"randomized controlled trial","title":"A randomized, double-blind, placebo-controlled trial of donepezil hydrochloride (Aricept) for reducing the incidence of postoperative delirium after elective total hip replacement","title_match":true,"year":2007},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/sundown-syndrome-in-persons-with-dementia-an-update-22216036","doi":"10.4306/pi.2011.8.4.275","journal":"Psychiatry investigation","n_participants":null,"pmid":"22216036","source_url":"https://pubmed.ncbi.nlm.nih.gov/22216036/","study_design":null,"title":"Sundown syndrome in persons with dementia: an update","title_match":false,"year":2011},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/enhancing-dementia-care-a-primary-care-based-memory-clinic-20977435","doi":"10.1111/j.1532-5415.2010.03130.x","journal":"Journal of the American Geriatrics Society","n_participants":151,"pmid":"20977435","source_url":"https://pubmed.ncbi.nlm.nih.gov/20977435/","study_design":null,"title":"Enhancing dementia care: a primary care-based memory clinic","title_match":false,"year":2010},{"alzhub_score":71,"alzhub_url":"https://alzhub.org/study/european-stroke-organisation-and-european-academy-of-neurology-joint-34746430","doi":"10.1177/23969873211042192","journal":"European stroke journal","n_participants":null,"pmid":"34746430","source_url":"https://pubmed.ncbi.nlm.nih.gov/34746430/","study_design":"randomized controlled trial","title":"European Stroke Organisation and European Academy of Neurology joint guidelines on post-stroke cognitive impairment","title_match":false,"year":2021},{"alzhub_score":74,"alzhub_url":"https://alzhub.org/study/multicomponent-geriatric-intervention-for-elderly-inpatients-with-16510862","doi":"10.1093/gerona/61.2.176","journal":"The journals of gerontology. Series A, Biological sciences and medical sciences","n_participants":87,"pmid":"16510862","source_url":"https://pubmed.ncbi.nlm.nih.gov/16510862/","study_design":null,"title":"Multicomponent geriatric intervention for elderly inpatients with delirium: a randomized, controlled trial","title_match":false,"year":2006},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/a-comparison-of-sleep-profiles-in-patients-with-dementia-with-lewy-11113983","doi":"10.1002/1099-1166(200011)15:11<1028::aid-gps227>3.0.co;2-e","journal":"International journal of geriatric psychiatry","n_participants":null,"pmid":"11113983","source_url":"https://pubmed.ncbi.nlm.nih.gov/11113983/","study_design":null,"title":"A comparison of sleep profiles in patients with dementia with lewy bodies and Alzheimer's disease","title_match":false,"year":2000},{"alzhub_score":69,"alzhub_url":"https://alzhub.org/study/dementia-medications-and-risk-of-falls-syncope-and-related-adverse-21649634","doi":"10.1111/j.1532-5415.2011.03450.x","journal":"Journal of the American Geriatrics Society","n_participants":null,"pmid":"21649634","source_url":"https://pubmed.ncbi.nlm.nih.gov/21649634/","study_design":"meta-analysis","title":"Dementia medications and risk of falls, syncope, and related adverse events: meta-analysis of randomized controlled trials","title_match":false,"year":2011},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/treatment-of-psychosis-and-dementia-in-parkinson-s-disease-24464490","doi":"10.1007/s11940-013-0281-2","journal":"Current treatment options in neurology","n_participants":null,"pmid":"24464490","source_url":"https://pubmed.ncbi.nlm.nih.gov/24464490/","study_design":null,"title":"Treatment of psychosis and dementia in Parkinson's disease","title_match":false,"year":2014},{"alzhub_score":64,"alzhub_url":"https://alzhub.org/study/daily-medication-use-in-nursing-home-residents-with-advanced-dementia-20406320","doi":"10.1111/j.1532-5415.2010.02819.x","journal":"Journal of the American Geriatrics Society","n_participants":323,"pmid":"20406320","source_url":"https://pubmed.ncbi.nlm.nih.gov/20406320/","study_design":"cohort study","title":"Daily medication use in nursing home residents with advanced dementia","title_match":false,"year":2010},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/withholding-discontinuing-and-withdrawing-medications-in-dementia-20524704","doi":"10.2165/11536760-000000000-00000","journal":"Drugs & aging","n_participants":null,"pmid":"20524704","source_url":"https://pubmed.ncbi.nlm.nih.gov/20524704/","study_design":null,"title":"Withholding, discontinuing and withdrawing medications in dementia patients at the end of life: a neglected problem in the disadvantaged dying?","title_match":false,"year":2010},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/cholinesterase-inhibitor-and-n-methyl-d-aspartic-acid-receptor-19622011","doi":"10.1089/jpm.2009.0059","journal":"Journal of palliative medicine","n_participants":null,"pmid":"19622011","source_url":"https://pubmed.ncbi.nlm.nih.gov/19622011/","study_design":null,"title":"Cholinesterase inhibitor and N-methyl-D-aspartic acid receptor antagonist use in older adults with end-stage dementia: a survey of hospice medical directors","title_match":true,"year":2009},{"alzhub_score":72,"alzhub_url":"https://alzhub.org/study/randomized-placebo-controlled-trial-of-the-effects-of-donepezil-on-14594748","doi":"10.1176/appi.ajp.160.11.2003","journal":"The American journal of psychiatry","n_participants":67,"pmid":"14594748","source_url":"https://pubmed.ncbi.nlm.nih.gov/14594748/","study_design":null,"title":"Randomized, placebo-controlled trial of the effects of donepezil on neuronal markers and hippocampal volumes in Alzheimer's disease","title_match":true,"year":2003},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/cholinergic-enhancement-of-frontal-lobe-activity-in-mild-cognitive-15140813","doi":"10.1093/brain/awh177","journal":"Brain : a journal of neurology","n_participants":null,"pmid":"15140813","source_url":"https://pubmed.ncbi.nlm.nih.gov/15140813/","study_design":null,"title":"Cholinergic enhancement of frontal lobe activity in mild cognitive impairment","title_match":false,"year":2004},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/memantine-is-a-clinically-well-tolerated-n-methyl-d-aspartate-nmda-10465680","doi":"10.1016/s0028-3908(99)00019-2","journal":"Neuropharmacology","n_participants":null,"pmid":"10465680","source_url":"https://pubmed.ncbi.nlm.nih.gov/10465680/","study_design":null,"title":"Memantine is a clinically well tolerated N-methyl-D-aspartate (NMDA) receptor antagonist--a review of preclinical data","title_match":true,"year":1999},{"alzhub_score":69,"alzhub_url":"https://alzhub.org/study/pharmacological-treatment-of-neuropsychiatric-symptoms-of-dementia-a-15687315","doi":"10.1001/jama.293.5.596","journal":"JAMA","n_participants":null,"pmid":"15687315","source_url":"https://pubmed.ncbi.nlm.nih.gov/15687315/","study_design":"systematic review","title":"Pharmacological treatment of neuropsychiatric symptoms of dementia: a review of the evidence","title_match":false,"year":2005},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/the-clinical-diagnostic-utility-of-transcranial-magnetic-stimulation-18063409","doi":"10.1016/j.clinph.2007.10.014","journal":"Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology","n_participants":null,"pmid":"18063409","source_url":"https://pubmed.ncbi.nlm.nih.gov/18063409/","study_design":null,"title":"The clinical diagnostic utility of transcranial magnetic stimulation: report of an IFCN committee","title_match":false,"year":2008},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/the-smallest-stroke-occlusion-of-one-penetrating-vessel-leads-to-23242312","doi":"10.1038/nn.3278","journal":"Nature neuroscience","n_participants":null,"pmid":"23242312","source_url":"https://pubmed.ncbi.nlm.nih.gov/23242312/","study_design":null,"title":"The smallest stroke: occlusion of one penetrating vessel leads to infarction and a cognitive deficit","title_match":false,"year":2013},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/failures-and-successes-of-nmda-receptor-antagonists-molecular-basis-15717010","doi":"10.1602/neurorx.1.1.101","journal":"NeuroRx : the journal of the American Society for Experimental NeuroTherapeutics","n_participants":null,"pmid":"15717010","source_url":"https://pubmed.ncbi.nlm.nih.gov/15717010/","study_design":null,"title":"Failures and successes of NMDA receptor antagonists: molecular basis for the use of open-channel blockers like memantine in the treatment of acute and chronic neurologic insults","title_match":true,"year":2004},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/management-of-agitation-and-aggression-associated-with-alzheimer-19488082","doi":"10.1038/nrneurol.2009.39","journal":"Nature reviews. Neurology","n_participants":null,"pmid":"19488082","source_url":"https://pubmed.ncbi.nlm.nih.gov/19488082/","study_design":null,"title":"Management of agitation and aggression associated with Alzheimer disease","title_match":false,"year":2009},{"alzhub_score":47,"alzhub_url":"https://alzhub.org/study/glutamate-based-therapeutic-approaches-clinical-trials-with-nmda-16359918","doi":"10.1016/j.coph.2005.12.002","journal":"Current opinion in pharmacology","n_participants":9000,"pmid":"16359918","source_url":"https://pubmed.ncbi.nlm.nih.gov/16359918/","study_design":null,"title":"Glutamate-based therapeutic approaches: clinical trials with NMDA antagonists","title_match":false,"year":2006},{"alzhub_score":62,"alzhub_url":"https://alzhub.org/study/donepezil-in-vascular-dementia-a-randomized-placebo-controlled-study-12939421","doi":"10.1212/01.wnl.0000078943.50032.fc","journal":"Neurology","n_participants":616,"pmid":"12939421","source_url":"https://pubmed.ncbi.nlm.nih.gov/12939421/","study_design":null,"title":"Donepezil in vascular dementia: a randomized, placebo-controlled study","title_match":true,"year":2003},{"alzhub_score":77,"alzhub_url":"https://alzhub.org/study/efficacy-and-tolerability-of-donepezil-in-vascular-dementia-positive-12970516","doi":"10.1161/01.str.0000091396.95360.e1","journal":"Stroke","n_participants":603,"pmid":"12970516","source_url":"https://pubmed.ncbi.nlm.nih.gov/12970516/","study_design":null,"title":"Efficacy and tolerability of donepezil in vascular dementia: positive results of a 24-week, multicenter, international, randomized, placebo-controlled clinical trial","title_match":true,"year":2003},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/dementia-of-alzheimer-s-disease-and-other-neurodegenerative-disorders-15519530","doi":"10.1016/j.phrs.2004.05.005","journal":"Pharmacological research","n_participants":null,"pmid":"15519530","source_url":"https://pubmed.ncbi.nlm.nih.gov/15519530/","study_design":null,"title":"Dementia of Alzheimer's disease and other neurodegenerative disorders--memantine, a new hope","title_match":true,"year":2005},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/galantamine-improves-cognition-hippocampal-inflammation-and-synaptic-29669582","doi":"10.1186/s12974-018-1141-5","journal":"Journal of neuroinflammation","n_participants":null,"pmid":"29669582","source_url":"https://pubmed.ncbi.nlm.nih.gov/29669582/","study_design":null,"title":"Galantamine improves cognition, hippocampal inflammation, and synaptic plasticity impairments induced by lipopolysaccharide in mice","title_match":true,"year":2018},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/neuroprotection-by-memantine-against-neurodegeneration-induced-by-12468047","doi":"10.1016/s0006-8993(02)03731-9","journal":"Brain research","n_participants":null,"pmid":"12468047","source_url":"https://pubmed.ncbi.nlm.nih.gov/12468047/","study_design":null,"title":"Neuroprotection by memantine against neurodegeneration induced by beta-amyloid(1-40)","title_match":true,"year":2002},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/discovery-of-a-potent-dual-inhibitor-of-acetylcholinesterase-and-33356266","doi":"10.1021/acs.jmedchem.0c01775","journal":"Journal of medicinal chemistry","n_participants":null,"pmid":"33356266","source_url":"https://pubmed.ncbi.nlm.nih.gov/33356266/","study_design":null,"title":"Discovery of a Potent Dual Inhibitor of Acetylcholinesterase and Butyrylcholinesterase with Antioxidant Activity that Alleviates Alzheimer-like Pathology in Old APP/PS1 Mice","title_match":false,"year":2021},{"alzhub_score":75,"alzhub_url":"https://alzhub.org/study/a-phase-ii-trial-of-tideglusib-in-alzheimer-s-disease-25537011","doi":"10.3233/jad-141959","journal":"Journal of Alzheimer's disease : JAD","n_participants":86,"pmid":"25537011","source_url":"https://pubmed.ncbi.nlm.nih.gov/25537011/","study_design":null,"title":"A phase II trial of tideglusib in Alzheimer's disease","title_match":false,"year":2015},{"alzhub_score":77,"alzhub_url":"https://alzhub.org/study/benefits-of-rivastigmine-on-attention-in-dementia-associated-with-16301500","doi":"10.1212/01.wnl.0000184517.69816.e9","journal":"Neurology","n_participants":487,"pmid":"16301500","source_url":"https://pubmed.ncbi.nlm.nih.gov/16301500/","study_design":null,"title":"Benefits of rivastigmine on attention in dementia associated with Parkinson disease","title_match":true,"year":2005},{"alzhub_score":76,"alzhub_url":"https://alzhub.org/study/rivastigmine-for-mild-cognitive-impairment-in-parkinson-disease-a-25914281","doi":"10.1002/mds.26236","journal":"Movement disorders : official journal of the Movement Disorder Society","n_participants":28,"pmid":"25914281","source_url":"https://pubmed.ncbi.nlm.nih.gov/25914281/","study_design":null,"title":"Rivastigmine for mild cognitive impairment in Parkinson disease: a placebo-controlled study","title_match":true,"year":2015},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/the-impact-of-neuroscience-on-society-cognitive-enhancement-in-26240429","doi":"10.1098/rstb.2014.0214","journal":"Philosophical transactions of the Royal Society of London. Series B, Biological sciences","n_participants":null,"pmid":"26240429","source_url":"https://pubmed.ncbi.nlm.nih.gov/26240429/","study_design":null,"title":"The impact of neuroscience on society: cognitive enhancement in neuropsychiatric disorders and in healthy people","title_match":false,"year":2015},{"alzhub_score":44,"alzhub_url":"https://alzhub.org/study/efficacy-and-safety-of-galantamine-in-patients-with-dementia-with-17409748","doi":"10.1159/000101512","journal":"Dementia and geriatric cognitive disorders","n_participants":50,"pmid":"17409748","source_url":"https://pubmed.ncbi.nlm.nih.gov/17409748/","study_design":"open-label trial","title":"Efficacy and safety of galantamine in patients with dementia with Lewy bodies: a 24-week open-label study","title_match":true,"year":2007},{"alzhub_score":81,"alzhub_url":"https://alzhub.org/study/a-1-year-randomized-placebo-controlled-study-of-donepezil-in-patients-11502918","doi":"10.1212/wnl.57.3.489","journal":"Neurology","n_participants":286,"pmid":"11502918","source_url":"https://pubmed.ncbi.nlm.nih.gov/11502918/","study_design":null,"title":"A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD","title_match":true,"year":2001},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/therapeutic-strategies-for-alzheimer-s-disease-in-clinical-trials-26721364","doi":"10.1016/j.pharep.2015.07.006","journal":"Pharmacological reports : PR","n_participants":null,"pmid":"26721364","source_url":"https://pubmed.ncbi.nlm.nih.gov/26721364/","study_design":null,"title":"Therapeutic strategies for Alzheimer's disease in clinical trials","title_match":false,"year":2016},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/therapeutic-approach-to-alzheimer-s-disease-current-treatments-and-35745693","doi":"10.3390/pharmaceutics14061117","journal":"Pharmaceutics","n_participants":null,"pmid":"35745693","source_url":"https://pubmed.ncbi.nlm.nih.gov/35745693/","study_design":null,"title":"Therapeutic Approach to Alzheimer's Disease: Current Treatments and New Perspectives","title_match":false,"year":2022},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/recent-advances-on-drug-development-and-emerging-therapeutic-agents-34181171","doi":"10.1007/s11033-021-06512-9","journal":"Molecular biology reports","n_participants":null,"pmid":"34181171","source_url":"https://pubmed.ncbi.nlm.nih.gov/34181171/","study_design":null,"title":"Recent advances on drug development and emerging therapeutic agents for Alzheimer's disease","title_match":false,"year":2021},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/reimagining-cholinergic-therapy-for-alzheimer-s-disease-35289363","doi":"10.1093/brain/awac096","journal":"Brain : a journal of neurology","n_participants":null,"pmid":"35289363","source_url":"https://pubmed.ncbi.nlm.nih.gov/35289363/","study_design":null,"title":"Reimagining cholinergic therapy for Alzheimer's disease","title_match":false,"year":2022},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/alzheimer-s-disease-targeting-the-glutamatergic-system-32048098","doi":"10.1007/s10522-020-09860-4","journal":"Biogerontology","n_participants":null,"pmid":"32048098","source_url":"https://pubmed.ncbi.nlm.nih.gov/32048098/","study_design":null,"title":"Alzheimer's disease: targeting the glutamatergic system","title_match":false,"year":2020},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/current-and-future-therapeutic-strategies-for-alzheimer-s-disease-an-37600514","doi":"10.3389/fnagi.2023.1206572","journal":"Frontiers in aging neuroscience","n_participants":null,"pmid":"37600514","source_url":"https://pubmed.ncbi.nlm.nih.gov/37600514/","study_design":null,"title":"Current and future therapeutic strategies for Alzheimer's disease: an overview of drug development bottlenecks","title_match":false,"year":2023},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/multi-target-directed-donepezil-like-ligands-for-alzheimer-s-disease-27252617","doi":"10.3389/fnins.2016.00205","journal":"Frontiers in neuroscience","n_participants":null,"pmid":"27252617","source_url":"https://pubmed.ncbi.nlm.nih.gov/27252617/","study_design":null,"title":"Multi-Target Directed Donepezil-Like Ligands for Alzheimer's Disease","title_match":true,"year":2016},{"alzhub_score":66,"alzhub_url":"https://alzhub.org/study/effects-of-oral-alz-801-valiltramiprosate-on-plasma-biomarkers-brain-38902571","doi":"10.1007/s40265-024-02067-8","journal":"Drugs","n_participants":80,"pmid":"38902571","source_url":"https://pubmed.ncbi.nlm.nih.gov/38902571/","study_design":"clinical trial","title":"Effects of Oral ALZ-801/Valiltramiprosate on Plasma Biomarkers, Brain Hippocampal Volume, and Cognition: Results of 2-Year Single-Arm, Open-Label, Phase 2 Trial in APOE4 Carriers with Early Alzheimer's Disease","title_match":false,"year":2024},{"alzhub_score":83,"alzhub_url":"https://alzhub.org/study/the-efficacy-and-safety-of-anti-amyloid-monoclonal-antibody-versus-40316479","doi":"10.1016/j.tjpad.2025.100195","journal":"The journal of prevention of Alzheimer's disease","n_participants":8010,"pmid":"40316479","source_url":"https://pubmed.ncbi.nlm.nih.gov/40316479/","study_design":"randomized controlled trial","title":"The efficacy and safety of anti-amyloid monoclonal antibody versus acetylcholinesterase inhibitor with an in-depth analysis across genotypes and disease stages: a systematic review and meta-analysis","title_match":true,"year":2025},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/anti-amyloid-treatments-in-alzheimer-s-disease-elegance-evidence-and-39698778","doi":"10.17219/acem/198674","journal":"Advances in clinical and experimental medicine : official organ Wroclaw Medical University","n_participants":null,"pmid":"39698778","source_url":"https://pubmed.ncbi.nlm.nih.gov/39698778/","study_design":null,"title":"Anti-amyloid treatments in Alzheimer's disease: elegance, evidence and ethics","title_match":false,"year":2024},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/acetylcholinesterase-inhibitors-reduce-brain-and-blood-interleukin-15852394","doi":"10.1002/ana.20454","journal":"Annals of neurology","n_participants":null,"pmid":"15852394","source_url":"https://pubmed.ncbi.nlm.nih.gov/15852394/","study_design":null,"title":"Acetylcholinesterase inhibitors reduce brain and blood interleukin-1beta production","title_match":true,"year":2005},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/recent-therapeutic-strategies-targeting-beta-amyloid-and-tauopathies-30634016","doi":"10.1016/j.brainresbull.2019.01.004","journal":"Brain research bulletin","n_participants":null,"pmid":"30634016","source_url":"https://pubmed.ncbi.nlm.nih.gov/30634016/","study_design":null,"title":"Recent therapeutic strategies targeting beta amyloid and tauopathies in Alzheimer's disease","title_match":false,"year":2019},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/one-for-all-hitting-multiple-alzheimer-s-disease-targets-with-one-drug-27199640","doi":"10.3389/fnins.2016.00177","journal":"Frontiers in neuroscience","n_participants":null,"pmid":"27199640","source_url":"https://pubmed.ncbi.nlm.nih.gov/27199640/","study_design":null,"title":"One for All? Hitting Multiple Alzheimer's Disease Targets with One Drug","title_match":false,"year":2016},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/drug-development-for-alzheimer-s-disease-review-29732929","doi":"10.1080/1061186x.2018.1474361","journal":"Journal of drug targeting","n_participants":null,"pmid":"29732929","source_url":"https://pubmed.ncbi.nlm.nih.gov/29732929/","study_design":null,"title":"Drug development for Alzheimer's disease: review","title_match":false,"year":2019},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/acetylcholinesterase-inhibitors-pharmacology-and-toxicology-24179466","doi":"10.2174/1570159x11311030006","journal":"Current neuropharmacology","n_participants":null,"pmid":"24179466","source_url":"https://pubmed.ncbi.nlm.nih.gov/24179466/","study_design":null,"title":"Acetylcholinesterase inhibitors: pharmacology and toxicology","title_match":true,"year":2013},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/the-cholinergic-hypothesis-of-alzheimer-s-disease-a-review-of-progress-10071091","doi":"10.1136/jnnp.66.2.137","journal":"Journal of neurology, neurosurgery, and psychiatry","n_participants":null,"pmid":"10071091","source_url":"https://pubmed.ncbi.nlm.nih.gov/10071091/","study_design":null,"title":"The cholinergic hypothesis of Alzheimer's disease: a review of progress","title_match":false,"year":1999},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/structures-of-human-acetylcholinesterase-in-complex-with-23035744","doi":"10.1021/jm300871x","journal":"Journal of medicinal chemistry","n_participants":null,"pmid":"23035744","source_url":"https://pubmed.ncbi.nlm.nih.gov/23035744/","study_design":null,"title":"Structures of human acetylcholinesterase in complex with pharmacologically important ligands","title_match":false,"year":2012},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/role-of-glutamate-and-nmda-receptors-in-alzheimer-s-disease-27662322","doi":"10.3233/jad-160763","journal":"Journal of Alzheimer's disease : JAD","n_participants":null,"pmid":"27662322","source_url":"https://pubmed.ncbi.nlm.nih.gov/27662322/","study_design":null,"title":"Role of Glutamate and NMDA Receptors in Alzheimer's Disease","title_match":false,"year":2017},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/abeta-oligomers-induce-neuronal-oxidative-stress-through-an-n-methyl-17308309","doi":"10.1074/jbc.m607483200","journal":"The Journal of biological chemistry","n_participants":null,"pmid":"17308309","source_url":"https://pubmed.ncbi.nlm.nih.gov/17308309/","study_design":null,"title":"Abeta oligomers induce neuronal oxidative stress through an N-methyl-D-aspartate receptor-dependent mechanism that is blocked by the Alzheimer drug memantine","title_match":true,"year":2007},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/efficacy-of-acetylcholinesterase-inhibitors-in-alzheimer-s-disease-33035532","doi":"10.1016/j.neuropharm.2020.108352","journal":"Neuropharmacology","n_participants":null,"pmid":"33035532","source_url":"https://pubmed.ncbi.nlm.nih.gov/33035532/","study_design":null,"title":"Efficacy of acetylcholinesterase inhibitors in Alzheimer's disease","title_match":true,"year":2021},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/drug-discovery-from-medicinal-plants-16198377","doi":"10.1016/j.lfs.2005.09.012","journal":"Life sciences","n_participants":null,"pmid":"16198377","source_url":"https://pubmed.ncbi.nlm.nih.gov/16198377/","study_design":null,"title":"Drug discovery from medicinal plants","title_match":false,"year":2005},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/paradigm-shift-in-neuroprotection-by-nmda-receptor-blockade-memantine-16424917","doi":"10.1038/nrd1958","journal":"Nature reviews. Drug discovery","n_participants":null,"pmid":"16424917","source_url":"https://pubmed.ncbi.nlm.nih.gov/16424917/","study_design":null,"title":"Paradigm shift in neuroprotection by NMDA receptor blockade: memantine and beyond","title_match":true,"year":2006},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/current-and-future-treatments-in-alzheimer-disease-an-update-32165850","doi":"10.1177/1179573520907397","journal":"Journal of central nervous system disease","n_participants":null,"pmid":"32165850","source_url":"https://pubmed.ncbi.nlm.nih.gov/32165850/","study_design":null,"title":"Current and Future Treatments in Alzheimer Disease: An Update","title_match":false,"year":2020},{"alzhub_score":57,"alzhub_url":"https://alzhub.org/study/efficacy-and-safety-of-rivastigmine-in-patients-with-alzheimer-s-10066203","doi":"10.1136/bmj.318.7184.633","journal":"BMJ (Clinical research ed.)","n_participants":725,"pmid":"10066203","source_url":"https://pubmed.ncbi.nlm.nih.gov/10066203/","study_design":null,"title":"Efficacy and safety of rivastigmine in patients with Alzheimer's disease: international randomised controlled trial","title_match":true,"year":1999},{"alzhub_score":75,"alzhub_url":"https://alzhub.org/study/safety-efficacy-and-biomarker-findings-of-pbt2-in-targeting-abeta-as-18672400","doi":"10.1016/s1474-4422(08)70167-4","journal":"The Lancet. Neurology","n_participants":78,"pmid":"18672400","source_url":"https://pubmed.ncbi.nlm.nih.gov/18672400/","study_design":"randomized controlled trial","title":"Safety, efficacy, and biomarker findings of PBT2 in targeting Abeta as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial","title_match":false,"year":2008},{"alzhub_score":69,"alzhub_url":"https://alzhub.org/study/long-term-donepezil-treatment-in-565-patients-with-alzheimer-s-15220031","doi":"10.1016/s0140-6736(04)16499-4","journal":"Lancet (London, England)","n_participants":null,"pmid":"15220031","source_url":"https://pubmed.ncbi.nlm.nih.gov/15220031/","study_design":null,"title":"Long-term donepezil treatment in 565 patients with Alzheimer's disease (AD2000): randomised double-blind trial","title_match":true,"year":2004},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/memantine-a-nmda-receptor-antagonist-that-improves-memory-by-17904591","doi":"10.1016/j.neuropharm.2007.07.013","journal":"Neuropharmacology","n_participants":null,"pmid":"17904591","source_url":"https://pubmed.ncbi.nlm.nih.gov/17904591/","study_design":null,"title":"Memantine: a NMDA receptor antagonist that improves memory by restoration of homeostasis in the glutamatergic system--too little activation is bad, too much is even worse","title_match":true,"year":2007},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/treatment-of-alzheimer-s-disease-current-status-and-new-perspectives-12941576","doi":"10.1016/s1474-4422(03)00502-7","journal":"The Lancet. Neurology","n_participants":null,"pmid":"12941576","source_url":"https://pubmed.ncbi.nlm.nih.gov/12941576/","study_design":null,"title":"Treatment of Alzheimer's disease: current status and new perspectives","title_match":false,"year":2003},{"alzhub_score":74,"alzhub_url":"https://alzhub.org/study/the-efficacy-and-safety-of-donepezil-in-patients-with-alzheimer-s-8915035","doi":"10.1159/000106895","journal":"Dementia (Basel, Switzerland)","n_participants":161,"pmid":"8915035","source_url":"https://pubmed.ncbi.nlm.nih.gov/8915035/","study_design":null,"title":"The efficacy and safety of donepezil in patients with Alzheimer's disease: results of a US Multicentre, Randomized, Double-Blind, Placebo-Controlled Trial. The Donepezil Study Group","title_match":true,"year":1996},{"alzhub_score":67,"alzhub_url":"https://alzhub.org/study/donepezil-and-memantine-for-moderate-to-severe-alzheimer-s-disease-22397651","doi":"10.1056/nejmoa1106668","journal":"The New England journal of medicine","n_participants":null,"pmid":"22397651","source_url":"https://pubmed.ncbi.nlm.nih.gov/22397651/","study_design":null,"title":"Donepezil and memantine for moderate-to-severe Alzheimer's disease","title_match":true,"year":2012},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/oligomeric-a-induced-synaptic-dysfunction-in-alzheimer-s-disease-25394486","doi":"10.1186/1750-1326-9-48","journal":"Molecular neurodegeneration","n_participants":null,"pmid":"25394486","source_url":"https://pubmed.ncbi.nlm.nih.gov/25394486/","study_design":null,"title":"Oligomeric A\u03b2-induced synaptic dysfunction in Alzheimer's disease","title_match":false,"year":2014},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/a-review-on-cholinesterase-inhibitors-for-alzheimer-s-disease-23435942","doi":"10.1007/s12272-013-0036-3","journal":"Archives of pharmacal research","n_participants":null,"pmid":"23435942","source_url":"https://pubmed.ncbi.nlm.nih.gov/23435942/","study_design":null,"title":"A review on cholinesterase inhibitors for Alzheimer's disease","title_match":true,"year":2013},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/amnesia-induced-in-mice-by-centrally-administered-beta-amyloid-8822355","doi":"10.1016/0006-8993(95)01032-7","journal":"Brain research","n_participants":null,"pmid":"8822355","source_url":"https://pubmed.ncbi.nlm.nih.gov/8822355/","study_design":null,"title":"Amnesia induced in mice by centrally administered beta-amyloid peptides involves cholinergic dysfunction","title_match":false,"year":1996},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/current-and-future-treatments-for-alzheimer-s-disease-23277790","doi":"10.1177/1756285612461679","journal":"Therapeutic advances in neurological disorders","n_participants":null,"pmid":"23277790","source_url":"https://pubmed.ncbi.nlm.nih.gov/23277790/","study_design":null,"title":"Current and future treatments for Alzheimer's disease","title_match":false,"year":2013},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/beta-amyloid-aggregation-induced-by-human-acetylcholinesterase-12527333","doi":"10.1016/s0006-2952(02)01514-9","journal":"Biochemical pharmacology","n_participants":null,"pmid":"12527333","source_url":"https://pubmed.ncbi.nlm.nih.gov/12527333/","study_design":null,"title":"beta-Amyloid aggregation induced by human acetylcholinesterase: inhibition studies","title_match":false,"year":2003},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/alzheimer-s-disease-amyloid-glutamate-nmda-receptors-and-memantine-22646481","doi":"10.1111/j.1476-5381.2012.02057.x","journal":"British journal of pharmacology","n_participants":null,"pmid":"22646481","source_url":"https://pubmed.ncbi.nlm.nih.gov/22646481/","study_design":null,"title":"Alzheimer's disease, \u03b2-amyloid, glutamate, NMDA receptors and memantine--searching for the connections","title_match":true,"year":2012},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/the-role-of-nmda-receptors-in-alzheimer-s-disease-30800052","doi":"10.3389/fnins.2019.00043","journal":"Frontiers in neuroscience","n_participants":null,"pmid":"30800052","source_url":"https://pubmed.ncbi.nlm.nih.gov/30800052/","study_design":null,"title":"The Role of NMDA Receptors in Alzheimer's Disease","title_match":false,"year":2019},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/mechanism-of-action-of-memantine-16368266","doi":"10.1016/j.coph.2005.09.007","journal":"Current opinion in pharmacology","n_participants":null,"pmid":"16368266","source_url":"https://pubmed.ncbi.nlm.nih.gov/16368266/","study_design":null,"title":"Mechanism of action of memantine","title_match":true,"year":2006},{"alzhub_score":64,"alzhub_url":"https://alzhub.org/study/efficacy-and-safety-of-donepezil-galantamine-and-rivastigmine-for-the-18686744","doi":null,"journal":"Clinical interventions in aging","n_participants":null,"pmid":"18686744","source_url":"https://pubmed.ncbi.nlm.nih.gov/18686744/","study_design":"randomized controlled trial","title":"Efficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of Alzheimer's disease: a systematic review and meta-analysis","title_match":true,"year":2008},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/amyloid-beta-peptides-in-human-plasma-and-tissues-and-their-19118806","doi":"10.1016/j.jalz.2008.10.004","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":null,"pmid":"19118806","source_url":"https://pubmed.ncbi.nlm.nih.gov/19118806/","study_design":"longitudinal study","title":"Amyloid beta peptides in human plasma and tissues and their significance for Alzheimer's disease","title_match":false,"year":2009},{"alzhub_score":54,"alzhub_url":"https://alzhub.org/study/a-double-blind-placebo-controlled-multicenter-study-of-tacrine-for-1406817","doi":"10.1056/nejm199210293271801","journal":"The New England journal of medicine","n_participants":215,"pmid":"1406817","source_url":"https://pubmed.ncbi.nlm.nih.gov/1406817/","study_design":null,"title":"A double-blind, placebo-controlled multicenter study of tacrine for Alzheimer's disease. The Tacrine Collaborative Study Group","title_match":false,"year":1992},{"alzhub_score":57,"alzhub_url":"https://alzhub.org/study/efficacy-and-safety-of-donepezil-galantamine-rivastigmine-and-24662102","doi":"10.3233/jad-132690","journal":"Journal of Alzheimer's disease : JAD","n_participants":null,"pmid":"24662102","source_url":"https://pubmed.ncbi.nlm.nih.gov/24662102/","study_design":null,"title":"Efficacy and safety of donepezil, galantamine, rivastigmine, and memantine for the treatment of Alzheimer's disease: a systematic review and meta-analysis","title_match":true,"year":2014},{"alzhub_score":76,"alzhub_url":"https://alzhub.org/study/efficacy-of-cholinesterase-inhibitors-in-the-treatment-of-12517232","doi":"10.1001/jama.289.2.210","journal":"JAMA","n_participants":29,"pmid":"12517232","source_url":"https://pubmed.ncbi.nlm.nih.gov/12517232/","study_design":"systematic review","title":"Efficacy of cholinesterase inhibitors in the treatment of neuropsychiatric symptoms and functional impairment in Alzheimer disease: a meta-analysis","title_match":true,"year":2003},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/memantine-preferentially-blocks-extrasynaptic-over-synaptic-nmda-20720132","doi":"10.1523/jneurosci.2488-10.2010","journal":"The Journal of neuroscience : the official journal of the Society for Neuroscience","n_participants":null,"pmid":"20720132","source_url":"https://pubmed.ncbi.nlm.nih.gov/20720132/","study_design":null,"title":"Memantine preferentially blocks extrasynaptic over synaptic NMDA receptor currents in hippocampal autapses","title_match":true,"year":2010},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/a-new-therapeutic-target-in-alzheimer-s-disease-treatment-attention-11900310","doi":"10.1185/0300799039117057","journal":"Current medical research and opinion","n_participants":null,"pmid":"11900310","source_url":"https://pubmed.ncbi.nlm.nih.gov/11900310/","study_design":null,"title":"A new therapeutic target in Alzheimer's disease treatment: attention to butyrylcholinesterase","title_match":false,"year":2001},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/neuropsychiatric-symptoms-in-patients-with-parkinson-s-disease-and-16820421","doi":"10.1136/jnnp.2005.083113","journal":"Journal of neurology, neurosurgery, and psychiatry","n_participants":537,"pmid":"16820421","source_url":"https://pubmed.ncbi.nlm.nih.gov/16820421/","study_design":null,"title":"Neuropsychiatric symptoms in patients with Parkinson's disease and dementia: frequency, profile and associated care giver stress","title_match":false,"year":2007},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/the-chemical-biology-of-clinically-tolerated-nmda-receptor-antagonists-16805772","doi":"10.1111/j.1471-4159.2006.03991.x","journal":"Journal of neurochemistry","n_participants":null,"pmid":"16805772","source_url":"https://pubmed.ncbi.nlm.nih.gov/16805772/","study_design":"clinical trial","title":"The chemical biology of clinically tolerated NMDA receptor antagonists","title_match":false,"year":2006},{"alzhub_score":69,"alzhub_url":"https://alzhub.org/study/memantine-in-severe-dementia-results-of-the-9m-best-study-benefit-and-10885864","doi":"10.1002/(sici)1099-1166(199902)14:2<135::aid-gps906>3.0.co;2-0","journal":"International journal of geriatric psychiatry","n_participants":166,"pmid":"10885864","source_url":"https://pubmed.ncbi.nlm.nih.gov/10885864/","study_design":null,"title":"Memantine in severe dementia: results of the 9M-Best Study (Benefit and efficacy in severely demented patients during treatment with memantine)","title_match":true,"year":1999},{"alzhub_score":67,"alzhub_url":"https://alzhub.org/study/cholinesterase-inhibitors-for-patients-with-alzheimer-s-disease-16081444","doi":"10.1136/bmj.331.7512.321","journal":"BMJ (Clinical research ed.)","n_participants":null,"pmid":"16081444","source_url":"https://pubmed.ncbi.nlm.nih.gov/16081444/","study_design":null,"title":"Cholinesterase inhibitors for patients with Alzheimer's disease: systematic review of randomised clinical trials","title_match":true,"year":2005},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/butyrylcholinesterase-an-important-new-target-in-alzheimer-s-disease-12636181","doi":"10.1017/s1041610203008676","journal":"International psychogeriatrics","n_participants":null,"pmid":"12636181","source_url":"https://pubmed.ncbi.nlm.nih.gov/12636181/","study_design":null,"title":"Butyrylcholinesterase: an important new target in Alzheimer's disease therapy","title_match":false,"year":2002},{"alzhub_score":75,"alzhub_url":"https://alzhub.org/study/memantine-in-patients-with-parkinson-s-disease-dementia-or-dementia-19520613","doi":"10.1016/s1474-4422(09)70146-2","journal":"The Lancet. Neurology","n_participants":72,"pmid":"19520613","source_url":"https://pubmed.ncbi.nlm.nih.gov/19520613/","study_design":null,"title":"Memantine in patients with Parkinson's disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial","title_match":true,"year":2009},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/insight-into-the-kinetic-of-amyloid-beta-1-42-peptide-self-17939148","doi":"10.1002/cbic.200700427","journal":"Chembiochem : a European journal of chemical biology","n_participants":null,"pmid":"17939148","source_url":"https://pubmed.ncbi.nlm.nih.gov/17939148/","study_design":null,"title":"Insight into the kinetic of amyloid beta (1-42) peptide self-aggregation: elucidation of inhibitors' mechanism of action","title_match":false,"year":2007},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/the-neuropharmacological-basis-for-the-use-of-memantine-in-the-14530799","doi":"10.1111/j.1527-3458.2003.tb00254.x","journal":"CNS drug reviews","n_participants":null,"pmid":"14530799","source_url":"https://pubmed.ncbi.nlm.nih.gov/14530799/","study_design":null,"title":"The neuropharmacological basis for the use of memantine in the treatment of Alzheimer's disease","title_match":true,"year":2003},{"alzhub_score":74,"alzhub_url":"https://alzhub.org/study/rosiglitazone-monotherapy-in-mild-to-moderate-alzheimer-s-disease-20733306","doi":"10.1159/000318845","journal":"Dementia and geriatric cognitive disorders","n_participants":693,"pmid":"20733306","source_url":"https://pubmed.ncbi.nlm.nih.gov/20733306/","study_design":"open-label trial","title":"Rosiglitazone monotherapy in mild-to-moderate Alzheimer's disease: results from a randomized, double-blind, placebo-controlled phase III study","title_match":false,"year":2010},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/low-acetylcholine-during-slow-wave-sleep-is-critical-for-declarative-14766981","doi":"10.1073/pnas.0305404101","journal":"Proceedings of the National Academy of Sciences of the United States of America","n_participants":null,"pmid":"14766981","source_url":"https://pubmed.ncbi.nlm.nih.gov/14766981/","study_design":null,"title":"Low acetylcholine during slow-wave sleep is critical for declarative memory consolidation","title_match":false,"year":2004},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/n-methyl-d-aspartate-nmda-receptor-antagonists-and-memantine-21875407","doi":"10.2174/156720512801322564","journal":"Current Alzheimer research","n_participants":null,"pmid":"21875407","source_url":"https://pubmed.ncbi.nlm.nih.gov/21875407/","study_design":null,"title":"N-methyl D-aspartate (NMDA) receptor antagonists and memantine treatment for Alzheimer's disease, vascular dementia and Parkinson's disease","title_match":true,"year":2012},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/galantamine-is-an-allosterically-potentiating-ligand-of-neuronal-12649296","doi":"10.1124/jpet.102.045773","journal":"The Journal of pharmacology and experimental therapeutics","n_participants":null,"pmid":"12649296","source_url":"https://pubmed.ncbi.nlm.nih.gov/12649296/","study_design":null,"title":"Galantamine is an allosterically potentiating ligand of neuronal nicotinic but not of muscarinic acetylcholine receptors","title_match":true,"year":2003},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/the-nmda-receptor-antagonist-memantine-as-a-symptomatological-and-12973747","doi":"10.1002/gps.938","journal":"International journal of geriatric psychiatry","n_participants":null,"pmid":"12973747","source_url":"https://pubmed.ncbi.nlm.nih.gov/12973747/","study_design":null,"title":"The NMDA receptor antagonist memantine as a symptomatological and neuroprotective treatment for Alzheimer's disease: preclinical evidence","title_match":true,"year":2003},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/revisiting-the-cholinergic-hypothesis-in-alzheimer-s-disease-emerging-30569080","doi":"10.14283/jpad.2018.43","journal":"The journal of prevention of Alzheimer's disease","n_participants":null,"pmid":"30569080","source_url":"https://pubmed.ncbi.nlm.nih.gov/30569080/","study_design":null,"title":"Revisiting the Cholinergic Hypothesis in Alzheimer's Disease: Emerging Evidence from Translational and Clinical Research","title_match":false,"year":2019},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/cholinesterase-inhibitors-for-the-treatment-of-alzheimer-s-disease-24944370","doi":"10.1016/s0011-393x(03)00059-6","journal":"Current therapeutic research, clinical and experimental","n_participants":null,"pmid":"24944370","source_url":"https://pubmed.ncbi.nlm.nih.gov/24944370/","study_design":null,"title":"Cholinesterase inhibitors for the treatment of Alzheimer's disease:: getting on and staying on","title_match":true,"year":2003},{"alzhub_score":78,"alzhub_url":"https://alzhub.org/study/efficacy-and-adverse-effects-of-cholinesterase-inhibitors-and-17689146","doi":"10.1016/s1474-4422(07)70195-3","journal":"The Lancet. Neurology","n_participants":3093,"pmid":"17689146","source_url":"https://pubmed.ncbi.nlm.nih.gov/17689146/","study_design":"systematic review","title":"Efficacy and adverse effects of cholinesterase inhibitors and memantine in vascular dementia: a meta-analysis of randomised controlled trials","title_match":true,"year":2007},{"alzhub_score":66,"alzhub_url":"https://alzhub.org/study/open-label-multicenter-phase-3-extension-study-of-the-safety-and-11255446","doi":"10.1001/archneur.58.3.427","journal":"Archives of neurology","n_participants":763,"pmid":"11255446","source_url":"https://pubmed.ncbi.nlm.nih.gov/11255446/","study_design":"clinical trial","title":"Open-label, multicenter, phase 3 extension study of the safety and efficacy of donepezil in patients with Alzheimer disease","title_match":true,"year":2001},{"alzhub_score":72,"alzhub_url":"https://alzhub.org/study/donepezil-in-patients-with-severe-alzheimer-s-disease-double-blind-16581404","doi":"10.1016/s0140-6736(06)68350-5","journal":"Lancet (London, England)","n_participants":128,"pmid":"16581404","source_url":"https://pubmed.ncbi.nlm.nih.gov/16581404/","study_design":null,"title":"Donepezil in patients with severe Alzheimer's disease: double-blind, parallel-group, placebo-controlled study","title_match":true,"year":2006},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/cholinesterase-inhibitors-used-in-the-treatment-of-alzheimer-s-15132713","doi":"10.2165/00002512-200421070-00004","journal":"Drugs & aging","n_participants":null,"pmid":"15132713","source_url":"https://pubmed.ncbi.nlm.nih.gov/15132713/","study_design":null,"title":"Cholinesterase inhibitors used in the treatment of Alzheimer's disease: the relationship between pharmacological effects and clinical efficacy","title_match":true,"year":2004},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/memantine-and-cholinesterase-inhibitors-complementary-mechanisms-in-23657927","doi":"10.1007/s12640-013-9398-z","journal":"Neurotoxicity research","n_participants":null,"pmid":"23657927","source_url":"https://pubmed.ncbi.nlm.nih.gov/23657927/","study_design":null,"title":"Memantine and cholinesterase inhibitors: complementary mechanisms in the treatment of Alzheimer's disease","title_match":true,"year":2013},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/clinical-pharmacokinetics-and-pharmacodynamics-of-cholinesterase-12162759","doi":"10.2165/00003088-200241100-00003","journal":"Clinical pharmacokinetics","n_participants":null,"pmid":"12162759","source_url":"https://pubmed.ncbi.nlm.nih.gov/12162759/","study_design":null,"title":"Clinical pharmacokinetics and pharmacodynamics of cholinesterase inhibitors","title_match":true,"year":2002},{"alzhub_score":71,"alzhub_url":"https://alzhub.org/study/treatment-of-alzheimer-s-disease-with-the-gsk-3-inhibitor-tideglusib-22936007","doi":"10.3233/jad-2012-120805","journal":"Journal of Alzheimer's disease : JAD","n_participants":null,"pmid":"22936007","source_url":"https://pubmed.ncbi.nlm.nih.gov/22936007/","study_design":null,"title":"Treatment of Alzheimer's disease with the GSK-3 inhibitor tideglusib: a pilot study","title_match":false,"year":2013},{"alzhub_score":66,"alzhub_url":"https://alzhub.org/study/an-overview-of-systematic-reviews-of-pharmacological-and-non-29143695","doi":"10.1017/s1041610217002344","journal":"International psychogeriatrics","n_participants":null,"pmid":"29143695","source_url":"https://pubmed.ncbi.nlm.nih.gov/29143695/","study_design":null,"title":"An overview of systematic reviews of pharmacological and non-pharmacological interventions for the treatment of behavioral and psychological symptoms of dementia","title_match":false,"year":2018},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/management-of-behavioral-problems-in-alzheimer-s-disease-20096151","doi":"10.1017/s1041610209991505","journal":"International psychogeriatrics","n_participants":null,"pmid":"20096151","source_url":"https://pubmed.ncbi.nlm.nih.gov/20096151/","study_design":null,"title":"Management of behavioral problems in Alzheimer's disease","title_match":false,"year":2010},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/galantamine-a-review-of-its-use-in-alzheimer-s-disease-11129124","doi":"10.2165/00003495-200060050-00008","journal":"Drugs","n_participants":285,"pmid":"11129124","source_url":"https://pubmed.ncbi.nlm.nih.gov/11129124/","study_design":null,"title":"Galantamine: a review of its use in Alzheimer's disease","title_match":true,"year":2000},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/kinetic-and-structural-studies-on-the-interaction-of-cholinesterases-11888271","doi":"10.1021/bi020016x","journal":"Biochemistry","n_participants":null,"pmid":"11888271","source_url":"https://pubmed.ncbi.nlm.nih.gov/11888271/","study_design":null,"title":"Kinetic and structural studies on the interaction of cholinesterases with the anti-Alzheimer drug rivastigmine","title_match":true,"year":2002},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/cholinesterase-inhibitors-in-the-treatment-of-alzheimer-s-disease-a-9880090","doi":"10.2165/00002018-199819060-00004","journal":"Drug safety","n_participants":null,"pmid":"9880090","source_url":"https://pubmed.ncbi.nlm.nih.gov/9880090/","study_design":null,"title":"Cholinesterase inhibitors in the treatment of Alzheimer's disease: a comparison of tolerability and pharmacology","title_match":true,"year":1998},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/mg2-imparts-nmda-receptor-subtype-selectivity-to-the-alzheimer-s-drug-19261873","doi":"10.1523/jneurosci.3703-08.2009","journal":"The Journal of neuroscience : the official journal of the Society for Neuroscience","n_participants":null,"pmid":"19261873","source_url":"https://pubmed.ncbi.nlm.nih.gov/19261873/","study_design":null,"title":"Mg2+ imparts NMDA receptor subtype selectivity to the Alzheimer's drug memantine","title_match":true,"year":2009},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/comparison-of-the-potency-kinetics-and-voltage-dependency-of-a-series-8570022","doi":"10.1016/0028-3908(95)00092-k","journal":"Neuropharmacology","n_participants":null,"pmid":"8570022","source_url":"https://pubmed.ncbi.nlm.nih.gov/8570022/","study_design":null,"title":"Comparison of the potency, kinetics and voltage-dependency of a series of uncompetitive NMDA receptor antagonists in vitro with anticonvulsive and motor impairment activity in vivo","title_match":false,"year":1995},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/mechanism-of-nmda-receptor-channel-block-by-mk-801-and-memantine-29670280","doi":"10.1038/s41586-018-0039-9","journal":"Nature","n_participants":null,"pmid":"29670280","source_url":"https://pubmed.ncbi.nlm.nih.gov/29670280/","study_design":null,"title":"Mechanism of NMDA receptor channel block by MK-801 and memantine","title_match":true,"year":2018},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/recent-development-of-multifunctional-agents-as-potential-drug-25386820","doi":"10.2174/0929867321666141106122628","journal":"Current medicinal chemistry","n_participants":null,"pmid":"25386820","source_url":"https://pubmed.ncbi.nlm.nih.gov/25386820/","study_design":null,"title":"Recent development of multifunctional agents as potential drug candidates for the treatment of Alzheimer's disease","title_match":false,"year":2015},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/development-and-evaluation-of-rivastigmine-loaded-chitosan-22561106","doi":"10.1016/j.ejps.2012.04.013","journal":"European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences","n_participants":null,"pmid":"22561106","source_url":"https://pubmed.ncbi.nlm.nih.gov/22561106/","study_design":null,"title":"Development and evaluation of rivastigmine loaded chitosan nanoparticles for brain targeting","title_match":true,"year":2012},{"alzhub_score":64,"alzhub_url":"https://alzhub.org/study/a-52-week-study-of-the-efficacy-of-rivastigmine-in-patients-with-mild-11096224","doi":"10.1159/000008243","journal":"European neurology","n_participants":null,"pmid":"11096224","source_url":"https://pubmed.ncbi.nlm.nih.gov/11096224/","study_design":"open-label trial","title":"A 52-week study of the efficacy of rivastigmine in patients with mild to moderately severe Alzheimer's disease","title_match":true,"year":2000},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/outcomes-of-alzheimer-s-disease-therapy-with-acetylcholinesterase-24845946","doi":"10.1517/14740338.2014.914168","journal":"Expert opinion on drug safety","n_participants":null,"pmid":"24845946","source_url":"https://pubmed.ncbi.nlm.nih.gov/24845946/","study_design":null,"title":"Outcomes of Alzheimer's disease therapy with acetylcholinesterase inhibitors and memantine","title_match":true,"year":2014},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/new-acetylcholinesterase-inhibitors-for-alzheimer-s-disease-22216416","doi":"10.1155/2012/728983","journal":"International journal of Alzheimer's disease","n_participants":null,"pmid":"22216416","source_url":"https://pubmed.ncbi.nlm.nih.gov/22216416/","study_design":null,"title":"New acetylcholinesterase inhibitors for Alzheimer's disease","title_match":true,"year":2012},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/glutamate-system-amyloid-peptides-and-tau-protein-functional-22894822","doi":"10.1503/jpn.110190","journal":"Journal of psychiatry & neuroscience : JPN","n_participants":null,"pmid":"22894822","source_url":"https://pubmed.ncbi.nlm.nih.gov/22894822/","study_design":null,"title":"Glutamate system, amyloid \u00df peptides and tau protein: functional interrelationships and relevance to Alzheimer disease pathology","title_match":false,"year":2013},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/amyloid-beta-peptide-and-nmda-induce-ros-from-nadph-oxidase-and-aa-18346200","doi":"10.1111/j.1471-4159.2008.05347.x","journal":"Journal of neurochemistry","n_participants":null,"pmid":"18346200","source_url":"https://pubmed.ncbi.nlm.nih.gov/18346200/","study_design":null,"title":"Amyloid beta peptide and NMDA induce ROS from NADPH oxidase and AA release from cytosolic phospholipase A2 in cortical neurons","title_match":false,"year":2008},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/donepezil-hydrochloride-e2020-and-other-acetylcholinesterase-10637367","doi":"10.2174/0929867003375191","journal":"Current medicinal chemistry","n_participants":null,"pmid":"10637367","source_url":"https://pubmed.ncbi.nlm.nih.gov/10637367/","study_design":null,"title":"Donepezil hydrochloride (E2020) and other acetylcholinesterase inhibitors","title_match":true,"year":2000},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/plants-used-in-chinese-and-indian-traditional-medicine-for-12895669","doi":"10.1016/s0091-3057(03)00128-x","journal":"Pharmacology, biochemistry, and behavior","n_participants":null,"pmid":"12895669","source_url":"https://pubmed.ncbi.nlm.nih.gov/12895669/","study_design":null,"title":"Plants used in Chinese and Indian traditional medicine for improvement of memory and cognitive function","title_match":false,"year":2003},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/allosteric-sensitization-of-nicotinic-receptors-by-galantamine-a-new-11230879","doi":"10.1016/s0006-3223(00)01109-4","journal":"Biological psychiatry","n_participants":null,"pmid":"11230879","source_url":"https://pubmed.ncbi.nlm.nih.gov/11230879/","study_design":null,"title":"Allosteric sensitization of nicotinic receptors by galantamine, a new treatment strategy for Alzheimer's disease","title_match":true,"year":2001},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/clinical-pharmacology-of-rivastigmine-a-new-generation-9737824","doi":"10.1016/s0149-2918(98)80127-6","journal":"Clinical therapeutics","n_participants":null,"pmid":"9737824","source_url":"https://pubmed.ncbi.nlm.nih.gov/9737824/","study_design":null,"title":"Clinical pharmacology of rivastigmine: a new-generation acetylcholinesterase inhibitor for the treatment of Alzheimer's disease","title_match":true,"year":1998},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/current-pharmacologic-treatment-of-dementia-a-clinical-practice-18316755","doi":"10.7326/0003-4819-148-5-200803040-00008","journal":"Annals of internal medicine","n_participants":null,"pmid":"18316755","source_url":"https://pubmed.ncbi.nlm.nih.gov/18316755/","study_design":null,"title":"Current pharmacologic treatment of dementia: a clinical practice guideline from the American College of Physicians and the American Academy of Family Physicians","title_match":false,"year":2008},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/poly-n-butylcyanoacrylate-nanoparticles-coated-with-polysorbate-80-18291351","doi":"10.1016/j.brainres.2008.01.039","journal":"Brain research","n_participants":null,"pmid":"18291351","source_url":"https://pubmed.ncbi.nlm.nih.gov/18291351/","study_design":null,"title":"Poly(n-butylcyanoacrylate) nanoparticles coated with polysorbate 80 for the targeted delivery of rivastigmine into the brain to treat Alzheimer's disease","title_match":true,"year":2008},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/practice-parameter-evaluation-and-treatment-of-depression-psychosis-16606910","doi":"10.1212/01.wnl.0000215428.46057.3d","journal":"Neurology","n_participants":null,"pmid":"16606910","source_url":"https://pubmed.ncbi.nlm.nih.gov/16606910/","study_design":null,"title":"Practice Parameter: evaluation and treatment of depression, psychosis, and dementia in Parkinson disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology","title_match":false,"year":2006},{"alzhub_score":74,"alzhub_url":"https://alzhub.org/study/efficacy-and-safety-of-cholinesterase-inhibitors-in-alzheimer-s-12975222","doi":null,"journal":"CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne","n_participants":5159,"pmid":"12975222","source_url":"https://pubmed.ncbi.nlm.nih.gov/12975222/","study_design":"meta-analysis","title":"Efficacy and safety of cholinesterase inhibitors in Alzheimer's disease: a meta-analysis","title_match":true,"year":2003},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/cognitive-symptoms-of-alzheimer-s-disease-clinical-management-and-31810978","doi":"10.1136/bmj.l6217","journal":"BMJ (Clinical research ed.)","n_participants":null,"pmid":"31810978","source_url":"https://pubmed.ncbi.nlm.nih.gov/31810978/","study_design":null,"title":"Cognitive symptoms of Alzheimer's disease: clinical management and prevention","title_match":false,"year":2019},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/new-pharmacological-strategies-for-treatment-of-alzheimer-s-disease-22035455","doi":"10.1111/j.1365-2125.2011.04134.x","journal":"British journal of clinical pharmacology","n_participants":null,"pmid":"22035455","source_url":"https://pubmed.ncbi.nlm.nih.gov/22035455/","study_design":"clinical trial","title":"New pharmacological strategies for treatment of Alzheimer's disease: focus on disease modifying drugs","title_match":false,"year":2012},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/plants-with-traditional-uses-and-activities-relevant-to-the-12557240","doi":"10.1002/ptr.1280","journal":"Phytotherapy research : PTR","n_participants":null,"pmid":"12557240","source_url":"https://pubmed.ncbi.nlm.nih.gov/12557240/","study_design":null,"title":"Plants with traditional uses and activities, relevant to the management of Alzheimer's disease and other cognitive disorders","title_match":false,"year":2003},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/synergistic-neurotoxicity-by-human-immunodeficiency-virus-proteins-10665489","doi":"10.1002/1531-8249(200002)47:2<186::aid-ana8>3.0.co;2-3","journal":"Annals of neurology","n_participants":null,"pmid":"10665489","source_url":"https://pubmed.ncbi.nlm.nih.gov/10665489/","study_design":null,"title":"Synergistic neurotoxicity by human immunodeficiency virus proteins Tat and gp120: protection by memantine","title_match":true,"year":2000},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/motor-cortex-hyperexcitability-to-transcranial-magnetic-stimulation-15026495","doi":"10.1136/jnnp.2003.018127","journal":"Journal of neurology, neurosurgery, and psychiatry","n_participants":28,"pmid":"15026495","source_url":"https://pubmed.ncbi.nlm.nih.gov/15026495/","study_design":null,"title":"Motor cortex hyperexcitability to transcranial magnetic stimulation in Alzheimer's disease","title_match":false,"year":2004},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/beta-amyloid-stimulated-microglia-induce-neuron-death-via-synergistic-15758166","doi":"10.1523/jneurosci.4998-04.2005","journal":"The Journal of neuroscience : the official journal of the Society for Neuroscience","n_participants":null,"pmid":"15758166","source_url":"https://pubmed.ncbi.nlm.nih.gov/15758166/","study_design":null,"title":"Beta-amyloid-stimulated microglia induce neuron death via synergistic stimulation of tumor necrosis factor alpha and NMDA receptors","title_match":false,"year":2005},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/acetylcholinesterase-inhibitory-activity-of-some-amaryllidaceae-12270757","doi":"10.1016/s0024-3205(02)02034-9","journal":"Life sciences","n_participants":null,"pmid":"12270757","source_url":"https://pubmed.ncbi.nlm.nih.gov/12270757/","study_design":null,"title":"Acetylcholinesterase inhibitory activity of some Amaryllidaceae alkaloids and Narcissus extracts","title_match":false,"year":2002},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/cholinesterases-a-target-of-pharmacology-and-toxicology-22286807","doi":"10.5507/bp.2011.036","journal":"Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia","n_participants":null,"pmid":"22286807","source_url":"https://pubmed.ncbi.nlm.nih.gov/22286807/","study_design":null,"title":"Cholinesterases, a target of pharmacology and toxicology","title_match":false,"year":2011},{"alzhub_score":59,"alzhub_url":"https://alzhub.org/study/phase-ii-study-of-donepezil-in-irradiated-brain-tumor-patients-effect-16549835","doi":"10.1200/jco.2005.03.3001","journal":"Journal of clinical oncology : official journal of the American Society of Clinical Oncology","n_participants":35,"pmid":"16549835","source_url":"https://pubmed.ncbi.nlm.nih.gov/16549835/","study_design":"open-label trial","title":"Phase II study of donepezil in irradiated brain tumor patients: effect on cognitive function, mood, and quality of life","title_match":true,"year":2006},{"alzhub_score":74,"alzhub_url":"https://alzhub.org/study/a-six-month-double-blind-randomized-placebo-controlled-study-of-a-17380489","doi":"10.1002/gps.1788","journal":"International journal of geriatric psychiatry","n_participants":null,"pmid":"17380489","source_url":"https://pubmed.ncbi.nlm.nih.gov/17380489/","study_design":null,"title":"A six-month double-blind, randomized, placebo-controlled study of a transdermal patch in Alzheimer's disease--rivastigmine patch versus capsule","title_match":true,"year":2007},{"alzhub_score":57,"alzhub_url":"https://alzhub.org/study/quetiapine-and-rivastigmine-and-cognitive-decline-in-alzheimer-s-15722369","doi":"10.1136/bmj.38369.459988.8f","journal":"BMJ (Clinical research ed.)","n_participants":93,"pmid":"15722369","source_url":"https://pubmed.ncbi.nlm.nih.gov/15722369/","study_design":null,"title":"Quetiapine and rivastigmine and cognitive decline in Alzheimer's disease: randomised double blind placebo controlled trial","title_match":true,"year":2005},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/syncope-and-its-consequences-in-patients-with-dementia-receiving-19433698","doi":"10.1001/archinternmed.2009.43","journal":"Archives of internal medicine","n_participants":null,"pmid":"19433698","source_url":"https://pubmed.ncbi.nlm.nih.gov/19433698/","study_design":"cohort study","title":"Syncope and its consequences in patients with dementia receiving cholinesterase inhibitors: a population-based cohort study","title_match":true,"year":2009},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/the-interplay-of-neurotransmitters-in-alzheimer-s-disease-16273023","doi":"10.1017/s1092852900014164","journal":"CNS spectrums","n_participants":null,"pmid":"16273023","source_url":"https://pubmed.ncbi.nlm.nih.gov/16273023/","study_design":null,"title":"The interplay of neurotransmitters in Alzheimer's disease","title_match":false,"year":2005},{"alzhub_score":77,"alzhub_url":"https://alzhub.org/study/the-efficacy-of-donepezil-in-the-treatment-of-neuropsychiatric-15277611","doi":"10.1212/01.wnl.0000129990.32253.7b","journal":"Neurology","n_participants":134,"pmid":"15277611","source_url":"https://pubmed.ncbi.nlm.nih.gov/15277611/","study_design":"open-label trial","title":"The efficacy of donepezil in the treatment of neuropsychiatric symptoms in Alzheimer disease","title_match":true,"year":2004},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/oxidative-stress-in-alzheimer-s-disease-current-knowledge-of-38165499","doi":"10.1007/s11033-023-09021-z","journal":"Molecular biology reports","n_participants":null,"pmid":"38165499","source_url":"https://pubmed.ncbi.nlm.nih.gov/38165499/","study_design":null,"title":"Oxidative stress in Alzheimer's disease: current knowledge of signaling pathways and therapeutics","title_match":false,"year":2024},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/the-excitotoxin-quinolinic-acid-induces-tau-phosphorylation-in-human-19623258","doi":"10.1371/journal.pone.0006344","journal":"PloS one","n_participants":null,"pmid":"19623258","source_url":"https://pubmed.ncbi.nlm.nih.gov/19623258/","study_design":null,"title":"The excitotoxin quinolinic acid induces tau phosphorylation in human neurons","title_match":false,"year":2009},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/the-glutamatergic-system-and-alzheimer-s-disease-therapeutic-12828500","doi":"10.2165/00023210-200317090-00004","journal":"CNS drugs","n_participants":null,"pmid":"12828500","source_url":"https://pubmed.ncbi.nlm.nih.gov/12828500/","study_design":null,"title":"The glutamatergic system and Alzheimer's disease: therapeutic implications","title_match":false,"year":2003},{"alzhub_score":83,"alzhub_url":"https://alzhub.org/study/memantine-monotherapy-for-alzheimer-s-disease-a-systematic-review-and-25860130","doi":"10.1371/journal.pone.0123289","journal":"PloS one","n_participants":2433,"pmid":"25860130","source_url":"https://pubmed.ncbi.nlm.nih.gov/25860130/","study_design":"meta-analysis","title":"Memantine monotherapy for Alzheimer's disease: a systematic review and meta-analysis","title_match":true,"year":2015},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/a-review-of-butyrylcholinesterase-as-a-therapeutic-target-in-the-23930233","doi":"10.4088/pcc.12r01412","journal":"The primary care companion for CNS disorders","n_participants":null,"pmid":"23930233","source_url":"https://pubmed.ncbi.nlm.nih.gov/23930233/","study_design":null,"title":"A review of butyrylcholinesterase as a therapeutic target in the treatment of Alzheimer's disease","title_match":false,"year":2013},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/multi-target-directed-drug-design-strategy-from-a-dual-binding-site-18047264","doi":"10.1021/jm701225u","journal":"Journal of medicinal chemistry","n_participants":null,"pmid":"18047264","source_url":"https://pubmed.ncbi.nlm.nih.gov/18047264/","study_design":null,"title":"Multi-target-directed drug design strategy: from a dual binding site acetylcholinesterase inhibitor to a trifunctional compound against Alzheimer's disease","title_match":true,"year":2007},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/acetylcholinesterase-inhibitors-as-disease-modifying-therapies-for-18855672","doi":"10.2174/092986708785909067","journal":"Current medicinal chemistry","n_participants":null,"pmid":"18855672","source_url":"https://pubmed.ncbi.nlm.nih.gov/18855672/","study_design":null,"title":"Acetylcholinesterase inhibitors as disease-modifying therapies for Alzheimer's disease","title_match":true,"year":2008},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/the-molecular-basis-of-memantine-action-in-alzheimer-s-disease-and-15974913","doi":"10.2174/1567205053585846","journal":"Current Alzheimer research","n_participants":null,"pmid":"15974913","source_url":"https://pubmed.ncbi.nlm.nih.gov/15974913/","study_design":"clinical trial","title":"The molecular basis of memantine action in Alzheimer's disease and other neurologic disorders: low-affinity, uncompetitive antagonism","title_match":true,"year":2005},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/current-and-future-treatments-in-alzheimer-s-disease-30925615","doi":"10.1055/s-0039-1678581","journal":"Seminars in neurology","n_participants":null,"pmid":"30925615","source_url":"https://pubmed.ncbi.nlm.nih.gov/30925615/","study_design":null,"title":"Current and Future Treatments in Alzheimer's Disease","title_match":false,"year":2019},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/amyloid-beta-peptide-oligomers-disrupt-axonal-transport-through-an-20610750","doi":"10.1523/jneurosci.1074-10.2010","journal":"The Journal of neuroscience : the official journal of the Society for Neuroscience","n_participants":null,"pmid":"20610750","source_url":"https://pubmed.ncbi.nlm.nih.gov/20610750/","study_design":null,"title":"Amyloid-beta peptide oligomers disrupt axonal transport through an NMDA receptor-dependent mechanism that is mediated by glycogen synthase kinase 3beta in primary cultured hippocampal neurons","title_match":false,"year":2010},{"alzhub_score":76,"alzhub_url":"https://alzhub.org/study/memantine-for-alzheimer-s-disease-an-updated-systematic-review-and-28922160","doi":"10.3233/jad-170424","journal":"Journal of Alzheimer's disease : JAD","n_participants":7567,"pmid":"28922160","source_url":"https://pubmed.ncbi.nlm.nih.gov/28922160/","study_design":"systematic review","title":"Memantine for Alzheimer's Disease: An Updated Systematic Review and Meta-analysis","title_match":true,"year":2017},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/amyloid-peptide-oligomers-directly-activate-nmda-receptors-21349580","doi":"10.1016/j.ceca.2011.02.001","journal":"Cell calcium","n_participants":null,"pmid":"21349580","source_url":"https://pubmed.ncbi.nlm.nih.gov/21349580/","study_design":null,"title":"Amyloid \u03b2 peptide oligomers directly activate NMDA receptors","title_match":false,"year":2011},{"alzhub_score":64,"alzhub_url":"https://alzhub.org/study/memantine-a-review-of-its-use-in-alzheimer-s-disease-16906789","doi":"10.2165/00003495-200666110-00015","journal":"Drugs","n_participants":null,"pmid":"16906789","source_url":"https://pubmed.ncbi.nlm.nih.gov/16906789/","study_design":"meta-analysis","title":"Memantine: a review of its use in Alzheimer's disease","title_match":true,"year":2006},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/naturally-occurring-acetylcholinesterase-inhibitors-and-their-30405413","doi":"10.3389/fphar.2018.01192","journal":"Frontiers in pharmacology","n_participants":null,"pmid":"30405413","source_url":"https://pubmed.ncbi.nlm.nih.gov/30405413/","study_design":null,"title":"Naturally Occurring Acetylcholinesterase Inhibitors and Their Potential Use for Alzheimer's Disease Therapy","title_match":true,"year":2018},{"alzhub_score":74,"alzhub_url":"https://alzhub.org/study/donepezil-for-the-treatment-of-agitation-in-alzheimer-s-disease-17914039","doi":"10.1056/nejmoa066583","journal":"The New England journal of medicine","n_participants":272,"pmid":"17914039","source_url":"https://pubmed.ncbi.nlm.nih.gov/17914039/","study_design":null,"title":"Donepezil for the treatment of agitation in Alzheimer's disease","title_match":true,"year":2007},{"alzhub_score":56,"alzhub_url":"https://alzhub.org/study/effects-of-a-flexible-galantamine-dose-in-alzheimer-s-disease-a-11606667","doi":"10.1136/jnnp.71.5.589","journal":"Journal of neurology, neurosurgery, and psychiatry","n_participants":386,"pmid":"11606667","source_url":"https://pubmed.ncbi.nlm.nih.gov/11606667/","study_design":null,"title":"Effects of a flexible galantamine dose in Alzheimer's disease: a randomised, controlled trial","title_match":true,"year":2001},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/redox-modulation-by-s-nitrosylation-contributes-to-protein-misfolding-21597461","doi":"10.1038/cdd.2011.65","journal":"Cell death and differentiation","n_participants":null,"pmid":"21597461","source_url":"https://pubmed.ncbi.nlm.nih.gov/21597461/","study_design":null,"title":"Redox modulation by S-nitrosylation contributes to protein misfolding, mitochondrial dynamics, and neuronal synaptic damage in neurodegenerative diseases","title_match":false,"year":2011},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/advances-in-the-treatment-of-alzheimer-s-disease-benefits-of-dual-11803198","doi":"10.1159/000047952","journal":"European neurology","n_participants":null,"pmid":"11803198","source_url":"https://pubmed.ncbi.nlm.nih.gov/11803198/","study_design":null,"title":"Advances in the treatment of Alzheimer's disease: benefits of dual cholinesterase inhibition","title_match":false,"year":2002},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/the-spectrum-of-behavioral-responses-to-cholinesterase-inhibitor-10555660","doi":"10.1001/archneur.56.11.1388","journal":"Archives of neurology","n_participants":86,"pmid":"10555660","source_url":"https://pubmed.ncbi.nlm.nih.gov/10555660/","study_design":"open-label trial","title":"The spectrum of behavioral responses to cholinesterase inhibitor therapy in Alzheimer disease","title_match":true,"year":1999},{"alzhub_score":82,"alzhub_url":"https://alzhub.org/study/safety-and-efficacy-of-galantamine-in-subjects-with-mild-cognitive-18322263","doi":"10.1212/01.wnl.0000303815.69777.26","journal":"Neurology","n_participants":2048,"pmid":"18322263","source_url":"https://pubmed.ncbi.nlm.nih.gov/18322263/","study_design":null,"title":"Safety and efficacy of galantamine in subjects with mild cognitive impairment","title_match":true,"year":2008},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/memantine-for-the-treatment-of-dementia-a-review-on-its-current-and-29254093","doi":"10.3233/jad-170672","journal":"Journal of Alzheimer's disease : JAD","n_participants":null,"pmid":"29254093","source_url":"https://pubmed.ncbi.nlm.nih.gov/29254093/","study_design":null,"title":"Memantine for the Treatment of Dementia: A Review on its Current and Future Applications","title_match":true,"year":2018},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/synthesis-biological-evaluation-and-molecular-modeling-of-donepezil-22023459","doi":"10.1021/jm200853t","journal":"Journal of medicinal chemistry","n_participants":null,"pmid":"22023459","source_url":"https://pubmed.ncbi.nlm.nih.gov/22023459/","study_design":null,"title":"Synthesis, biological evaluation, and molecular modeling of donepezil and N-[(5-(benzyloxy)-1-methyl-1H-indol-2-yl)methyl]-N-methylprop-2-yn-1-amine hybrids as new multipotent cholinesterase/monoamine oxidase inhibitors for the treatment of Alzheimer's disease","title_match":true,"year":2011},{"alzhub_score":74,"alzhub_url":"https://alzhub.org/study/benefits-of-cognitive-motor-intervention-in-mci-and-mild-to-moderate-15623698","doi":"10.1212/01.wnl.0000147478.03911.28","journal":"Neurology","n_participants":null,"pmid":"15623698","source_url":"https://pubmed.ncbi.nlm.nih.gov/15623698/","study_design":null,"title":"Benefits of cognitive-motor intervention in MCI and mild to moderate Alzheimer disease","title_match":false,"year":2004},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/acetylcholinesterase-inhibitors-novel-activities-of-old-molecules-15304241","doi":"10.1016/j.phrs.2003.12.027","journal":"Pharmacological research","n_participants":null,"pmid":"15304241","source_url":"https://pubmed.ncbi.nlm.nih.gov/15304241/","study_design":null,"title":"Acetylcholinesterase inhibitors: novel activities of old molecules","title_match":true,"year":2004},{"alzhub_score":67,"alzhub_url":"https://alzhub.org/study/nanotechnology-based-drug-delivery-systems-for-the-treatment-of-26345528","doi":"10.2147/ijn.s87148","journal":"International journal of nanomedicine","n_participants":null,"pmid":"26345528","source_url":"https://pubmed.ncbi.nlm.nih.gov/26345528/","study_design":"systematic review","title":"Nanotechnology-based drug delivery systems for the treatment of Alzheimer's disease","title_match":false,"year":2015},{"alzhub_score":53,"alzhub_url":"https://alzhub.org/study/cost-effectiveness-of-donepezil-in-the-treatment-of-mild-or-moderate-10214734","doi":"10.1212/wnl.52.6.1138","journal":"Neurology","n_participants":null,"pmid":"10214734","source_url":"https://pubmed.ncbi.nlm.nih.gov/10214734/","study_design":"cross-sectional","title":"Cost-effectiveness of donepezil in the treatment of mild or moderate Alzheimer's disease","title_match":true,"year":1999},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/long-term-effects-of-the-concomitant-use-of-memantine-with-19204022","doi":"10.1136/jnnp.2008.158964","journal":"Journal of neurology, neurosurgery, and psychiatry","n_participants":null,"pmid":"19204022","source_url":"https://pubmed.ncbi.nlm.nih.gov/19204022/","study_design":null,"title":"Long-term effects of the concomitant use of memantine with cholinesterase inhibition in Alzheimer disease","title_match":true,"year":2009},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/age-but-not-diagnosis-is-the-main-predictor-of-plasma-amyloid-beta-12873852","doi":"10.1001/archneur.60.7.958","journal":"Archives of neurology","n_participants":146,"pmid":"12873852","source_url":"https://pubmed.ncbi.nlm.nih.gov/12873852/","study_design":null,"title":"Age but not diagnosis is the main predictor of plasma amyloid beta-protein levels","title_match":false,"year":2003},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/alzheimer-s-disease-drug-development-pipeline-few-candidates-frequent-25024750","doi":"10.1186/alzrt269","journal":"Alzheimer's research & therapy","n_participants":null,"pmid":"25024750","source_url":"https://pubmed.ncbi.nlm.nih.gov/25024750/","study_design":"clinical trial","title":"Alzheimer's disease drug-development pipeline: few candidates, frequent failures","title_match":false,"year":2014},{"alzhub_score":76,"alzhub_url":"https://alzhub.org/study/evidence-based-prevention-of-alzheimer-s-disease-systematic-review-32690803","doi":"10.1136/jnnp-2019-321913","journal":"Journal of neurology, neurosurgery, and psychiatry","n_participants":44,"pmid":"32690803","source_url":"https://pubmed.ncbi.nlm.nih.gov/32690803/","study_design":"systematic review","title":"Evidence-based prevention of Alzheimer's disease: systematic review and meta-analysis of 243 observational prospective studies and 153 randomised controlled trials","title_match":false,"year":2020},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/anticholinesterases-medical-applications-of-neurochemical-principles-7722478","doi":"10.1046/j.1471-4159.1995.64051909.x","journal":"Journal of neurochemistry","n_participants":null,"pmid":"7722478","source_url":"https://pubmed.ncbi.nlm.nih.gov/7722478/","study_design":null,"title":"Anticholinesterases: medical applications of neurochemical principles","title_match":false,"year":1995},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/the-cholinergic-system-in-the-pathophysiology-and-treatment-of-29850777","doi":"10.1093/brain/awy132","journal":"Brain : a journal of neurology","n_participants":null,"pmid":"29850777","source_url":"https://pubmed.ncbi.nlm.nih.gov/29850777/","study_design":null,"title":"The cholinergic system in the pathophysiology and treatment of Alzheimer's disease","title_match":false,"year":2018},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/abeta-oligomer-induced-aberrations-in-synapse-composition-shape-and-17251419","doi":"10.1523/jneurosci.3501-06.2007","journal":"The Journal of neuroscience : the official journal of the Society for Neuroscience","n_participants":null,"pmid":"17251419","source_url":"https://pubmed.ncbi.nlm.nih.gov/17251419/","study_design":null,"title":"Abeta oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer's disease","title_match":false,"year":2007},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/acetylcholinesterase-from-3d-structure-to-function-20138030","doi":"10.1016/j.cbi.2010.01.042","journal":"Chemico-biological interactions","n_participants":null,"pmid":"20138030","source_url":"https://pubmed.ncbi.nlm.nih.gov/20138030/","study_design":null,"title":"Acetylcholinesterase: from 3D structure to function","title_match":false,"year":2010},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/natural-products-and-derivatives-affecting-neurotransmission-relevant-15956811","doi":"10.1159/000085382","journal":"Neuro-Signals","n_participants":null,"pmid":"15956811","source_url":"https://pubmed.ncbi.nlm.nih.gov/15956811/","study_design":null,"title":"Natural products and derivatives affecting neurotransmission relevant to Alzheimer's and Parkinson's disease","title_match":false,"year":2005},{"alzhub_score":64,"alzhub_url":"https://alzhub.org/study/the-use-of-cholinesterase-inhibitors-across-all-stages-of-alzheimer-s-26033268","doi":"10.1007/s40266-015-0273-x","journal":"Drugs & aging","n_participants":null,"pmid":"26033268","source_url":"https://pubmed.ncbi.nlm.nih.gov/26033268/","study_design":"meta-analysis","title":"The Use of Cholinesterase Inhibitors Across All Stages of Alzheimer's Disease","title_match":true,"year":2015},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/use-of-anticholinergic-medications-by-older-adults-with-dementia-12028169","doi":"10.1046/j.1532-5415.2002.50208.x","journal":"Journal of the American Geriatrics Society","n_participants":418,"pmid":"12028169","source_url":"https://pubmed.ncbi.nlm.nih.gov/12028169/","study_design":null,"title":"Use of anticholinergic medications by older adults with dementia","title_match":false,"year":2002},{"alzhub_score":47,"alzhub_url":"https://alzhub.org/study/health-care-utilization-and-costs-of-alzheimer-s-disease-the-role-of-12144008","doi":null,"journal":"Family medicine","n_participants":1366,"pmid":"12144008","source_url":"https://pubmed.ncbi.nlm.nih.gov/12144008/","study_design":null,"title":"Health care utilization and costs of Alzheimer's disease: the role of co-morbid conditions, disease stage, and pharmacotherapy","title_match":false,"year":2002},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/compression-or-expansion-of-dementia-in-germany-an-observational-26537590","doi":"10.1186/s13195-015-0146-x","journal":"Alzheimer's research & therapy","n_participants":null,"pmid":"26537590","source_url":"https://pubmed.ncbi.nlm.nih.gov/26537590/","study_design":null,"title":"Compression or expansion of dementia in Germany? An observational study of short-term trends in incidence and death rates of dementia between 2006/07 and 2009/10 based on German health insurance data","title_match":false,"year":2015},{"alzhub_score":64,"alzhub_url":"https://alzhub.org/study/drug-persistency-patterns-for-patients-treated-with-rivastigmine-or-15804207","doi":"10.18553/jmcp.2005.11.3.231","journal":"Journal of managed care pharmacy : JMCP","n_participants":392,"pmid":"15804207","source_url":"https://pubmed.ncbi.nlm.nih.gov/15804207/","study_design":"cohort study","title":"Drug persistency patterns for patients treated with rivastigmine or donepezil in usual care settings","title_match":true,"year":2005},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/benzodiazepine-use-and-risk-of-developing-alzheimer-s-disease-a-case-28078633","doi":"10.1007/s40263-016-0404-x","journal":"CNS drugs","n_participants":null,"pmid":"28078633","source_url":"https://pubmed.ncbi.nlm.nih.gov/28078633/","study_design":"case-control study","title":"Benzodiazepine Use and Risk of Developing Alzheimer's Disease: A Case-Control Study Based on Swiss Claims Data","title_match":false,"year":2017},{"alzhub_score":78,"alzhub_url":"https://alzhub.org/study/representation-of-patients-with-dementia-in-clinical-trials-of-15604527","doi":null,"journal":"The Canadian journal of clinical pharmacology = Journal canadien de pharmacologie clinique","n_participants":3423,"pmid":"15604527","source_url":"https://pubmed.ncbi.nlm.nih.gov/15604527/","study_design":"systematic review","title":"Representation of patients with dementia in clinical trials of donepezil","title_match":true,"year":2004},{"alzhub_score":70,"alzhub_url":"https://alzhub.org/study/presymptomatic-plasma-biomarkers-in-autosomal-dominant-alzheimer-s-42637536","doi":"10.1136/jnnp-2026-339037","journal":"Journal of neurology, neurosurgery, and psychiatry","n_participants":113,"pmid":"42637536","source_url":"https://pubmed.ncbi.nlm.nih.gov/42637536/","study_design":"cohort study","title":"Presymptomatic plasma biomarkers in autosomal dominant Alzheimer's disease: sequence and timing","title_match":false,"year":2026},{"alzhub_score":39,"alzhub_url":"https://alzhub.org/study/using-amyloid-pet-imaging-to-diagnose-alzheimer-s-disease-in-patients-32556533","doi":"10.1007/s00415-020-09969-z","journal":"Journal of neurology","n_participants":null,"pmid":"32556533","source_url":"https://pubmed.ncbi.nlm.nih.gov/32556533/","study_design":null,"title":"Using amyloid PET imaging to diagnose Alzheimer's disease in patients with multiple sclerosis","title_match":false,"year":2020},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/treatment-of-alzheimer-disease-39620846","doi":"10.1212/con.0000000000001503","journal":"Continuum (Minneapolis, Minn.)","n_participants":null,"pmid":"39620846","source_url":"https://pubmed.ncbi.nlm.nih.gov/39620846/","study_design":null,"title":"Treatment of Alzheimer Disease","title_match":false,"year":2024},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/donanemab-another-anti-alzheimer-s-drug-with-risk-and-uncertain-38830549","doi":"10.1016/j.arr.2024.102348","journal":"Ageing research reviews","n_participants":null,"pmid":"38830549","source_url":"https://pubmed.ncbi.nlm.nih.gov/38830549/","study_design":null,"title":"Donanemab, another anti-Alzheimer's drug with risk and uncertain benefit","title_match":false,"year":2024},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/profile-of-gantenerumab-and-its-potential-in-the-treatment-of-24255592","doi":"10.2147/dddt.s53401","journal":"Drug design, development and therapy","n_participants":null,"pmid":"24255592","source_url":"https://pubmed.ncbi.nlm.nih.gov/24255592/","study_design":null,"title":"Profile of gantenerumab and its potential in the treatment of Alzheimer's disease","title_match":false,"year":2013},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/pharmacological-interventions-in-dementia-41047647","doi":"10.11477/mf.030126030530050943","journal":"No shinkei geka. Neurological surgery","n_participants":null,"pmid":"41047647","source_url":"https://pubmed.ncbi.nlm.nih.gov/41047647/","study_design":null,"title":"[Pharmacological Interventions in Dementia]","title_match":false,"year":2025},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/aducanumab-a-novel-anti-amyloid-monoclonal-antibody-for-the-treatment-35928986","doi":"10.52965/001c.31925","journal":"Health psychology research","n_participants":null,"pmid":"35928986","source_url":"https://pubmed.ncbi.nlm.nih.gov/35928986/","study_design":null,"title":"Aducanumab, a Novel Anti-Amyloid Monoclonal Antibody, for the Treatment of Alzheimer's Disease: A Comprehensive Review","title_match":false,"year":2022},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/multi-targeting-phytochemicals-for-alzheimer-s-disease-39815655","doi":"10.1002/ptr.8435","journal":"Phytotherapy research : PTR","n_participants":null,"pmid":"39815655","source_url":"https://pubmed.ncbi.nlm.nih.gov/39815655/","study_design":null,"title":"Multi-Targeting Phytochemicals for Alzheimer's Disease","title_match":false,"year":2025},{"alzhub_score":39,"alzhub_url":"https://alzhub.org/study/new-treatment-modalities-in-alzheimer-s-disease-31417922","doi":"10.12998/wjcc.v7.i14.1764","journal":"World journal of clinical cases","n_participants":null,"pmid":"31417922","source_url":"https://pubmed.ncbi.nlm.nih.gov/31417922/","study_design":null,"title":"New treatment modalities in Alzheimer's disease","title_match":false,"year":2019},{"alzhub_score":39,"alzhub_url":"https://alzhub.org/study/mechanisms-of-anticholinesterase-interference-with-tau-aggregation-32091331","doi":"10.2174/1567205017666200224120926","journal":"Current Alzheimer research","n_participants":null,"pmid":"32091331","source_url":"https://pubmed.ncbi.nlm.nih.gov/32091331/","study_design":"clinical trial","title":"Mechanisms of Anticholinesterase Interference with Tau Aggregation Inhibitor Activity in a Tau-Transgenic Mouse Model","title_match":false,"year":2020},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/alzheimer-disease-treatment-of-cognitive-and-functional-symptoms-39283851","doi":null,"journal":"American family physician","n_participants":null,"pmid":"39283851","source_url":"https://pubmed.ncbi.nlm.nih.gov/39283851/","study_design":null,"title":"Alzheimer Disease: Treatment of Cognitive and Functional Symptoms","title_match":false,"year":2024},{"alzhub_score":71,"alzhub_url":"https://alzhub.org/study/evaluating-the-efficacy-and-safety-of-alzheimer-s-disease-drugs-a-38640313","doi":"10.1097/md.0000000000037799","journal":"Medicine","n_participants":null,"pmid":"38640313","source_url":"https://pubmed.ncbi.nlm.nih.gov/38640313/","study_design":"meta-analysis","title":"Evaluating the efficacy and safety of Alzheimer's disease drugs: A meta-analysis and systematic review","title_match":false,"year":2024},{"alzhub_score":71,"alzhub_url":"https://alzhub.org/study/safety-and-efficacy-of-acetylcholinesterase-inhibitors-for-alzheimer-38439609","doi":"10.17219/acem/176051","journal":"Advances in clinical and experimental medicine : official organ Wroclaw Medical University","n_participants":null,"pmid":"38439609","source_url":"https://pubmed.ncbi.nlm.nih.gov/38439609/","study_design":"systematic review","title":"Safety and efficacy of acetylcholinesterase inhibitors for Alzheimer's disease: A systematic review and meta-analysis","title_match":true,"year":2024},{"alzhub_score":50,"alzhub_url":"https://alzhub.org/study/clinical-practice-guidelines-for-dementia-recommendations-for-39944527","doi":"10.12779/dnd.2025.24.1.1","journal":"Dementia and neurocognitive disorders","n_participants":null,"pmid":"39944527","source_url":"https://pubmed.ncbi.nlm.nih.gov/39944527/","study_design":null,"title":"Clinical Practice Guidelines for Dementia: Recommendations for Cholinesterase Inhibitors and Memantine","title_match":true,"year":2025},{"alzhub_score":50,"alzhub_url":"https://alzhub.org/study/galantamine-memantine-combination-in-the-treatment-of-parkinson-s-39766362","doi":"10.3390/brainsci14121163","journal":"Brain sciences","n_participants":null,"pmid":"39766362","source_url":"https://pubmed.ncbi.nlm.nih.gov/39766362/","study_design":null,"title":"Galantamine-Memantine Combination in the Treatment of Parkinson's Disease Dementia","title_match":true,"year":2024},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/anti-dementia-drugs-anti-alzheimer-s-disease-drugs-37194514","doi":"10.11477/mf.1416202360","journal":"Brain and nerve = Shinkei kenkyu no shinpo","n_participants":null,"pmid":"37194514","source_url":"https://pubmed.ncbi.nlm.nih.gov/37194514/","study_design":null,"title":"[Anti-Dementia Drugs (Anti-Alzheimer's Disease Drugs)]","title_match":false,"year":2023},{"alzhub_score":68,"alzhub_url":"https://alzhub.org/study/a-pharmacoeconomic-evaluation-of-cholinesterase-inhibitors-and-29999427","doi":"10.1080/14656566.2018.1499727","journal":"Expert opinion on pharmacotherapy","n_participants":null,"pmid":"29999427","source_url":"https://pubmed.ncbi.nlm.nih.gov/29999427/","study_design":"systematic review","title":"A pharmacoeconomic evaluation of cholinesterase inhibitors and memantine for the treatment of Alzheimer's disease","title_match":true,"year":2018},{"alzhub_score":82,"alzhub_url":"https://alzhub.org/study/effect-of-long-term-pharmacological-treatments-on-alzheimer-disease-a-39312316","doi":"10.1097/md.0000000000039753","journal":"Medicine","n_participants":7214,"pmid":"39312316","source_url":"https://pubmed.ncbi.nlm.nih.gov/39312316/","study_design":"systematic review","title":"Effect of long-term pharmacological treatments on Alzheimer disease: A systematic review and network meta-analysis","title_match":false,"year":2024},{"alzhub_score":46,"alzhub_url":"https://alzhub.org/study/galantamine-memantine-combination-in-the-treatment-of-alzheimer-s-32829072","doi":"10.1016/j.psychres.2020.113409","journal":"Psychiatry research","n_participants":null,"pmid":"32829072","source_url":"https://pubmed.ncbi.nlm.nih.gov/32829072/","study_design":null,"title":"Galantamine-Memantine combination in the treatment of Alzheimer's disease and beyond","title_match":true,"year":2020},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/a-novel-formulation-donepezil-patch-37381137","doi":"10.4140/tcp.n.2023.300","journal":"The Senior care pharmacist","n_participants":null,"pmid":"37381137","source_url":"https://pubmed.ncbi.nlm.nih.gov/37381137/","study_design":null,"title":"A Novel Formulation: Donepezil Patch","title_match":true,"year":2023},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/acetylcholinesterase-enzyme-inhibitor-molecules-with-therapeutic-34602041","doi":"10.2174/1871527320666210928160159","journal":"CNS & neurological disorders drug targets","n_participants":null,"pmid":"34602041","source_url":"https://pubmed.ncbi.nlm.nih.gov/34602041/","study_design":null,"title":"Acetylcholinesterase Enzyme Inhibitor Molecules with Therapeutic Potential for Alzheimer's Disease","title_match":false,"year":2022},{"alzhub_score":63,"alzhub_url":"https://alzhub.org/study/galantamine-plasma-concentration-and-cognitive-response-in-alzheimer-31106076","doi":"10.7717/peerj.6887","journal":"PeerJ","n_participants":22,"pmid":"31106076","source_url":"https://pubmed.ncbi.nlm.nih.gov/31106076/","study_design":"cohort study","title":"Galantamine plasma concentration and cognitive response in Alzheimer's disease","title_match":true,"year":2019},{"alzhub_score":71,"alzhub_url":"https://alzhub.org/study/comparison-of-cholinesterase-inhibitor-safety-in-real-world-practice-31921965","doi":"10.1016/j.trci.2019.09.011","journal":"Alzheimer's & dementia (New York, N. Y.)","n_participants":null,"pmid":"31921965","source_url":"https://pubmed.ncbi.nlm.nih.gov/31921965/","study_design":"randomized controlled trial","title":"Comparison of cholinesterase inhibitor safety in real-world practice","title_match":true,"year":2019},{"alzhub_score":39,"alzhub_url":"https://alzhub.org/study/cholinesterase-inhibitors-for-alzheimer-s-disease-multitargeting-31593530","doi":"10.2174/1381612825666191008103141","journal":"Current pharmaceutical design","n_participants":null,"pmid":"31593530","source_url":"https://pubmed.ncbi.nlm.nih.gov/31593530/","study_design":null,"title":"Cholinesterase Inhibitors for Alzheimer's Disease: Multitargeting Strategy Based on Anti-Alzheimer's Drugs Repositioning","title_match":true,"year":2019},{"alzhub_score":39,"alzhub_url":"https://alzhub.org/study/france-will-no-more-reimburse-available-symptomatic-drugs-against-30282371","doi":"10.3233/jad-180843","journal":"Journal of Alzheimer's disease : JAD","n_participants":null,"pmid":"30282371","source_url":"https://pubmed.ncbi.nlm.nih.gov/30282371/","study_design":null,"title":"France Will No More Reimburse Available Symptomatic Drugs Against Alzheimer's Disease","title_match":false,"year":2018},{"alzhub_score":39,"alzhub_url":"https://alzhub.org/study/acetylcholinesterase-inhibitors-for-treating-dementia-symptoms-a-28678552","doi":"10.1080/14740338.2017.1351540","journal":"Expert opinion on drug safety","n_participants":null,"pmid":"28678552","source_url":"https://pubmed.ncbi.nlm.nih.gov/28678552/","study_design":null,"title":"Acetylcholinesterase inhibitors for treating dementia symptoms - a safety evaluation","title_match":true,"year":2017},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/the-latest-advances-in-the-diagnosis-and-treatment-of-dementia-38222245","doi":"10.7759/cureus.50522","journal":"Cureus","n_participants":null,"pmid":"38222245","source_url":"https://pubmed.ncbi.nlm.nih.gov/38222245/","study_design":null,"title":"The Latest Advances in the Diagnosis and Treatment of Dementia","title_match":false,"year":2023},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/memantine-er-donepezil-a-review-in-alzheimer-s-disease-26519339","doi":"10.1007/s40263-015-0287-2","journal":"CNS drugs","n_participants":null,"pmid":"26519339","source_url":"https://pubmed.ncbi.nlm.nih.gov/26519339/","study_design":null,"title":"Memantine ER/Donepezil: A Review in Alzheimer's Disease","title_match":true,"year":2015},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/cholinesterase-inhibitors-and-beyond-19355843","doi":"10.2174/156720509787602861","journal":"Current Alzheimer research","n_participants":null,"pmid":"19355843","source_url":"https://pubmed.ncbi.nlm.nih.gov/19355843/","study_design":null,"title":"Cholinesterase inhibitors and beyond","title_match":true,"year":2009},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/drug-delivery-systems-as-a-strategy-to-improve-the-efficacy-of-fda-36365114","doi":"10.3390/pharmaceutics14112296","journal":"Pharmaceutics","n_participants":null,"pmid":"36365114","source_url":"https://pubmed.ncbi.nlm.nih.gov/36365114/","study_design":null,"title":"Drug Delivery Systems as a Strategy to Improve the Efficacy of FDA-Approved Alzheimer's Drugs","title_match":false,"year":2022},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/can-we-do-better-in-developing-new-drugs-for-alzheimer-s-disease-19896588","doi":"10.1016/j.jalz.2009.09.002","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":null,"pmid":"19896588","source_url":"https://pubmed.ncbi.nlm.nih.gov/19896588/","study_design":null,"title":"Can we do better in developing new drugs for Alzheimer's disease?","title_match":false,"year":2009},{"alzhub_score":75,"alzhub_url":"https://alzhub.org/study/pharmacologic-treatments-for-dementia-and-the-risk-of-developing-age-39446320","doi":"10.1001/jamanetworkopen.2024.41166","journal":"JAMA network open","n_participants":846,"pmid":"39446320","source_url":"https://pubmed.ncbi.nlm.nih.gov/39446320/","study_design":"cohort study","title":"Pharmacologic Treatments for Dementia and the Risk of Developing Age-Related Macular Degeneration","title_match":false,"year":2024},{"alzhub_score":73,"alzhub_url":"https://alzhub.org/study/risk-of-overactive-bladder-associated-with-cholinesterase-inhibitors-34854475","doi":"10.1111/jgs.17579","journal":"Journal of the American Geriatrics Society","n_participants":524975,"pmid":"34854475","source_url":"https://pubmed.ncbi.nlm.nih.gov/34854475/","study_design":"cohort study","title":"Risk of overactive bladder associated with cholinesterase inhibitors in dementia","title_match":true,"year":2022},{"alzhub_score":54,"alzhub_url":"https://alzhub.org/study/cholinesterase-inhibitor-utilization-the-impact-of-provincial-drug-27565287","doi":"10.1016/j.jval.2016.03.1832","journal":"Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research","n_participants":null,"pmid":"27565287","source_url":"https://pubmed.ncbi.nlm.nih.gov/27565287/","study_design":"cohort study","title":"Cholinesterase Inhibitor Utilization: The Impact of Provincial Drug Policy on Discontinuation","title_match":true,"year":2016},{"alzhub_score":46,"alzhub_url":"https://alzhub.org/study/qt-interval-prolongation-and-torsades-de-pointes-with-donepezil-32874532","doi":"10.1177/2042098620942416","journal":"Therapeutic advances in drug safety","n_participants":13,"pmid":"32874532","source_url":"https://pubmed.ncbi.nlm.nih.gov/32874532/","study_design":"case report","title":"QT interval prolongation and Torsades de Pointes with donepezil, rivastigmine and galantamine","title_match":true,"year":2020},{"alzhub_score":39,"alzhub_url":"https://alzhub.org/study/correlation-between-donepezil-and-qtc-prolongation-and-torsades-de-32025385","doi":"10.7759/cureus.6451","journal":"Cureus","n_participants":null,"pmid":"32025385","source_url":"https://pubmed.ncbi.nlm.nih.gov/32025385/","study_design":null,"title":"Correlation Between Donepezil and QTc Prolongation and Torsades de Pointes: A Very Rare Phenomenon","title_match":true,"year":2019},{"alzhub_score":68,"alzhub_url":"https://alzhub.org/study/the-efficacy-and-safety-of-memantine-for-the-treatment-of-alzheimer-s-30222469","doi":"10.1080/14740338.2018.1524870","journal":"Expert opinion on drug safety","n_participants":null,"pmid":"30222469","source_url":"https://pubmed.ncbi.nlm.nih.gov/30222469/","study_design":"meta-analysis","title":"The efficacy and safety of memantine for the treatment of Alzheimer's disease","title_match":true,"year":2018},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/effect-of-donepezil-tacrine-galantamine-and-rivastigmine-on-26760993","doi":"10.3390/molecules21010053","journal":"Molecules (Basel, Switzerland)","n_participants":null,"pmid":"26760993","source_url":"https://pubmed.ncbi.nlm.nih.gov/26760993/","study_design":null,"title":"Effect of Donepezil, Tacrine, Galantamine and Rivastigmine on Acetylcholinesterase Inhibition in Dugesia tigrina","title_match":true,"year":2016},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/donepezil-ameliorates-a-pathology-but-not-tau-pathology-in-5xfad-mice-35850693","doi":"10.1186/s13041-022-00948-1","journal":"Molecular brain","n_participants":null,"pmid":"35850693","source_url":"https://pubmed.ncbi.nlm.nih.gov/35850693/","study_design":null,"title":"Donepezil ameliorates A\u03b2 pathology but not tau pathology in 5xFAD mice","title_match":true,"year":2022},{"alzhub_score":39,"alzhub_url":"https://alzhub.org/study/cholinesterase-as-a-target-for-drug-development-in-alzheimer-s-disease-31773661","doi":"10.1007/978-1-0716-0163-1_18","journal":"Methods in molecular biology (Clifton, N.J.)","n_participants":null,"pmid":"31773661","source_url":"https://pubmed.ncbi.nlm.nih.gov/31773661/","study_design":null,"title":"Cholinesterase as a Target for Drug Development in Alzheimer's Disease","title_match":false,"year":2020},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/comparative-study-of-rivastigmine-and-galantamine-on-the-transgenic-35992376","doi":"10.1016/j.crphar.2022.100120","journal":"Current research in pharmacology and drug discovery","n_participants":null,"pmid":"35992376","source_url":"https://pubmed.ncbi.nlm.nih.gov/35992376/","study_design":null,"title":"Comparative study of rivastigmine and galantamine on the transgenic Drosophila model of Alzheimer's disease","title_match":true,"year":2022},{"alzhub_score":71,"alzhub_url":"https://alzhub.org/study/comparative-safety-of-cholinesterase-inhibitors-and-memantine-for-41188985","doi":"10.1186/s13643-025-02961-6","journal":"Systematic reviews","n_participants":null,"pmid":"41188985","source_url":"https://pubmed.ncbi.nlm.nih.gov/41188985/","study_design":"systematic review","title":"Comparative safety of cholinesterase inhibitors and memantine for dementia: a protocol for a network meta-analysis of randomized controlled trials","title_match":true,"year":2025},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/simultaneous-usage-of-dementia-medications-and-anticholinergics-among-28387023","doi":"10.1111/psyg.12267","journal":"Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society","n_participants":304,"pmid":"28387023","source_url":"https://pubmed.ncbi.nlm.nih.gov/28387023/","study_design":null,"title":"Simultaneous usage of dementia medications and anticholinergics among Asians and Pacific Islanders","title_match":false,"year":2017},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/is-long-term-treatment-of-alzheimer-s-disease-with-cholinesterase-17953456","doi":"10.2165/00002512-200724110-00001","journal":"Drugs & aging","n_participants":null,"pmid":"17953456","source_url":"https://pubmed.ncbi.nlm.nih.gov/17953456/","study_design":"open-label trial","title":"Is long-term treatment of Alzheimer's disease with cholinesterase inhibitor therapy justified?","title_match":true,"year":2007},{"alzhub_score":39,"alzhub_url":"https://alzhub.org/study/transdermal-drug-delivery-systems-and-their-potential-in-alzheimer-s-32552655","doi":"10.2174/1871527319666200618150046","journal":"CNS & neurological disorders drug targets","n_participants":null,"pmid":"32552655","source_url":"https://pubmed.ncbi.nlm.nih.gov/32552655/","study_design":null,"title":"Transdermal Drug Delivery Systems and their Potential in Alzheimer's Disease Management","title_match":false,"year":2020},{"alzhub_score":73,"alzhub_url":"https://alzhub.org/study/antimuscarinic-cascade-across-individual-cholinesterase-inhibitors-in-34027602","doi":"10.1007/s40266-021-00863-5","journal":"Drugs & aging","n_participants":47059,"pmid":"34027602","source_url":"https://pubmed.ncbi.nlm.nih.gov/34027602/","study_design":"cohort study","title":"Antimuscarinic Cascade Across Individual Cholinesterase Inhibitors in Older Adults with Dementia","title_match":true,"year":2021},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/symptomatic-effect-of-donepezil-rivastigmine-galantamine-and-15654502","doi":"10.1007/s00213-004-2132-z","journal":"Psychopharmacology","n_participants":null,"pmid":"15654502","source_url":"https://pubmed.ncbi.nlm.nih.gov/15654502/","study_design":null,"title":"Symptomatic effect of donepezil, rivastigmine, galantamine and memantine on cognitive deficits in the APP23 model","title_match":true,"year":2005},{"alzhub_score":39,"alzhub_url":"https://alzhub.org/study/benzofuran-and-indole-promising-scaffolds-for-drug-development-in-29742314","doi":"10.1002/cmdc.201800156","journal":"ChemMedChem","n_participants":null,"pmid":"29742314","source_url":"https://pubmed.ncbi.nlm.nih.gov/29742314/","study_design":null,"title":"Benzofuran and Indole: Promising Scaffolds for Drug Development in Alzheimer's Disease","title_match":false,"year":2018},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/combination-of-acetylcholinesterase-inhibitors-and-nmda-receptor-37051629","doi":"10.1080/15376516.2023.2202730","journal":"Toxicology mechanisms and methods","n_participants":null,"pmid":"37051629","source_url":"https://pubmed.ncbi.nlm.nih.gov/37051629/","study_design":null,"title":"Combination of acetylcholinesterase inhibitors and NMDA receptor antagonists increases survival rate in soman-poisoned mice","title_match":true,"year":2023},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/therapeutic-potential-of-multifunctional-derivatives-of-33342413","doi":"10.2174/1570159x19666201218103434","journal":"Current neuropharmacology","n_participants":null,"pmid":"33342413","source_url":"https://pubmed.ncbi.nlm.nih.gov/33342413/","study_design":null,"title":"Therapeutic Potential of Multifunctional Derivatives of Cholinesterase Inhibitors","title_match":true,"year":2021},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/dementia-drug-consumption-in-the-basque-country-between-2006-and-2011-25449962","doi":"10.1016/j.nrl.2014.09.006","journal":"Neurologia (Barcelona, Spain)","n_participants":null,"pmid":"25449962","source_url":"https://pubmed.ncbi.nlm.nih.gov/25449962/","study_design":null,"title":"Dementia drug consumption in the Basque Country between 2006 and 2011","title_match":false,"year":2016},{"alzhub_score":39,"alzhub_url":"https://alzhub.org/study/natural-and-synthetic-drugs-used-for-the-treatment-of-the-dementia-32037088","doi":"10.1016/j.bbrc.2020.01.123","journal":"Biochemical and biophysical research communications","n_participants":null,"pmid":"32037088","source_url":"https://pubmed.ncbi.nlm.nih.gov/32037088/","study_design":null,"title":"Natural and synthetic drugs used for the treatment of the dementia","title_match":false,"year":2020},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/alzheimer-s-disease-treatment-the-share-of-herbal-medicines-33953850","doi":"10.22038/ijbms.2020.50536.11512","journal":"Iranian journal of basic medical sciences","n_participants":null,"pmid":"33953850","source_url":"https://pubmed.ncbi.nlm.nih.gov/33953850/","study_design":null,"title":"Alzheimer's disease treatment: The share of herbal medicines","title_match":false,"year":2021},{"alzhub_score":71,"alzhub_url":"https://alzhub.org/study/alzheimer-s-disease-medication-and-risk-of-all-cause-mortality-and-31338414","doi":"10.1016/j.trci.2019.05.005","journal":"Alzheimer's & dementia (New York, N. Y.)","n_participants":21558,"pmid":"31338414","source_url":"https://pubmed.ncbi.nlm.nih.gov/31338414/","study_design":"cohort study","title":"Alzheimer's disease medication and risk of all-cause mortality and all-cause hospitalization: A retrospective cohort study","title_match":false,"year":2019},{"alzhub_score":64,"alzhub_url":"https://alzhub.org/study/efficacy-of-cholinesterase-inhibitors-in-vascular-dementia-an-updated-26918649","doi":"10.1159/000444253","journal":"European neurology","n_participants":null,"pmid":"26918649","source_url":"https://pubmed.ncbi.nlm.nih.gov/26918649/","study_design":null,"title":"Efficacy of Cholinesterase Inhibitors in Vascular Dementia: An Updated Meta-Analysis","title_match":true,"year":2016},{"alzhub_score":66,"alzhub_url":"https://alzhub.org/study/cholinesterase-inhibitors-in-dementia-with-lewy-bodies-a-comparative-17265415","doi":"10.1002/gps.1759","journal":"International journal of geriatric psychiatry","n_participants":null,"pmid":"17265415","source_url":"https://pubmed.ncbi.nlm.nih.gov/17265415/","study_design":"randomized controlled trial","title":"Cholinesterase inhibitors in dementia with Lewy bodies: a comparative analysis","title_match":true,"year":2007},{"alzhub_score":77,"alzhub_url":"https://alzhub.org/study/different-cholinesterase-inhibitor-effects-on-csf-cholinesterases-in-19199870","doi":"10.2174/156720509787313961","journal":"Current Alzheimer research","n_participants":63,"pmid":"19199870","source_url":"https://pubmed.ncbi.nlm.nih.gov/19199870/","study_design":"open-label trial","title":"Different cholinesterase inhibitor effects on CSF cholinesterases in Alzheimer patients","title_match":true,"year":2009},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/potential-therapeutic-natural-products-against-alzheimer-s-disease-33915501","doi":"10.1016/j.biopha.2021.111609","journal":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie","n_participants":null,"pmid":"33915501","source_url":"https://pubmed.ncbi.nlm.nih.gov/33915501/","study_design":null,"title":"Potential therapeutic natural products against Alzheimer's disease with Reference of Acetylcholinesterase","title_match":false,"year":2021},{"alzhub_score":39,"alzhub_url":"https://alzhub.org/study/assessing-the-binding-of-cholinesterase-inhibitors-by-docking-and-28711758","doi":"10.1016/j.jmgm.2017.06.027","journal":"Journal of molecular graphics & modelling","n_participants":null,"pmid":"28711758","source_url":"https://pubmed.ncbi.nlm.nih.gov/28711758/","study_design":null,"title":"Assessing the binding of cholinesterase inhibitors by docking and molecular dynamics studies","title_match":true,"year":2017},{"alzhub_score":54,"alzhub_url":"https://alzhub.org/study/movement-disorders-associated-with-acetylcholinesterase-inhibitors-in-40224553","doi":"10.4103/bc.bc_134_24","journal":"Brain circulation","n_participants":33,"pmid":"40224553","source_url":"https://pubmed.ncbi.nlm.nih.gov/40224553/","study_design":null,"title":"Movement disorders associated with acetylcholinesterase inhibitors in Alzheimer's dementia: A systematic review","title_match":true,"year":2025},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/prevalence-of-cholinesterase-inhibitors-in-subjects-with-dementia-in-18508393","doi":"10.1002/pds.1613","journal":"Pharmacoepidemiology and drug safety","n_participants":null,"pmid":"18508393","source_url":"https://pubmed.ncbi.nlm.nih.gov/18508393/","study_design":null,"title":"Prevalence of cholinesterase inhibitors in subjects with dementia in Europe","title_match":true,"year":2008},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/donepezil-markedly-potentiates-memantine-neurotoxicity-in-the-adult-17112636","doi":"10.1016/j.neurobiolaging.2006.10.020","journal":"Neurobiology of aging","n_participants":null,"pmid":"17112636","source_url":"https://pubmed.ncbi.nlm.nih.gov/17112636/","study_design":null,"title":"Donepezil markedly potentiates memantine neurotoxicity in the adult rat brain","title_match":true,"year":2008},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/consumption-of-drugs-for-alzheimer-s-disease-on-the-brazilian-private-37971177","doi":"10.11606/s1518-8787.2023057005128","journal":"Revista de saude publica","n_participants":null,"pmid":"37971177","source_url":"https://pubmed.ncbi.nlm.nih.gov/37971177/","study_design":null,"title":"Consumption of drugs for Alzheimer's disease on the Brazilian private market","title_match":false,"year":2023},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/patterns-and-predictors-of-cholinesterase-inhibitor-use-in-dementia-40687401","doi":"10.1002/trc2.70136","journal":"Alzheimer's & dementia (New York, N. Y.)","n_participants":null,"pmid":"40687401","source_url":"https://pubmed.ncbi.nlm.nih.gov/40687401/","study_design":null,"title":"Patterns and predictors of cholinesterase inhibitor use in dementia with Lewy bodies","title_match":true,"year":2025},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/cholinesterase-inhibitors-associated-torsade-de-pointes-qt-38273821","doi":"10.3389/fphar.2023.1343650","journal":"Frontiers in pharmacology","n_participants":null,"pmid":"38273821","source_url":"https://pubmed.ncbi.nlm.nih.gov/38273821/","study_design":null,"title":"Cholinesterase inhibitors-associated torsade de pointes/QT prolongation: a real-world pharmacovigilance study","title_match":true,"year":2023},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/tolerability-of-cholinesterase-inhibitors-a-population-based-study-of-28138912","doi":"10.1007/s40266-017-0438-x","journal":"Drugs & aging","n_participants":null,"pmid":"28138912","source_url":"https://pubmed.ncbi.nlm.nih.gov/28138912/","study_design":"cohort study","title":"Tolerability of Cholinesterase Inhibitors: A Population-Based Study of Persistence, Adherence, and Switching","title_match":true,"year":2017},{"alzhub_score":39,"alzhub_url":"https://alzhub.org/study/pharmacogenetic-considerations-when-prescribing-cholinesterase-32520597","doi":"10.1080/17425255.2020.1779700","journal":"Expert opinion on drug metabolism & toxicology","n_participants":null,"pmid":"32520597","source_url":"https://pubmed.ncbi.nlm.nih.gov/32520597/","study_design":null,"title":"Pharmacogenetic considerations when prescribing cholinesterase inhibitors for the treatment of Alzheimer's disease","title_match":true,"year":2020},{"alzhub_score":50,"alzhub_url":"https://alzhub.org/study/acetylcholinesterase-inhibitors-and-sleep-architecture-in-patients-16872233","doi":"10.2165/00002512-200623060-00005","journal":"Drugs & aging","n_participants":41,"pmid":"16872233","source_url":"https://pubmed.ncbi.nlm.nih.gov/16872233/","study_design":null,"title":"Acetylcholinesterase inhibitors and sleep architecture in patients with Alzheimer's disease","title_match":true,"year":2006},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/galantamine-improves-sleep-quality-in-patients-with-dementia-25777522","doi":"10.1007/s13760-015-0453-9","journal":"Acta neurologica Belgica","n_participants":87,"pmid":"25777522","source_url":"https://pubmed.ncbi.nlm.nih.gov/25777522/","study_design":null,"title":"Galantamine improves sleep quality in patients with dementia","title_match":true,"year":2015},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/rivastigmine-a-brain-region-selective-acetylcholinesterase-inhibitor-11139819","doi":"10.1517/13543784.8.10.1673","journal":"Expert opinion on investigational drugs","n_participants":null,"pmid":"11139819","source_url":"https://pubmed.ncbi.nlm.nih.gov/11139819/","study_design":null,"title":"Rivastigmine, a brain-region selective acetylcholinesterase inhibitor for treating Alzheimer's disease: review and current status","title_match":true,"year":1999},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/prevalence-of-treated-patients-with-alzheimer-s-disease-current-37537656","doi":"10.1186/s13195-023-01271-0","journal":"Alzheimer's research & therapy","n_participants":null,"pmid":"37537656","source_url":"https://pubmed.ncbi.nlm.nih.gov/37537656/","study_design":null,"title":"Prevalence of treated patients with Alzheimer's disease: current trends and COVID-19 impact","title_match":false,"year":2023},{"alzhub_score":39,"alzhub_url":"https://alzhub.org/study/a-molecular-approach-in-drug-development-for-alzheimer-s-disease-29990843","doi":"10.1016/j.biopha.2018.06.147","journal":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie","n_participants":null,"pmid":"29990843","source_url":"https://pubmed.ncbi.nlm.nih.gov/29990843/","study_design":null,"title":"A molecular approach in drug development for Alzheimer's disease","title_match":false,"year":2018},{"alzhub_score":68,"alzhub_url":"https://alzhub.org/study/memantine-as-add-on-medication-to-acetylcholinesterase-inhibitor-27822591","doi":"10.1007/s00115-016-0237-3","journal":"Der Nervenarzt","n_participants":null,"pmid":"27822591","source_url":"https://pubmed.ncbi.nlm.nih.gov/27822591/","study_design":"meta-analysis","title":"[Memantine as add-on medication to acetylcholinesterase inhibitor therapy for Alzheimer dementia]","title_match":true,"year":2017},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/carbamate-as-a-potential-anti-alzheimer-s-pharmacophore-a-review-37694498","doi":"10.1002/ddr.22113","journal":"Drug development research","n_participants":null,"pmid":"37694498","source_url":"https://pubmed.ncbi.nlm.nih.gov/37694498/","study_design":null,"title":"Carbamate as a potential anti-Alzheimer's pharmacophore: A review","title_match":false,"year":2023},{"alzhub_score":39,"alzhub_url":"https://alzhub.org/study/clinically-relevant-drug-interactions-with-anti-alzheimer-s-drugs-28260511","doi":"10.2174/1871527316666170303144817","journal":"CNS & neurological disorders drug targets","n_participants":null,"pmid":"28260511","source_url":"https://pubmed.ncbi.nlm.nih.gov/28260511/","study_design":null,"title":"Clinically Relevant Drug Interactions with Anti-Alzheimer's Drugs","title_match":false,"year":2017},{"alzhub_score":68,"alzhub_url":"https://alzhub.org/study/risk-of-rhabdomyolysis-with-donepezil-compared-with-rivastigmine-or-31527187","doi":"10.1503/cmaj.190337","journal":"CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne","n_participants":300,"pmid":"31527187","source_url":"https://pubmed.ncbi.nlm.nih.gov/31527187/","study_design":"cohort study","title":"Risk of rhabdomyolysis with donepezil compared with rivastigmine or galantamine: a population-based cohort study","title_match":true,"year":2019},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/polypharmacological-potential-of-phosphodiesterase-5-inhibitors-for-38270120","doi":"10.14336/ad.2023.1129","journal":"Aging and disease","n_participants":null,"pmid":"38270120","source_url":"https://pubmed.ncbi.nlm.nih.gov/38270120/","study_design":null,"title":"Polypharmacological Potential of Phosphodiesterase 5 Inhibitors for the Treatment of Neurocognitive Disorders","title_match":false,"year":2024},{"alzhub_score":70,"alzhub_url":"https://alzhub.org/study/predictors-of-response-to-acetylcholinesterase-inhibitors-in-dementia-36203811","doi":"10.3389/fnins.2022.998224","journal":"Frontiers in neuroscience","n_participants":null,"pmid":"36203811","source_url":"https://pubmed.ncbi.nlm.nih.gov/36203811/","study_design":"systematic review","title":"Predictors of response to acetylcholinesterase inhibitors in dementia: A systematic review","title_match":true,"year":2022},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/donepezil-in-the-treatment-of-patients-with-alzheimer-s-disease-19811041","doi":"10.1586/14737175.1.1.11","journal":"Expert review of neurotherapeutics","n_participants":null,"pmid":"19811041","source_url":"https://pubmed.ncbi.nlm.nih.gov/19811041/","study_design":"open-label trial","title":"Donepezil in the treatment of patients with Alzheimer's disease","title_match":true,"year":2001},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/pharmacologic-treatments-of-dementia-12171061","doi":"10.1016/s0025-7125(02)00007-x","journal":"The Medical clinics of North America","n_participants":null,"pmid":"12171061","source_url":"https://pubmed.ncbi.nlm.nih.gov/12171061/","study_design":null,"title":"Pharmacologic treatments of dementia","title_match":false,"year":2002},{"alzhub_score":84,"alzhub_url":"https://alzhub.org/study/systematic-review-of-sex-specific-reporting-of-data-cholinesterase-28832937","doi":"10.1111/jgs.15020","journal":"Journal of the American Geriatrics Society","n_participants":15971,"pmid":"28832937","source_url":"https://pubmed.ncbi.nlm.nih.gov/28832937/","study_design":null,"title":"Systematic Review of Sex-Specific Reporting of Data: Cholinesterase Inhibitor Example","title_match":true,"year":2017},{"alzhub_score":66,"alzhub_url":"https://alzhub.org/study/acetylcholinesterase-inhibitors-and-memantine-for-neuroenhancement-in-20193764","doi":"10.1016/j.phrs.2010.02.009","journal":"Pharmacological research","n_participants":null,"pmid":"20193764","source_url":"https://pubmed.ncbi.nlm.nih.gov/20193764/","study_design":"systematic review","title":"Acetylcholinesterase inhibitors and memantine for neuroenhancement in healthy individuals: a systematic review","title_match":true,"year":2010},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/neurological-and-psychiatric-practitioners-views-on-alzheimer-s-19052454","doi":"10.1159/000180117","journal":"Dementia and geriatric cognitive disorders","n_participants":null,"pmid":"19052454","source_url":"https://pubmed.ncbi.nlm.nih.gov/19052454/","study_design":null,"title":"Neurological and psychiatric practitioners' views on Alzheimer's disease and treatment thereof","title_match":false,"year":2008},{"alzhub_score":73,"alzhub_url":"https://alzhub.org/study/antipsychotic-initiation-among-older-dementia-patients-using-33763822","doi":"10.1007/s40266-021-00851-9","journal":"Drugs & aging","n_participants":23433,"pmid":"33763822","source_url":"https://pubmed.ncbi.nlm.nih.gov/33763822/","study_design":"cohort study","title":"Antipsychotic Initiation Among Older Dementia Patients Using Cholinesterase Inhibitors: A National Retrospective Cohort Study","title_match":true,"year":2021},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/rivastigmine-in-the-treatment-of-alzheimer-s-disease-an-update-18044073","doi":"10.2147/ciia.2007.2.1.17","journal":"Clinical interventions in aging","n_participants":null,"pmid":"18044073","source_url":"https://pubmed.ncbi.nlm.nih.gov/18044073/","study_design":null,"title":"Rivastigmine in the treatment of Alzheimer's disease: an update","title_match":true,"year":2007},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/rivastigmine-a-new-generation-cholinesterase-inhibitor-for-the-10641971","doi":"10.1592/phco.20.1.1.34664","journal":"Pharmacotherapy","n_participants":1324,"pmid":"10641971","source_url":"https://pubmed.ncbi.nlm.nih.gov/10641971/","study_design":null,"title":"Rivastigmine, a new-generation cholinesterase inhibitor for the treatment of Alzheimer's disease","title_match":true,"year":2000},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/new-therapeutics-beyond-amyloid-and-tau-for-the-treatment-of-33268824","doi":"10.1038/s41401-020-00565-5","journal":"Acta pharmacologica Sinica","n_participants":null,"pmid":"33268824","source_url":"https://pubmed.ncbi.nlm.nih.gov/33268824/","study_design":null,"title":"New therapeutics beyond amyloid-\u03b2 and tau for the treatment of Alzheimer's disease","title_match":false,"year":2021},{"alzhub_score":66,"alzhub_url":"https://alzhub.org/study/galantamine-for-alzheimer-s-disease-20113148","doi":"10.1517/17425251003592137","journal":"Expert opinion on drug metabolism & toxicology","n_participants":null,"pmid":"20113148","source_url":"https://pubmed.ncbi.nlm.nih.gov/20113148/","study_design":"meta-analysis","title":"Galantamine for Alzheimer's disease","title_match":true,"year":2010},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/analysis-of-treatment-pattern-of-anti-dementia-medications-in-newly-35292697","doi":"10.1038/s41598-022-08595-1","journal":"Scientific reports","n_participants":8653,"pmid":"35292697","source_url":"https://pubmed.ncbi.nlm.nih.gov/35292697/","study_design":null,"title":"Analysis of treatment pattern of anti-dementia medications in newly diagnosed Alzheimer's dementia using OMOP CDM","title_match":false,"year":2022},{"alzhub_score":39,"alzhub_url":"https://alzhub.org/study/pharmacotherapy-for-vascular-cognitive-impairment-28786085","doi":"10.1007/s40263-017-0459-3","journal":"CNS drugs","n_participants":null,"pmid":"28786085","source_url":"https://pubmed.ncbi.nlm.nih.gov/28786085/","study_design":null,"title":"Pharmacotherapy for Vascular Cognitive Impairment","title_match":false,"year":2017},{"alzhub_score":64,"alzhub_url":"https://alzhub.org/study/association-between-statin-use-and-sepsis-risk-in-patients-with-31075943","doi":"10.3390/ijerph16091626","journal":"International journal of environmental research and public health","n_participants":308,"pmid":"31075943","source_url":"https://pubmed.ncbi.nlm.nih.gov/31075943/","study_design":"cohort study","title":"Association between Statin Use and Sepsis Risk in Patients with Dementia: A Retrospective Cohort Study","title_match":false,"year":2019},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/combination-therapy-of-cholinesterase-inhibitor-donepezil-or-25624417","doi":"10.3233/jad-143084","journal":"Journal of Alzheimer's disease : JAD","n_participants":61,"pmid":"25624417","source_url":"https://pubmed.ncbi.nlm.nih.gov/25624417/","study_design":null,"title":"Combination Therapy of Cholinesterase Inhibitor (Donepezil or Galantamine) plus Memantine in the Okayama Memantine Study","title_match":true,"year":2015},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/galantamine-potentiates-the-neuroprotective-effect-of-memantine-23532860","doi":"10.1002/brb3.118","journal":"Brain and behavior","n_participants":null,"pmid":"23532860","source_url":"https://pubmed.ncbi.nlm.nih.gov/23532860/","study_design":null,"title":"Galantamine potentiates the neuroprotective effect of memantine against NMDA-induced excitotoxicity","title_match":true,"year":2013},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/dysphagia-risk-in-patients-prescribed-rivastigmine-a-systematic-35964196","doi":"10.3233/jad-220583","journal":"Journal of Alzheimer's disease : JAD","n_participants":null,"pmid":"35964196","source_url":"https://pubmed.ncbi.nlm.nih.gov/35964196/","study_design":null,"title":"Dysphagia Risk in Patients Prescribed Rivastigmine: A Systematic Analysis of FDA Adverse Event Reporting System","title_match":true,"year":2022},{"alzhub_score":54,"alzhub_url":"https://alzhub.org/study/effects-of-donepezil-galantamine-and-rivastigmine-in-938-italian-20088621","doi":"10.2165/11310960-000000000-00000","journal":"CNS drugs","n_participants":938,"pmid":"20088621","source_url":"https://pubmed.ncbi.nlm.nih.gov/20088621/","study_design":null,"title":"Effects of donepezil, galantamine and rivastigmine in 938 Italian patients with Alzheimer's disease: a prospective, observational study","title_match":true,"year":2010},{"alzhub_score":78,"alzhub_url":"https://alzhub.org/study/rivastigmine-and-donepezil-treatment-in-moderate-to-moderately-severe-16083542","doi":"10.1185/030079905x56565","journal":"Current medical research and opinion","n_participants":495,"pmid":"16083542","source_url":"https://pubmed.ncbi.nlm.nih.gov/16083542/","study_design":null,"title":"Rivastigmine and donepezil treatment in moderate to moderately-severe Alzheimer's disease over a 2-year period","title_match":true,"year":2005},{"alzhub_score":66,"alzhub_url":"https://alzhub.org/study/are-cholinesterase-inhibitors-effective-in-the-management-of-the-19538824","doi":"10.1017/s1041610209990354","journal":"International psychogeriatrics","n_participants":null,"pmid":"19538824","source_url":"https://pubmed.ncbi.nlm.nih.gov/19538824/","study_design":"systematic review","title":"Are cholinesterase inhibitors effective in the management of the behavioral and psychological symptoms of dementia in Alzheimer's disease? A systematic review of randomized, placebo-controlled trials of donepezil, rivastigmine and galantamine","title_match":true,"year":2009},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/tryptamine-a-privileged-scaffold-for-the-management-of-alzheimer-s-37675624","doi":"10.1002/ddr.22111","journal":"Drug development research","n_participants":null,"pmid":"37675624","source_url":"https://pubmed.ncbi.nlm.nih.gov/37675624/","study_design":null,"title":"Tryptamine: A privileged scaffold for the management of Alzheimer's disease","title_match":false,"year":2023},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/treatment-of-parkinson-s-disease-with-cognitive-impairment-current-33920698","doi":"10.3390/bs11040054","journal":"Behavioral sciences (Basel, Switzerland)","n_participants":null,"pmid":"33920698","source_url":"https://pubmed.ncbi.nlm.nih.gov/33920698/","study_design":null,"title":"Treatment of Parkinson's Disease with Cognitive Impairment: Current Approaches and Future Directions","title_match":false,"year":2021},{"alzhub_score":39,"alzhub_url":"https://alzhub.org/study/clinical-efficacy-and-safety-of-donepezil-in-the-treatment-of-30349215","doi":"10.2147/cia.s159920","journal":"Clinical interventions in aging","n_participants":null,"pmid":"30349215","source_url":"https://pubmed.ncbi.nlm.nih.gov/30349215/","study_design":null,"title":"Clinical efficacy and safety of donepezil in the treatment of Alzheimer's disease in Chinese patients","title_match":true,"year":2018},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/transdermal-therapeutic-systems-for-the-treatment-of-alzheimer-s-37990896","doi":"10.2174/0118715273275957231102044934","journal":"CNS & neurological disorders drug targets","n_participants":null,"pmid":"37990896","source_url":"https://pubmed.ncbi.nlm.nih.gov/37990896/","study_design":null,"title":"Transdermal Therapeutic Systems for the Treatment of Alzheimer's Disease: A Patent Review","title_match":false,"year":2024},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/galantamine-memantine-hybrids-for-alzheimer-s-disease-the-influence-37734258","doi":"10.1016/j.ejmech.2023.115803","journal":"European journal of medicinal chemistry","n_participants":null,"pmid":"37734258","source_url":"https://pubmed.ncbi.nlm.nih.gov/37734258/","study_design":null,"title":"Galantamine-memantine hybrids for Alzheimer's disease: The influence of linker rigidity in biological activity and pharmacokinetic properties","title_match":true,"year":2023},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/treatment-of-vascular-dementia-evidence-from-clinical-trials-with-15537522","doi":"10.1016/j.jns.2004.09.018","journal":"Journal of the neurological sciences","n_participants":null,"pmid":"15537522","source_url":"https://pubmed.ncbi.nlm.nih.gov/15537522/","study_design":null,"title":"Treatment of vascular dementia--evidence from clinical trials with cholinesterase inhibitors","title_match":true,"year":2004},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/review-of-donepezil-rivastigmine-galantamine-and-memantine-for-the-15211527","doi":"10.1002/gps.1077","journal":"International journal of geriatric psychiatry","n_participants":null,"pmid":"15211527","source_url":"https://pubmed.ncbi.nlm.nih.gov/15211527/","study_design":null,"title":"Review of donepezil, rivastigmine, galantamine and memantine for the treatment of dementia in Alzheimer's disease in adults with Down syndrome: implications for the intellectual disability population","title_match":true,"year":2004},{"alzhub_score":59,"alzhub_url":"https://alzhub.org/study/risk-of-pneumonia-in-new-users-of-cholinesterase-inhibitors-for-25912671","doi":"10.1111/jgs.13380","journal":"Journal of the American Geriatrics Society","n_participants":null,"pmid":"25912671","source_url":"https://pubmed.ncbi.nlm.nih.gov/25912671/","study_design":"cohort study","title":"Risk of pneumonia in new users of cholinesterase inhibitors for dementia","title_match":true,"year":2015},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/a-population-based-study-of-dosing-and-persistence-with-anti-dementia-23443628","doi":"10.1007/s00228-013-1483-y","journal":"European journal of clinical pharmacology","n_participants":20729,"pmid":"23443628","source_url":"https://pubmed.ncbi.nlm.nih.gov/23443628/","study_design":null,"title":"A population-based study of dosing and persistence with anti-dementia medications","title_match":false,"year":2013},{"alzhub_score":79,"alzhub_url":"https://alzhub.org/study/systematic-review-of-pharmacological-interventions-for-people-with-35109724","doi":"10.1080/13607863.2022.2032601","journal":"Aging & mental health","n_participants":135,"pmid":"35109724","source_url":"https://pubmed.ncbi.nlm.nih.gov/35109724/","study_design":"meta-analysis","title":"Systematic review of pharmacological interventions for people with Lewy body dementia","title_match":false,"year":2023},{"alzhub_score":78,"alzhub_url":"https://alzhub.org/study/efficacy-and-safety-of-gv1001-in-patients-with-moderate-to-severe-33771205","doi":"10.1186/s13195-021-00803-w","journal":"Alzheimer's research & therapy","n_participants":31,"pmid":"33771205","source_url":"https://pubmed.ncbi.nlm.nih.gov/33771205/","study_design":"clinical trial","title":"Efficacy and safety of GV1001 in patients with moderate-to-severe Alzheimer's disease already receiving donepezil: a phase 2 randomized, double-blind, placebo-controlled, multicenter clinical trial","title_match":true,"year":2021},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/economic-evaluations-during-early-phase-ii-drug-development-a-role-11735674","doi":"10.2165/00019053-200119110-00001","journal":"PharmacoEconomics","n_participants":null,"pmid":"11735674","source_url":"https://pubmed.ncbi.nlm.nih.gov/11735674/","study_design":null,"title":"Economic evaluations during early (phase II) drug development: a role for clinical trial simulations?","title_match":false,"year":2001},{"alzhub_score":75,"alzhub_url":"https://alzhub.org/study/a-randomized-double-blind-placebo-controlled-phase-ii-study-assessing-30530975","doi":"10.3233/jad-180759","journal":"Journal of Alzheimer's disease : JAD","n_participants":null,"pmid":"30530975","source_url":"https://pubmed.ncbi.nlm.nih.gov/30530975/","study_design":"post-hoc analysis","title":"A Randomized, Double-Blind, Placebo-Controlled, Phase II Study Assessing Safety, Tolerability, and Efficacy of Bryostatin in the Treatment of Moderately Severe to Severe Alzheimer's Disease","title_match":false,"year":2019},{"alzhub_score":82,"alzhub_url":"https://alzhub.org/study/safety-efficacy-and-tolerability-of-memantine-for-cognitive-and-34942135","doi":"10.1016/s1474-4422(21)00369-0","journal":"The Lancet. Neurology","n_participants":81,"pmid":"34942135","source_url":"https://pubmed.ncbi.nlm.nih.gov/34942135/","study_design":"clinical trial","title":"Safety, efficacy, and tolerability of memantine for cognitive and adaptive outcome measures in adolescents and young adults with Down syndrome: a randomised, double-blind, placebo-controlled phase 2 trial","title_match":true,"year":2022},{"alzhub_score":61,"alzhub_url":"https://alzhub.org/study/the-behavioral-effects-of-combination-therapy-of-memantine-and-33685036","doi":"10.30773/pi.2020.0329","journal":"Psychiatry investigation","n_participants":148,"pmid":"33685036","source_url":"https://pubmed.ncbi.nlm.nih.gov/33685036/","study_design":null,"title":"The Behavioral Effects of Combination Therapy of Memantine and Acetylcholinesterase Inhibitors Compared with Acetylcholinesterase Inhibitors Alone in Patients with Moderate Alzheimer's Dementia: A Double-Blind Randomized Placebo-Controlled Trial","title_match":true,"year":2021},{"alzhub_score":39,"alzhub_url":"https://alzhub.org/study/pioglitazone-for-the-treatment-of-alzheimer-s-disease-27885860","doi":"10.1080/13543784.2017.1265504","journal":"Expert opinion on investigational drugs","n_participants":null,"pmid":"27885860","source_url":"https://pubmed.ncbi.nlm.nih.gov/27885860/","study_design":null,"title":"Pioglitazone for the treatment of Alzheimer's disease","title_match":false,"year":2017},{"alzhub_score":50,"alzhub_url":"https://alzhub.org/study/bryostatin-placebo-controlled-trials-indicate-cognitive-restoration-35124654","doi":"10.3233/jad-215545","journal":"Journal of Alzheimer's disease : JAD","n_participants":95,"pmid":"35124654","source_url":"https://pubmed.ncbi.nlm.nih.gov/35124654/","study_design":null,"title":"Bryostatin Placebo-Controlled Trials Indicate Cognitive Restoration Above Baseline for Advanced Alzheimer's Disease in the Absence of Memantine1","title_match":false,"year":2022},{"alzhub_score":77,"alzhub_url":"https://alzhub.org/study/galantamine-a-randomized-double-blind-dose-comparison-in-patients-11571763","doi":"10.1002/gps.409","journal":"International journal of geriatric psychiatry","n_participants":285,"pmid":"11571763","source_url":"https://pubmed.ncbi.nlm.nih.gov/11571763/","study_design":null,"title":"Galantamine: a randomized, double-blind, dose comparison in patients with Alzheimer's disease","title_match":true,"year":2001},{"alzhub_score":80,"alzhub_url":"https://alzhub.org/study/safety-and-efficacy-of-idalopirdine-a-5-ht6-receptor-antagonist-in-25297016","doi":"10.1016/s1474-4422(14)70198-x","journal":"The Lancet. Neurology","n_participants":278,"pmid":"25297016","source_url":"https://pubmed.ncbi.nlm.nih.gov/25297016/","study_design":"clinical trial","title":"Safety and efficacy of idalopirdine, a 5-HT6 receptor antagonist, in patients with moderate Alzheimer's disease (LADDER): a randomised, double-blind, placebo-controlled phase 2 trial","title_match":false,"year":2014},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/hearing-all-about-donepezil-its-role-in-the-field-of-auditory-41141199","doi":"10.7759/cureus.93143","journal":"Cureus","n_participants":null,"pmid":"41141199","source_url":"https://pubmed.ncbi.nlm.nih.gov/41141199/","study_design":null,"title":"Hearing All About Donepezil: Its Role in the Field of Auditory Processing","title_match":true,"year":2025},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/current-and-emerging-therapeutic-approaches-for-vascular-cognitive-41498480","doi":"10.1016/j.jacc.2025.09.1502","journal":"Journal of the American College of Cardiology","n_participants":null,"pmid":"41498480","source_url":"https://pubmed.ncbi.nlm.nih.gov/41498480/","study_design":null,"title":"Current and Emerging Therapeutic Approaches for Vascular Cognitive Impairment and Dementia","title_match":false,"year":2026},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/cognition-in-late-life-depression-treatment-considerations-24665414","doi":"10.1007/s40501-013-0001-2","journal":"Current treatment options in psychiatry","n_participants":null,"pmid":"24665414","source_url":"https://pubmed.ncbi.nlm.nih.gov/24665414/","study_design":null,"title":"Cognition in Late Life Depression: Treatment Considerations","title_match":false,"year":2014},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/donepezil-regulates-lps-and-a-stimulated-neuroinflammation-through-34638977","doi":"10.3390/ijms221910637","journal":"International journal of molecular sciences","n_participants":null,"pmid":"34638977","source_url":"https://pubmed.ncbi.nlm.nih.gov/34638977/","study_design":null,"title":"Donepezil Regulates LPS and A\u03b2-Stimulated Neuroinflammation through MAPK/NLRP3 Inflammasome/STAT3 Signaling","title_match":true,"year":2021},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/microbiota-gut-brain-axis-and-related-therapeutics-in-alzheimer-s-37076953","doi":"10.1515/revneuro-2023-0006","journal":"Reviews in the neurosciences","n_participants":null,"pmid":"37076953","source_url":"https://pubmed.ncbi.nlm.nih.gov/37076953/","study_design":null,"title":"Microbiota-gut-brain axis and related therapeutics in Alzheimer's disease: prospects for multitherapy and inflammation control","title_match":false,"year":2023},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/psychosis-management-in-lewy-body-dementia-a-comprehensive-clinical-33461372","doi":"10.1177/0891988720988916","journal":"Journal of geriatric psychiatry and neurology","n_participants":null,"pmid":"33461372","source_url":"https://pubmed.ncbi.nlm.nih.gov/33461372/","study_design":null,"title":"Psychosis Management in Lewy Body Dementia: A Comprehensive Clinical Approach","title_match":false,"year":2022},{"alzhub_score":61,"alzhub_url":"https://alzhub.org/study/racial-ethnic-disparities-in-initiation-and-persistent-use-of-anti-35218291","doi":"10.1002/alz.12623","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":null,"pmid":"35218291","source_url":"https://pubmed.ncbi.nlm.nih.gov/35218291/","study_design":"longitudinal study","title":"Racial/ethnic disparities in initiation and persistent use of anti-dementia medications","title_match":false,"year":2022},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/cost-effectiveness-of-florbetapir-pet-in-alzheimer-s-disease-a-26231002","doi":null,"journal":"The journal of mental health policy and economics","n_participants":null,"pmid":"26231002","source_url":"https://pubmed.ncbi.nlm.nih.gov/26231002/","study_design":null,"title":"Cost-Effectiveness of Florbetapir-PET in Alzheimer's Disease: A Spanish Societal Perspective","title_match":false,"year":2015},{"alzhub_score":46,"alzhub_url":"https://alzhub.org/study/causal-effect-of-conventional-anti-dementia-drugs-on-economic-burden-40855523","doi":"10.1186/s12877-025-06298-6","journal":"BMC geriatrics","n_participants":null,"pmid":"40855523","source_url":"https://pubmed.ncbi.nlm.nih.gov/40855523/","study_design":null,"title":"Causal effect of conventional anti-dementia drugs on economic burden: an orthogonal double/debiased machine learning approach","title_match":false,"year":2025},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/the-modulatory-effects-of-hericium-erinaceus-and-donepezil-on-amyloid-7cc2f407","doi":"10.64898/2026.10.06.757182","journal":"bioRxiv","n_participants":null,"pmid":null,"source_url":"https://doi.org/10.64898/2026.10.06.757182","study_design":null,"title":"The modulatory effects of Hericium erinaceus and donepezil on amyloid accumulation and autophagy-associated clearance in A\u03b2 1-42 -induced N2a cells","title_match":true,"year":2026},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/aph-1a-and-cdk5-expression-correlates-with-tau-hyperphosphorylation-f749be57","doi":"10.21203/rs.3.rs-11257702/v1","journal":"Research Square","n_participants":null,"pmid":null,"source_url":"https://doi.org/10.21203/rs.3.rs-11257702/v1","study_design":null,"title":"APH-1A and CDK5 Expression Correlates with Tau Hyperphosphorylation and Its Attenuation by Brahmi and Donep-M in STZ induced Alzheimer\u2019s Disease Model","title_match":false,"year":2026},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/causaldiffchem-causal-network-restoration-for-therapeutic-0dd7e989","doi":"10.21203/rs.3.rs-11272130/v1","journal":"Research Square","n_participants":null,"pmid":null,"source_url":"https://doi.org/10.21203/rs.3.rs-11272130/v1","study_design":null,"title":"CausalDiffChem: Causal Network Restoration for Therapeutic Prioritization and Repurposing Across Diseases","title_match":false,"year":2026},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/simulating-the-effects-of-gamma-oscillation-treatment-on-selective-f876eb5b","doi":"10.21203/rs.3.rs-11199141/v2","journal":"Research Square","n_participants":null,"pmid":null,"source_url":"https://doi.org/10.21203/rs.3.rs-11199141/v2","study_design":null,"title":"Simulating the Effects of Gamma Oscillation Treatment on Selective Neurotransmitters Using The Virtual Brain and Complex Pathway Simulator","title_match":false,"year":2026},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/amyloid-and-tau-cerebrospinal-fluid-biomarker-normalization-in-a-1d9e787e","doi":"10.21203/rs.3.rs-10778388/v1","journal":"Research Square","n_participants":null,"pmid":null,"source_url":"https://doi.org/10.21203/rs.3.rs-10778388/v1","study_design":null,"title":"Amyloid and Tau Cerebrospinal Fluid Biomarker Normalization in a Patient with Alzheimer\u2019s Disease treated with Lecanemab: A Case Report","title_match":false,"year":2026},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/natural-sesquiterpenoids-from-laggera-pterodonta-as-bioactive-5f7606f8","doi":"10.21203/rs.3.rs-11218173/v1","journal":"Research Square","n_participants":null,"pmid":null,"source_url":"https://doi.org/10.21203/rs.3.rs-11218173/v1","study_design":null,"title":"Natural Sesquiterpenoids from Laggera pterodonta as bioactive Acetylcholinesterase Inhibitors: Insights from DFT, Molecular Docking, and ADMET Profiling","title_match":true,"year":2026},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/substituent-effects-on-electronic-properties-and-acetylcholinesterase-f06e02fb","doi":"10.21203/rs.3.rs-11082767/v1","journal":"Research Square","n_participants":null,"pmid":null,"source_url":"https://doi.org/10.21203/rs.3.rs-11082767/v1","study_design":null,"title":"Substituent Effects on Electronic Properties and Acetylcholinesterase Inhibitory Potential of Donepezil Analogues: A DFT, Molecular Docking, and ADMET Study with Dynamics Validation of the Lead Candidate","title_match":true,"year":2026},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/docking-guided-design-and-biological-evaluation-of-a-lead-convolvine-86ec91fb","doi":"10.21203/rs.3.rs-10890265/v1","journal":"Research Square","n_participants":null,"pmid":null,"source_url":"https://doi.org/10.21203/rs.3.rs-10890265/v1","study_design":null,"title":"Docking-Guided Design and Biological Evaluation of a Lead Convolvine-Based Acetylcholinesterase Inhibitor for Alzheimer's Disease","title_match":true,"year":2026},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/in-silico-design-and-physicochemical-characterisation-of-a-dual-29a49622","doi":"10.21203/rs.3.rs-10822803/v1","journal":"Research Square","n_participants":null,"pmid":null,"source_url":"https://doi.org/10.21203/rs.3.rs-10822803/v1","study_design":null,"title":"In silico design and physicochemical characterisation of a dual-action intranasal nanoparticle formulation for Alzheimer\u2019s disease","title_match":false,"year":2026},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/biocatalytic-production-of-galantamine-in-yeast-through-cytochrome-d33b0eda","doi":"10.64898/2026.09.09.750345","journal":"bioRxiv","n_participants":null,"pmid":null,"source_url":"https://doi.org/10.64898/2026.09.09.750345","study_design":null,"title":"Biocatalytic Production of Galantamine in Yeast through Cytochrome P450 Optimization","title_match":true,"year":2026},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/synergistic-nano-architectures-how-date-seed-phytochemicals-and-9ea25c4a","doi":"10.21203/rs.3.rs-10617300/v1","journal":"Research Square","n_participants":null,"pmid":null,"source_url":"https://doi.org/10.21203/rs.3.rs-10617300/v1","study_design":null,"title":"Synergistic Nano-Architectures: How Date Seed Phytochemicals and Cellulose Matrices Template Silver Nanoparticles for Multifunctional Therapy","title_match":false,"year":2026},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/structural-optimization-of-coumarin-pyridine-hybrid-derivative-salts-0ffeafec","doi":"10.21203/rs.3.rs-10583076/v1","journal":"Research Square","n_participants":null,"pmid":null,"source_url":"https://doi.org/10.21203/rs.3.rs-10583076/v1","study_design":null,"title":"Structural optimization of coumarin-pyridine hybrid derivative salts as potent acetylcholinesterase inhibitors","title_match":true,"year":2026},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/discovery-of-natural-cholinesterase-inhibitors-via-integrated-3e3bf661","doi":"10.21203/rs.3.rs-10417596/v1","journal":"Research Square","n_participants":null,"pmid":null,"source_url":"https://doi.org/10.21203/rs.3.rs-10417596/v1","study_design":null,"title":"Discovery of Natural Cholinesterase Inhibitors via Integrated Computational Studies using Labdane-Related Diterpenoids-based Pharmacophore Model and in-vitro studies","title_match":true,"year":2026},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/computational-screening-of-fda-approved-drugs-as-potential-bace1-2e030f13","doi":"10.21203/rs.3.rs-10465925/v1","journal":"Research Square","n_participants":null,"pmid":null,"source_url":"https://doi.org/10.21203/rs.3.rs-10465925/v1","study_design":null,"title":"Computational Screening of FDA-Approved Drugs as Potential BACE1 Inhibitors for Alzheimer's Disease Drug Repurposing","title_match":false,"year":2026},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/phenolic-chemotypic-diversity-in-tunisian-hertia-cheirifolia-e54b0b73","doi":"10.21203/rs.3.rs-10140560/v1","journal":"Research Square","n_participants":null,"pmid":null,"source_url":"https://doi.org/10.21203/rs.3.rs-10140560/v1","study_design":null,"title":"Phenolic chemotypic diversity in Tunisian Hertia cheirifolia populations: influence of plant organs and phenological stages on antioxidant and anti-acetylcholinesterase activities","title_match":false,"year":2026},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/treatment-effects-of-cholinesterase-inhibitors-in-alzheimers-disease-f682c193","doi":"10.64898/2026.02.11.26346078","journal":"medRxiv","n_participants":4049,"pmid":null,"source_url":"https://doi.org/10.64898/2026.02.11.26346078","study_design":null,"title":"Treatment Effects of Cholinesterase Inhibitors in Alzheimer\u2019s Disease: a Causal Machine Learning Approach","title_match":true,"year":2026},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/amantadine-donepezil-and-memantine-associated-arrhythmia-in-an-4235e404","doi":"10.21203/rs.3.rs-9807496/v1","journal":"Research Square","n_participants":null,"pmid":null,"source_url":"https://doi.org/10.21203/rs.3.rs-9807496/v1","study_design":null,"title":"Amantadine, Donepezil and Memantine Associated Arrhythmia in an Elderly Patient","title_match":true,"year":2026},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/reducing-placebo-response-in-clinical-trials-of-agitation-in-59dea31b","doi":"10.64898/2026.06.03.26354808","journal":"medRxiv","n_participants":null,"pmid":null,"source_url":"https://doi.org/10.64898/2026.06.03.26354808","study_design":null,"title":"Reducing placebo response in clinical trials of agitation in Alzheimer\u2019s disease","title_match":false,"year":2026},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/neuroprotective-potential-of-acetylcholinesterase-inhibitors-from-eba68491","doi":"10.14293/pr2199.004339.v1","journal":"ScienceOpen Preprints","n_participants":null,"pmid":null,"source_url":"https://doi.org/10.14293/pr2199.004339.v1","study_design":"narrative review","title":"Neuroprotective potential of Acetylcholinesterase Inhibitors from Natural Sources in Combating Neurodegenerative Diseases","title_match":true,"year":2026},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/dt0104-the-efficacy-of-rvt101-a-5ht6-receptor-antagonist-as-an-d54d3985","doi":"10.1016/j.jalz.2015.08.154","journal":"Alzheimer s & Dementia","n_participants":684,"pmid":null,"source_url":"https://doi.org/10.1016/j.jalz.2015.08.154","study_design":"clinical trial","title":"DT\u201001\u201004: The efficacy of RVT\u2010101, a 5\u2010ht6 receptor antagonist, as an adjunct to donepezil in adults with mild\u2010to\u2010moderate Alzheimer's disease: Completer analysis of a phase 2b study","title_match":true,"year":2015},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/memantine-loaded-plga-pegylated-nanoparticles-for-alzheimers-disease-29587747","doi":"10.1186/s12951-018-0356-z","journal":"Journal of Nanobiotechnology","n_participants":null,"pmid":"29587747","source_url":"https://pubmed.ncbi.nlm.nih.gov/29587747/","study_design":null,"title":"Memantine loaded PLGA PEGylated nanoparticles for Alzheimer\u2019s disease: in vitro and in vivo characterization","title_match":true,"year":2018},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/amantadine-and-memantine-are-nmda-receptor-antagonists-with-7884411","doi":null,"journal":"PubMed","n_participants":null,"pmid":"7884411","source_url":"https://pubmed.ncbi.nlm.nih.gov/7884411/","study_design":null,"title":"Amantadine and memantine are NMDA receptor antagonists with neuroprotective properties","title_match":true,"year":1994},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/medicinal-plants-and-alzheimer-s-disease-from-ethnobotany-to-10411211","doi":"10.1211/0022357991772808","journal":"Journal of Pharmacy and Pharmacology","n_participants":null,"pmid":"10411211","source_url":"https://pubmed.ncbi.nlm.nih.gov/10411211/","study_design":null,"title":"Medicinal Plants and Alzheimer's Disease: from Ethnobotany to Phytotherapy","title_match":false,"year":1999},{"alzhub_score":57,"alzhub_url":"https://alzhub.org/study/donepezil-for-dementia-in-parkinson-s-disease-a-randomised-double-15965198","doi":"10.1136/jnnp.2004.050682","journal":"Journal of Neurology Neurosurgery & Psychiatry","n_participants":22,"pmid":"15965198","source_url":"https://pubmed.ncbi.nlm.nih.gov/15965198/","study_design":null,"title":"Donepezil for dementia in Parkinson's disease: a randomised, double blind, placebo controlled, crossover study","title_match":true,"year":2005},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/donepezil-an-update-17472546","doi":"10.1517/14656566.8.7.1011","journal":"Expert Opinion on Pharmacotherapy","n_participants":null,"pmid":"17472546","source_url":"https://pubmed.ncbi.nlm.nih.gov/17472546/","study_design":null,"title":"Donepezil: an update","title_match":true,"year":2007},{"alzhub_score":47,"alzhub_url":"https://alzhub.org/study/memantine-for-agitation-aggression-and-psychosis-in-moderately-severe-18294023","doi":"10.4088/jcp.v69n0302","journal":"The Journal of Clinical Psychiatry","n_participants":null,"pmid":"18294023","source_url":"https://pubmed.ncbi.nlm.nih.gov/18294023/","study_design":null,"title":"Memantine for Agitation/Aggression and Psychosis in Moderately Severe to Severe Alzheimer's Disease","title_match":true,"year":2008},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/research-and-development-of-donepezil-hydrochloride-a-new-type-of-12083745","doi":"10.1254/jjp.89.7","journal":"The Japanese Journal of Pharmacology","n_participants":null,"pmid":"12083745","source_url":"https://pubmed.ncbi.nlm.nih.gov/12083745/","study_design":null,"title":"Research and Development of Donepezil Hydrochloride, a New Type of Acetylcholinesterase Inhibitor","title_match":true,"year":2002},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/efficacy-of-donepezil-on-behavioral-symptoms-in-patients-with-12670060","doi":"10.1017/s104161020200858x","journal":"International Psychogeriatrics","n_participants":144,"pmid":"12670060","source_url":"https://pubmed.ncbi.nlm.nih.gov/12670060/","study_design":null,"title":"Efficacy of Donepezil on Behavioral Symptoms in Patients With Moderate to Severe Alzheimer\u2019s Disease","title_match":true,"year":2002},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/donepezil-for-treatment-of-dementia-with-lewy-bodies-a-case-series-of-9785144","doi":"10.1017/s1041610298005341","journal":"International Psychogeriatrics","n_participants":null,"pmid":"9785144","source_url":"https://pubmed.ncbi.nlm.nih.gov/9785144/","study_design":null,"title":"Donepezil for Treatment of Dementia With Lewy Bodies: A Case Series of Nine Patients","title_match":true,"year":1998},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/randomized-placebocontrolled-trial-of-donepezil-in-cognitive-14716693","doi":"10.1002/gps.993","journal":"International Journal of Geriatric Psychiatry","n_participants":null,"pmid":"14716693","source_url":"https://pubmed.ncbi.nlm.nih.gov/14716693/","study_design":null,"title":"Randomized placebo\u2010controlled trial of donepezil in cognitive impairment in Parkinson's disease","title_match":true,"year":2004},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/behavioral-effects-of-memantine-in-alzheimer-disease-patients-16832078","doi":"10.1212/01.wnl.0000223333.42368.f1","journal":"Neurology","n_participants":null,"pmid":"16832078","source_url":"https://pubmed.ncbi.nlm.nih.gov/16832078/","study_design":null,"title":"Behavioral effects of memantine in Alzheimer disease patients receiving donepezil treatment","title_match":true,"year":2006},{"alzhub_score":53,"alzhub_url":"https://alzhub.org/study/improvement-in-behavioural-symptoms-in-patients-with-moderate-to-18058838","doi":"10.1002/gps.1949","journal":"International Journal of Geriatric Psychiatry","n_participants":2311,"pmid":"18058838","source_url":"https://pubmed.ncbi.nlm.nih.gov/18058838/","study_design":null,"title":"Improvement in behavioural symptoms in patients with moderate to severe Alzheimer's disease by memantine: a pooled data analysis","title_match":true,"year":2007},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/management-of-mild-cognitive-impairment-mci-the-need-for-national-and-32019392","doi":"10.1080/15622975.2019.1696473","journal":"The World Journal of Biological Psychiatry","n_participants":null,"pmid":"32019392","source_url":"https://pubmed.ncbi.nlm.nih.gov/32019392/","study_design":null,"title":"Management of mild cognitive impairment (MCI): The need for national and international guidelines","title_match":false,"year":2020},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/drugs-for-alzheimer-s-disease-are-they-effective-20498822","doi":null,"journal":"PubMed Central","n_participants":null,"pmid":"20498822","source_url":"https://pubmed.ncbi.nlm.nih.gov/20498822/","study_design":null,"title":"Drugs for Alzheimer's disease: are they effective?","title_match":false,"year":2010},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/study-of-the-use-of-antidepressants-for-depression-in-dementia-the-23438937","doi":"10.3310/hta17070","journal":"Health Technology Assessment","n_participants":326,"pmid":"23438937","source_url":"https://pubmed.ncbi.nlm.nih.gov/23438937/","study_design":"randomized controlled trial","title":"Study of the use of antidepressants for depression in dementia: the HTA-SADD trial \u2013 a multicentre, randomised, double-blind, placebo-controlled trial of the clinical effectiveness and cost-effectiveness of sertraline and mirtazapine","title_match":false,"year":2013},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/the-clinical-and-cost-effectiveness-of-donepezil-rivastigmine-16409879","doi":"10.3310/hta10010","journal":"Health Technology Assessment","n_participants":null,"pmid":"16409879","source_url":"https://pubmed.ncbi.nlm.nih.gov/16409879/","study_design":"systematic review","title":"The clinical and cost-effectiveness of donepezil, rivastigmine, galantamine and memantine for Alzheimer's disease","title_match":true,"year":2006},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/donepezil-for-dementia-with-lewy-bodies-a-randomized-placebo-044b4853","doi":"10.1186/s13195-014-0083-0","journal":"Alzheimer's Research & Therapy","n_participants":142,"pmid":null,"source_url":"https://doi.org/10.1186/s13195-014-0083-0","study_design":null,"title":"Donepezil for dementia with Lewy bodies: a randomized, placebo-controlled, confirmatory phase III trial","title_match":true,"year":2015},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/long-term-donepezil-use-for-dementia-with-lewy-bodies-results-from-an-88c17657","doi":"10.1186/s13195-014-0081-2","journal":"Alzheimer's Research & Therapy","n_participants":100,"pmid":null,"source_url":"https://doi.org/10.1186/s13195-014-0081-2","study_design":"clinical trial","title":"Long-term donepezil use for dementia with Lewy bodies: results from an open-label extension of Phase III trial","title_match":true,"year":2015},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/donepezil-decreases-annual-rate-of-hippocampal-atrophy-in-suspected-240dc82b","doi":"10.1016/j.jalz.2014.10.003","journal":"Alzheimer's & Dementia","n_participants":null,"pmid":null,"source_url":"https://doi.org/10.1016/j.jalz.2014.10.003","study_design":null,"title":"Donepezil decreases annual rate of hippocampal atrophy in suspected prodromal Alzheimer's disease","title_match":true,"year":2015},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/increased-myd88-blood-transcript-in-a-mouse-model-of-alzheimer-s-35277123","doi":"10.1186/s12868-022-00699-8","journal":"BMC neuroscience","n_participants":null,"pmid":"35277123","source_url":"https://pubmed.ncbi.nlm.nih.gov/35277123/","study_design":null,"title":"Increased MYD88 blood transcript in a mouse model of Alzheimer's disease","title_match":false,"year":2022},{"alzhub_score":53,"alzhub_url":"https://alzhub.org/study/efficacy-of-lt-i-gt-ginkgo-biloba-lt-i-gt-as-an-adjunct-to-donepezil-40134691","doi":"10.3389/fneur.2025.1563056","journal":"Frontiers in neurology","n_participants":101,"pmid":"40134691","source_url":"https://pubmed.ncbi.nlm.nih.gov/40134691/","study_design":null,"title":"Efficacy of Ginkgo biloba as an adjunct to donepezil in amyloid PET-positive Alzheimer's patients","title_match":true,"year":2025},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/mirnas-and-stem-cells-as-promising-diagnostic-and-therapeutic-targets-37212107","doi":"10.3233/jad-221298","journal":"Journal of Alzheimer's disease : JAD","n_participants":null,"pmid":"37212107","source_url":"https://pubmed.ncbi.nlm.nih.gov/37212107/","study_design":null,"title":"miRNAs and Stem Cells as Promising Diagnostic and Therapeutic Targets for Alzheimer's Disease","title_match":false,"year":2023},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/cholinesterases-new-roles-in-brain-function-and-in-alzheimer-s-disease-12675140","doi":"10.1023/a:1022869222652","journal":"Neurochemical research","n_participants":null,"pmid":"12675140","source_url":"https://pubmed.ncbi.nlm.nih.gov/12675140/","study_design":null,"title":"Cholinesterases: new roles in brain function and in Alzheimer's disease","title_match":false,"year":2003},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/alzheimer-s-disease-a-review-from-the-pathophysiology-to-diagnosis-30191777","doi":"10.2174/0929867323666161213101126","journal":"Current medicinal chemistry","n_participants":null,"pmid":"30191777","source_url":"https://pubmed.ncbi.nlm.nih.gov/30191777/","study_design":null,"title":"Alzheimer's Disease: A Review from the Pathophysiology to Diagnosis, New Perspectives for Pharmacological Treatment","title_match":false,"year":2018},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/effects-of-the-online-computerized-cognitive-training-program-beynex-31887854","doi":"10.3906/sag-1905-244","journal":"Turkish journal of medical sciences","n_participants":60,"pmid":"31887854","source_url":"https://pubmed.ncbi.nlm.nih.gov/31887854/","study_design":null,"title":"Effects of the online computerized cognitive training program BEYNEX on the cognitive tests of individuals with subjective cognitive impairment and Alzheimer\u2019s disease on rivastigmine therapy","title_match":true,"year":2020},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/palladium-platinum-bimetallic-modified-mxene-nanozyme-for-highly-39406077","doi":"10.1016/j.talanta.2024.127020","journal":"Talanta","n_participants":null,"pmid":"39406077","source_url":"https://pubmed.ncbi.nlm.nih.gov/39406077/","study_design":null,"title":"Palladium-platinum bimetallic modified MXene nanozyme for highly sensitive detection of active substances with acetylcholinesterase inhibitory effect","title_match":false,"year":2025},{"alzhub_score":62,"alzhub_url":"https://alzhub.org/study/how-to-advance-the-pharmacological-management-of-cognitive-impairment-39973493","doi":"10.1177/1877718x251315645","journal":"Journal of Parkinson's disease","n_participants":null,"pmid":"39973493","source_url":"https://pubmed.ncbi.nlm.nih.gov/39973493/","study_design":"longitudinal study","title":"How to advance the pharmacological management of cognitive impairment in Parkinson's disease","title_match":false,"year":2026},{"alzhub_score":72,"alzhub_url":"https://alzhub.org/study/effects-of-a-personalised-adapted-computerised-cognitive-stimulation-40326579","doi":"10.23938/assn.1118","journal":"Anales del sistema sanitario de Navarra","n_participants":null,"pmid":"40326579","source_url":"https://pubmed.ncbi.nlm.nih.gov/40326579/","study_design":"randomized controlled trial","title":"[Effects of a personalised, adapted computerised cognitive stimulation programme versus stimulating leisure activities in younger and older adults with mild or subjective cognitive impairment. Protocol for a randomised controlled trial]","title_match":false,"year":2025},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/alzheimer-s-disease-pathogenesis-and-therapeutic-interventions-15177383","doi":"10.1016/j.jocn.2003.12.007","journal":"Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia","n_participants":null,"pmid":"15177383","source_url":"https://pubmed.ncbi.nlm.nih.gov/15177383/","study_design":null,"title":"Alzheimer's disease pathogenesis and therapeutic interventions","title_match":false,"year":2004}]}